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 i 
Abstract 
A poor maternal diet leads to offspring with a greater risk of developing chronic diseases 
later in life.  This thesis considered whether a low protein diet during pregnancy in sheep 
affected the development of the fetal kidney, and how this impacted upon adult renal 
function when challenged by obesity.  Pregnant ewes were fed either a control diet or a 
diet that was isocaloric but contained only 50% of the protein, in either early or late 
gestation.  The effects of the diet were assessed on the ewe, day 65 fetuses (0.44 
gestation), and two year old offspring which had been subjected to an obesogenic 
environment (ab libitum feed and reduced exercise).  Few effects were observed on the 
ewe, confirming that the nutritional insult was relatively mild.  Fetal renal vasculature 
(assessed by vascular corrosion casts) was not different between groups, although the 
microvasculature was significantly reduced in the early protein group, as evidenced by 
CD34+ staining of endothelial cells.  This was accompanied by a reduction in angiogenic 
factors compared to control animals.  Protein-energy malnutrition in the ewe led to 
reduced urea in maternal and fetal plasma, along with a concomitant reduction in ornithine 
in the fetal plasma and amniotic fluid.  Other amino acids were relatively unaffected.  In the 
adult sheep there were no effects on long-term renal function in the group fed low protein 
late in pregnancy, despite the lambs having lower birth weights and a period of postnatal 
catch up growth compared to the other groups.  However, the group fed low protein during 
early pregnancy had reduced nephron number, microalbumuria and reduced renal function 
as assessed by gamma scintigraphy.  There was also evidence of microvascular rarefaction 
which may have been exacerbated by obesity.  This study did not reveal any consistent sex-
specific effects of the maternal low protein diet.  This study emphasises the importance of 
diet quality rather than quantity, and the importance of consuming a well-balanced diet 
during pregnancy to protect against future chronic diseases. 
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 1 
1. Introduction 
1.1 Health and Disease 
Increasing life expectancy coupled with an increase in the mortality and co-morbidities 
associated with rising levels of obesity is leading to an additional economic burden.  In the 
UK, total expenditure on health as a percentage of Gross Domestic Product has risen from 
6.9 % in 1999 to 9.4 % in 2009 (World Health Organisation, 2012).  Additionally, 
government expenditure per capita on health rose from $1763 to $3285 during this decade, 
an increase of over 86% (World Health Organisation, 2012). 
In England and Wales in 2010 circulatory disease was the most common cause of death, 
accounting for 32% of all deaths (Office for National Statistics, 2008).  In addition a further 
2.2% of deaths had the primary cause listed as obesity, diabetes mellitus or renal disease, 
although these diseases often co-exist with each other and with other non-communicable 
 ‘ůŝĨĞƐƚǇůĞ ?ĚŝƐĞĂƐĞƐ ?ƐƵĐŚĂƐĐĂƌĚŝŽǀĂƐĐƵůĂƌĚŝƐĞĂƐ ?s ) ?/ŶƵƌŽƉĞƚŚĞŵŽƌƚĂůŝƚǇƌĂƚĞƐĨƌŽŵ
circulatory disease are higher, with 48% of deaths due to CVD (British Heart Foundation, 
2008).   
However, the large impact of non-communicable disease on society is not limited to 
mortality alone, as the morbidity associated with these diseases is also of huge importance.  
The Disability Adjusted Life Year (DALY) is a measure of disease burden that combines the 
time lost due to disability along with the reduced life expectancy due to a disease, and one 
DALY is considered to be one lost year of healthy life (Murray et al., 2002).  In 2004 in the 
UK the DALY was estimated at a total of 1.25 million, or 2,083 per 100,000 population 
(World Health Organisation, 2006).  As more people become obese and suffer the 
associated co-morbidities this burden is likely to increase.  
 2 
Globally the leading risks for mortality are hypertension, smoking, high blood glucose, 
physical inactivity, and overweight/obesity, all of which increase the risk of chronic lifestyle 
diseases such as CVD, type II diabetes and chronic kidney disease (World Health 
Organisation, 2009).  These risks affect countries across all income groups, and are not 
limited to the wealthiest countries. 
1.2 Kidney Disease 
The vast majority of kidney disease falls under the umbrella term of chronic kidney disease 
(CKD), which is a gradual loss of kidney function over time.  The two main causes of CKD are 
hypertension (Bakris and Ritz, 2009) and diabetes (Crook, 2002), both of which lead to 
nephron damage and a decline in the ability of the kidney to function.  The incidence of 
CKD also increases greatly with age (Winearls and Glassock, 2009) and obesity (Cignarelli 
and Lamacchia, 2007), so ageing populations coupled with increased prevalence of obesity 
mean it has become a major public health issue.  Estimates of the prevalence of stage 3-5 
CKD in the general population have ranged from 4.7 % in the USA (Coresh et al., 2003), 
8.5% in the UK (Stevens et al., 2007) and Mexico (Amato et al., 2005), to 11.2% in Australia 
(Chadban et al., 2003).  Stage 5 CKD (end-stage renal disease), is increasing at 5  W 8 % per 
annum and the global cost of providing dialysis has been estimated at $70 - $75 billion US 
dollars annually (Lysaght, 2002). 
Severity of CKD is assessed according to the criteria shown in Table 1.1 and graded from 
stage 1 (mild) to stage 5 (end-stage renal disease, ESRD).  Early stage CKD is usually 
asymptomatic and often identified during routine medical examinations.  The mammalian 
kidney has such a huge functional reserve that uraemia  W toxic build up of waste products 
in the blood - only becomes evident at CKD stages 3-5, i.e. when there has been a loss of 
50-70% glomeruli with glomerular filtration rate (GFR) declining to <30 ml.min-1 (Reilly and 
Perazella, 2002).  However, identification at an early stage is useful because CKD increases 
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risk of CVD, there is the potential to try to slow the progression of the damage, and certain 
medications are contraindicated for those with renal disease (O'Callaghan, 2009).  
Table 1.1: US National Kidney Foundation NDOQI Stages of CKD 
Stage Description GFR (ml.min
-1
.1.73 m-
2
) 
1 Kidney damage with normal or raised GFR >90 
2 Kidney damage with mildly reduced GFR 60 W89 
3 Moderately reduced GFR 30 W59 
4 Severe reduction in GFR 15 W29 
5 Kidney failure <15 
NDOQI  W National Disease Outcomes Quality Initiative; CKD  W Chronic Kidney Disease; GFR  W glomerular 
filtration rate. Source: National Kidney Foundation (National Kidney Foundation, 2002) 
 
The most common cause of renal failure is diabetic nephropathy and this accounts for 
around 22% of renal failure in the UK (The Renal Association, 2008).  The UK Prospective 
Diabetes Study observed that a quarter of patients with type II diabetes developed 
microalbuminuria within ten years of diagnosis (Adler et al., 2003). Progression to 
macroalbuminuria was estimated at 2.8% per year, and to elevated plasma creatinine or 
renal replacement therapy at 2.3% per year, with those in the latter groups having an 
annual death rate of 19.2% (Adler et al., 2003). 
Dialysis is the only viable alternative to transplantation for those with ESRD and the 
economic costs of providing such treatment are immense.  In Europe around 2% of 
healthcare budgets are already taken up by dialysis costs (El Nahas and Bello, 2005), and 
this is likely to increase substantially if the trend of ESRD increasing at 5  W 8% per year 
continues (Lysaght, 2002). 
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The rising incidence of obesity, type II diabetes and associated co-morbidities including 
hypertension and kidney disease is not limited to westernised countries.  It is thought that 
emerging countries such as India and China are likely to be the most detrimentally affected, 
as people from Asia tend to be particularly vulnerable to type II diabetes and suffer for a 
longer time from its complications (Yoon et al., 2006).  Incidence of CKD increases greatly 
with age, so ageing populations coupled with an increase in type II diabetes are likely to 
lead to much higher levels of CKD (Stevens et al., 2007). 
The International Diabetes Federation estimates that 285 million people worldwide had 
diabetes in 2010 and this is likely to be 438 million by 2030 (International Diabetes 
Federation, 2009).  A similar pattern is envisaged in the UK, with 2.6 million people 
diagnosed in 2009, rising to an estimated four million by 2025 (Diabetes UK, 2009).  The 
increasing incidence of obesity is contributing to the epidemic of type II diabetes.  Around 
two-thirds of adults in the UK are overweight or obese, with estimated figures for 2010 of 
67.8% of males and 63.8% of women having a Body Mass Index(BMI) > 25.0 (World Health 
Organisation Global InfoBase, 2010).  
Taken together it is clear that the burden of chronic non-communicable disease is 
increasing globally, and it is imperative therefore to understand the aetiology/pathology 
and progression of disease so that interventions can be made early to prevent the onset of 
morbidity and ultimately mortality.  However, the diseases described above are often 
multi-factorial (such as hypertension) and their cause can be lifestyle-related, genetic or a 
combination of both.  In recent years the risk of succumbing to such diseases has even been 
shown to be influenced by prenatal growth and development. 
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1.3 Health and Diet 
The link between diet and health has long been recognised.  Back in the mid-1700s James 
Lind was the first to suggest that a disease (scurvy) could be cured by citrus fruits (Sutton, 
2003), although the concept of vitamins was not yet known.  Up until the 1950s most 
government public health initiatives were concerned with preventing deficiencies of 
nutrients or a lack of energy intake, however this changed during this decade with the 
recognition that over-nutrition could lead to chronic diseases (Duguid, 1954; Page et al., 
1957).  In recent decades dietary excess and its associated health problems have replaced 
concerns about dietary deficiency as the major food-related public health issue facing 
Westernised countries (Hill and Peters, 1998; Nestle, 1999).   
However, obesity, hypertension and CKD are conditions virtually absent in hunter-gatherer 
communities whose diet is largely natural and unrefined (Eaton and Eaton, 2000), unlike 
the diet commonly consumed in Westernised societies (Cordain et al., 2005).  During the 
Palaeolithic era (2.6 million  W ~10,000 years ago) humankind evolved from early humans 
into the modern Homo sapiens, and therefore evolved to be suited to the diet available 
during that time (Cordain et al., 2005).  A paleolithic diet was high in plant materials, such 
as fruit, vegetables, seeds and nuts, and also high in lean protein and/or fish (Cordain et al., 
2005; Jew et al., 2009).   
It was not until the advent of the agricultural revolution during the Neolithic period that 
carbohydrates became the staple foods for most societies (Jew et al., 2009), yet the human 
genome has remained largely unchanged during this period despite our diet changing 
greatly, particularly during the last century (O'Keefe and Cordain, 2004).  In the UK in 
2008/9 the percentage of energy intake from fat was 35%, from protein 18%, and from 
carbohydrates 47% (Food Standards Agency, 2009), whereas in the Paleolithic period these 
percentages were estimated to be fat 22%, protein 37%, and carbohydrates 41% (Eaton and 
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Konner, 1997).  Other differences between the paleolithic and western diets include 
changes in glycaemic load, sodium-potassium ratio, and fibre content (Cordain et al., 2005).   
Studies have shown that even very short-term paleolithic-style diets improve glucose 
tolerance (Lindeberg et al., 2007), blood pressure and lipid profiles (Frassetto et al., 2009).  
Therefore dietary change (from a western toward a palaeolithic diet) is a potentially 
important preventative factor that could help mitigate the rise in non-communicable 
disease (Narayan et al., 2010; Daar et al., 2007).  However, criticisms of the paleolithic-style 
diets are that they are difficult to follow, in particular to source meat of a similar fat:lean 
composition of the wild meat available in the Paleolithic era, and that the lack of non-
communicable disease in hunter-gatherer communities today is confounded by other 
factors such as their increased activity levels, and lower life expectancy (Nestle, 1999; 
Milton, 2000). 
Indeed considering the effect of any type of diet on disease risk is likely to be confounded 
by a variety of factors, partly because dietary changes tend to involve a range of changes 
rather than just one in isolation.  For example following a low fat diet may involve changes 
in the types of fat ingested as well as the overall amounts, and also an increase perhaps in 
other food groups as the individual replaces high fat products with other foodstuffs.  
Furthermore, people following certain types of diets are also likely to have other 
differences in lifestyle.  For example vegetarians have been shown to have reduced risk of 
several chronic diseases, but most markedly ischaemic heart disease (Key et al., 1996), yet 
these results are often confounded by other factors: vegetarians tend to drink less alcohol, 
smoke fewer cigarettes and take more exercise than non-vegetarians (Appleby et al., 2002).  
Hence, animal studies, where dietary effects can be studied in isolation from other lifestyle 
or environment factors, have informed much of the research about disease risk and diet. 
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1.3.1 Monogastic vs Ruminant Digestion  
The major difference between monogastic animals and ruminants is that the latter have a 
four-chambered stomach, which is divided into four parts, called the rumen, reticulum, 
omasum and abomasum.  A symbiotic relationship with microorganisms in the rumen 
enables the ruminant to digest cell plant wall material that is indigestible to monogastrics 
(Fuller, 2004).  
In both monogastic animals and ruminants, food is eaten and then subjected to mechanical 
disruption by the teeth and to chemical degradation by salivary enzymes in the mouth 
which begin to break down starch (Gibney et al., 2003; Hill et al., 2008).  In a monogastric 
species the bolus continues down the oesophagus into the stomach for further digestion by 
gastric juices that contain pepsin which starts protein digestion (Geissler and Powers, 
2011).  However, in the ruminant the bolus moves down the oesophagus into the first 
chamber of the stomach: the rumen (McDonald et al., 2011).  The solids remaining are 
regurgitated and subjected to further maceration and chemical breakdown to reduce 
particle size (Fuller, 2004).  In the rumen and reticulum bacteria, protozoa and fungi digest 
ƚŚĞĨŝďƌŽƵƐƉůĂŶƚŵĂƚĞƌŝĂůƐƵĐŚĂƐĐĞůůƵůŽƐĞďǇƵƐŝŶŐĞŶǌǇŵĞƐƚŚĂƚďƌĞĂŬƚŚĞɴ-glycosidic 
bonds (Kay, 1998).   This result in the production of simple sugars, methane, carbon dioxide, 
and volatile free fatty acids: the latter is the main source of energy for a ruminant (Kay, 
1998).  Once the particle size is small enough, the digesta passes through into the omasum, 
where most of the water is removed, and next into the abomasum for further digestion 
(Fuller, 2004).  The abomasum is broadly equivalent to the stomach of a monogastric 
animal, and further digestion occurs before the digesta (or chyme) moves into the 
intestines for nutrient absorption (McDonald et al., 2011).  In both monogastrics and 
ruminants once the chyme is in the small intestines bile and enzymes from the pancreas 
and intestines further digest the fats and proteins, and villi aid the absorption of nutrients 
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(Gibney et al., 2003; Hill et al., 2008).  Peristalsis transports the remaining liquid to the large 
intestine, where fermentation of the gut bacteria breaks down any further nutrients which 
are absorbed, before waste is excreted as faeces (Geissler and Powers, 2011; McDonald et 
al., 2011). 
 
1.4 Mammalian kidney development 
1.4.1 Early embryonic development 
Development involves five main processes: cell division, growth, differentiation, pattern 
formation and morphogenesis. These processes are not linear, but overlap with each other 
(Twyman, 2001).  In brief, the early stages of development are as follows (Wolpert et al., 
2001; Twyman, 2001): 
1. The egg is fertilised by the sperm and the male and female nuclei fuse together to 
form a diploid zygote. 
2. Mitotic cell divisions occur without significant growth and therefore become 
progressively smaller each time. This is called cleavage. 
3. After around a dozen cleavages the cells are arranged into a ball shape around a 
fluid-filled cavity, known as a blastula. 
4. The next stage is gastrulation, during which the cells migrate and become organised 
into three germ layers called the ectoderm, mesoderm and endoderm.  
These layers produce a specific range of differentiated cell types (Figure 1.1). 
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Figure 1.1: Early stages of development of the embryo 
 
1.4.2 Nephrogenesis 
The formation of the kidney has been studied to a great extent in several animal models, 
where the early stages of development can be carried out in vitro or mice can be genetically 
manipulated so that both the cellular and molecular basis of organogenesis can be 
investigated (Costantini and Kopan, 2010).  There are three stages of mammalian kidney 
development  W pronephros, mesonephros and metanephros  W but only the latter develops 
into the mature adult kidney (Kuure et al., 2000). The nephron epithelial cells and collecting 
duct system originates from the intermediate mesoderm and the pronephric duct and 
pronephric tubules are thought to form as separate structures (Vize et al., 1997).  The 
pronephros develops very early in gestation (20 d in humans; gestation = 268 d) and in 
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mammals is a non-functional kidney (Polin et al., 2004), but most of the pronephric duct 
regresses apart from the caudal region which becomes the Wolffian (or nephric) duct 
(Kuure et al., 2000).  
The second of the transitional kidneys - the mesonephros - originates in the aorta-gonad-
mesonephros (AGM) zone of the mesoderm, and its development is activated when the 
pronephric duct induces mesenchymal cells to condense (Kuure et al., 2000).  In most, but 
not all, mammals the mesonephros is functional and acts as a transient filtration unit until 
the metanephros develops and takes over (Dressler, 2006).  However, in other species such 
as fish and amphibians the mesonephros becomes the functional adult kidney (Polin et al., 
2004).  
The metanephros arises when the nephric duct develops an outgrowth called the ureteric 
bud at its caudal end, and this bud interacts with the metanephric  mesenchyme (Dressler, 
2006).  The metanephric mesenchyme contains the progenitor cells for the nephrons but 
also signals to the nephric duct at the caudal end to form a ureteric bud (Costantini and 
Kopan, 2010).  Figure 1.2 shows the process of nephron development.  First the ureteric 
bud narrows at the tip and forms an ampulla, and the metanephric mesenchyme cluster 
around this and condense (Moritz and Wintour, 1999; Vainio and Lin, 2002).  This 
condensation induces the ureteric bud to rise cranially and to branch (Wintour, 1997).   
Mouse cell culture models of the developing metanephric kidney have demonstrated that 
the branching of the ureteric bud continues for around 10  W 15 generations (Srinivas et al., 
1999; Costantini, 2006).  The cells proliferate in both the tip and the truck of the ureteric 
bud, however at different rates according to the phase of development, i.e whether it is 
during branching or collecting duct elongation (Michael and Davies, 2004).  At each branch 
tip one side causes the mesenchyme to condense and the other branch continues onward 
to branch again (Wintour, 1997).  The ureteric bud simultaneously induces the metanephric 
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mesenchyme to convert to epithelial cells, whilst other mesenchymal cells convert to 
interstitial stroma (Dressler, 2006).  The epithelial cells form into a tube called the 
nephrogenic vesicle (Moritz and Wintour, 1999) which is still attached to the ureteric bud at 
one end (Dressler, 2006).  One cleft develops in the vesicle which becomes the comma-
shaped body, then a second cleft develops to produce the S-shaped body (Dressler, 2006).  
Endothelial cells migrate into the s-shaped body which develops into the glomerulus and 
proximal and distal tubules, and the ureteric bud develops into the collecting duct system 
(Vainio and Lin, 2002).  The base of the S-shaped body is invaded by capillaries that form 
the glomerulus, whilst the top fuses to the top of the ureteric bud and eventually becomes 
the collecting duct (Wintour and Moritz, 1997).  dŚĞƚŽƉŚĂůĨŽĨƚŚĞ ‘^ ?ĞůŽŶŐĂƚĞƐƚŽďĞĐŽŵĞ
the proximal and distal tubules (Wintour, 1997) ?dŚĞůŽǁĞƌƉĂƌƚŽĨƚŚĞ ‘^ ?ĨŽƌŵƐƚŚĞƌĞŶĂů
corpuscle, i.e. the glomerulus ĂŶĚŽǁŵĂŶ ?ƐĐĂƉƐƵůĞ(Clark and Bertram, 1999).  Initially 
ƚŚŝƐŶĂƐĐĞŶƚŐůŽŵĞƌƵůƵƐĐŽŶƚĂŝŶƐƉƌŝŵŝƚŝǀĞƉŽĚŽĐǇƚĞƐ ?ĂŽǁŵĂŶ ?ƐĐĂƉƐƵůĞĂŶĚĂĐĂƉŝůůĂƌǇ
loop (Quaggin and Kreidberg, 2008).   
Basal laminae from the podocytes and the proliferating endothelial cells of the capillary 
fuse together to form the glomerular basement membrane (Dressler, 2006).  Podocytes 
wrap around the capillary loops and extend projections, called foot processes, which 
interlink with other foot processes and form the slit diaphragm (Quaggin and Kreidberg, 
2008).  The renal corpuscle continues to develop, for example, by the differentiation of cells 
into podocytes, whilst simultaneously the tubule also differentiates into its different 
regions (Clark and Bertram, 1999). 
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Figure 1.2: Nephron development.   
Induction of the ureteric bud (A) is accompanied by a mesenchymal induction and condensation, branching of 
the ureteric bud and formation of a comma-shaped body (B). A second cleft develops and the s-shaped body (C) 
is formed.  This fuses with the ureteric bud and a continuous tubule is formed (D), which develops into a fully 
functioning nephron (E). Adapted from Clark and Bertram, 1999 
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The ureteric bud continues to branch and generate new nephrons.  This nephrogenic zone 
is around the edge of the cortex (Figure 1.3).  As newer nephrons develop, the more 
mature ones move towards the medulla and therefore the first glomeruli to develop are 
found deepest in the cortex and the last to develop are around the edge (Dressler, 2006; 
Wintour, 1997).   The final part of the kidney to develop is the outer medulla which 
contains the loops of Henle from the nephrons close to the cortex-medulla border 
(Wintour, 1997).  
 
Figure 1.3: Fetal sheep kidney at day 65 gestation 
Nephrogenic zone where new nephrons form (N) indicated by arrows; M, metanephric mesenchyme; 
ĚĞǀĞůŽƉŝŶŐĐĂůǇĐĞƐ ? )ĂŶĚƌĞŶĂůƉĞůǀŝƐ ?ZW ) ?ƵƚŚŽƌ ?ƐŝůůƵƐƚƌĂƚŝŽŶ ? 
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1.4.3 Vascular development 
ŶŐŝŽďůĂƐƚƐŵŝŐƌĂƚĞƚŽƚŚĞůĂƚĞƌĂůŵĞƐŽĚĞƌŵƚŽĨŽƌŵ ‘ďůŽŽĚŝƐůĂŶĚƐ ?ŝŶƚŚĞǇŽůŬƐĂĐ(Flamme 
et al., 1997).  Each blood island separates into a core of hemangioblasts (which will become 
the first blood cells) surrounded by endothelial cells (Polverini, 1995).  These endothelial 
cells develop into the blood vessel endothelium, and some of the cells start to differentiate 
into angioblasts (Larsen, 1998).  During vasculogenesis,  angioblasts are assembled into the 
main vessels, and then angiogenesis extends these vessels with further branching 
eventually to form an extensive network of arterioles, venules and capillaries (Wolpert et 
al., 2001).  The primitive venous system is made up of the cardinal system (which drains the 
head, neck, body wall and limbs), the vitelline veins (which drain the gut), and the umbilical 
veins which carry oxygenated blood from the placenta to the embryo (Larsen, 1998). 
The arterial system in the embryo develops as folding takes the endocardial tubes into the 
thorax, and they connect to the dorsal aortae to form the first aortic arches (Larsen 1998).  
These five pairs of arches form the major vessels of the head, neck and thorax, the dorsal 
pair fuse to form a single aorta which sprouts three branches through angiogenesis 
(Wolpert et al, 2001).  These three branches become: 
x Ventral vitelline arteries, which supply the gut, 
x Dorsolateral insegmental arteries which supply the head, neck, spinal column and 
limbs, and 
x Lateral arteries, which supply the retroperitoneal organs, including the kidney 
(Larsen, 1998). 
Glomerular capillary development starts when a capillary loop invades the cleft between 
the S-shaped body and the nascent podocytes (Quaggin and Kreidberg, 2008).  The loop 
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divides into six to eight loops and the endothelial cells become fenestrated to allow 
filtration of the blood (Potter, 1965). 
1.4.4 Molecular control of development 
The molecular control of kidney development is complex and involves over 200 genes 
(Costantini, 2006; Dressler, 2009).  Some of the main candidates are summarised in Table 
1.2 below. 
Table 1.2: Molecular control of kidney development 
Molecular event Genes involved 
Ureteric bud branching GDNF, Ret, angiotensin II 
Mesenchymal condensation WT-1, Pax 2, bFGF 
Mesenchymal-to-epithelial conversion Wnt-4, laminins, FGF8 
Angiogenesis s'& ?ŶŐŝŽƉŽŝĞƚŝŶƐ ?dŝĞ ? ?ď&'& ?d'&ɴ 
Glomerular development VEGFA, PDGF, Notch 1&2, cadherins 
FGF, fibroblast growth factor; GDNF, glial cell-derived neurotrophic factor; Pax 2, paired box 2; PDGF, platelet 
derived growth factor; TGFɴ ?ƚƌĂŶƐĨŽƌŵŝŶŐŐƌŽǁƚŚĨĂĐƚŽƌɴ ?s'& ?ǀĂƐĐƵůĂƌĞŶĚŽƚŚĞůŝĂůŐƌŽǁƚŚĨĂĐƚŽƌ ?td-1, 
WIlms tumour 1; WNT-4, wingless-type MMTV integration site family member 4  (Clark and Bertram, 1999; 
Quaggin and Kreidberg, 2008; Woolf et al., 2009; Faa et al., 2012)  
Glial  cell derived neurotrophic factor (GDNF) is a growth factor secreted by the 
metanephric mesenchyme in response to Pax 2 (Brophy et al., 2001).  GDNF signals through 
Ret, a tyrosine kinase receptor (Shakya et al., 2005).  Knockout mice for either gene usually 
fail to develop kidneys in the embryo as the ureteric bed fails to emerge from the nephric 
duct (Schuchardt et al., 1996; Sanchez et al., 1996), therefore indicating their importance at 
the very early stages of metanephric development as the ureteric bud begins to emerge 
and branch.  This finding is backed up by in vitro studies, where explanted mouse embryo 
urogenital regions can be induced to form ureteric buds in the presence of GDNF (Vega et 
al., 1996; Michael and Davies, 2004).   However in knockout mice lacking GDNF and Ret a 
small proportion of mice still form ureteric buds (Schuchardt et al., 1996) thus there must 
be some functional redundancy with other genes. 
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Some of this functional redundancy may be explained by the role of the fibroblast growth 
factor (FGF) family, members of which bind to related receptors and activate many of the 
same signalling pathways (Eswarakumar et al., 2005; Michos et al., 2010).  FGF1  W 10 are all 
expressed in the developing kidney, although knockout mice for most of the FGFs do not 
have noticeable kidney defects, suggesting that there is overlap in function for many of 
these genes (Qiao et al., 2001).  The exceptions are FGF7-/- mice which develop smaller 
kidneys with fewer nephrons (Qiao et al., 1999), and FGF10-/- mice which have smaller 
kidneys with dysplasia of the outer medulla (Ohuchi et al., 2000).  However, although 
knockout models do not exhibit major defects, this does not mean that the FGFs do not 
have an important role in kidney development, rather that in their total absence, other 
genes are able to compensate to some extent.  In fact many other studies have shown 
important roles for the FGF family; for example, FGF8 is needed for the survival of nephron 
progenitor cells and formation of the S-shaped bodies (Grieshammer et al., 2005), and FGF2 
aids survival of metanephric mesenchymal cells (Perantoni et al., 1995). 
Also interacting with FGF is bone morphogenic protein 7 (BMP7), which is expressed in the 
ureteric bud and in nascent nephrons (Godin et al., 1999).  In explants of metanephric 
mesenchyme BMP7 has been demonstrated to promote survival by preventing apoptosis 
(Dudley et al., 1999).  Also, knockout mice lacking BMP7 die shortly after birth due to 
kidney defects, which are caused a lack of differentiation of the metanephric mesenchymal 
cells (Luo et al., 1995); thus BMP7 has more than one role at this stage of development. 
Paired box 2 (Pax2) and wingless-type MMTV integration site family member 4 (Wnt4) are 
also involved in the metanephric mesenchyme differentiation.  Pax2 induces the 
metanephric mesenchyme to differentiate towards a nephron lineage (Tamimi et al., 2008), 
although mutant mice lacking both Pax2 and Pax8 genes are unable to form even the 
pronephros (Bouchard et al., 2002).  Wnt4 induces the cap mesenchymal cells to undergo a 
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mesenchymal-epithelial transformation into the renal vesicle (Kispert et al., 1998), a finding 
confirmed by another study (McMahon et al., 2008) where Wnt4-/- mutants failed to form 
renal vesicles during embryonic development. 
Wilms Tumor 1 (WT1) gene encodes a transcription factor with wide-ranging effects on the 
expression of genes involved in kidney development (Faa et al., 2012).  It may also be 
involved in post-transcriptional regulation (Scharnhorst et al., 2001).  It is expressed in the 
metanephric mesenchyme where it increases as the mesenchyme condensates around the 
tip of the ureteric bud (Armstrong et al., 1993).   Later in development the expression 
decreases, and in mature animals WT1 is only expressed in podocytes (Gao et al., 2005).  
WT1-/- mice are embryonically lethal due to a failure of the ureteric bud to emerge from the 
nephric duct (Kreidberg et al., 1993).  However, WT1 is needed at several times during 
development, as demonstrated by one study (Davies et al., 2004) which used an siRNA-
based method to switch off the WT1 at different stages of development in mouse kidney 
explants.  The results showed that although early in development a lack of WT1 leads to a 
lack of growth of the ureteric bud, where WT1 was ablated later in gestation the ureteric 
bud remained intact but there was abnormal cell proliferation and nephron development 
was seriously impaired. 
WT1 also regulates the expression of vascular endothelial growth factor (VEGF) in the 
mesenchyme (Gao et al., 2005).  VEGF has multiple roles during renal development.  In 
metanephric kidney culture it has been shown that VEGFA stimulates cell proliferation and 
branching morphogenesis as well as nephrogenesis (Tufro et al., 1999; Tufro, 2000).  VEGFA 
is also expressed in early podocytes in the S-shaped bodies (Kretzler et al., 1998) and its 
major receptors VEGF receptors 1 and 2 (VEGFR1 and VEGFR2) are expressed in the 
adjacent endothelial cells (Robert et al., 1998).  Signalling between VEGFA and endothelial 
cells is crucial for mesangial cell migration and survival (Eremina et al., 2006) and for the 
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induction of the development of the fenestrae in the endothelial cells of the glomerular 
capillaries (Eremina et al., 2003). 
Given the wide variety of roles that VEGF has it is no surprise that absence of VEGF has 
detrimental effects.  Homozygous knockout mice for either VEGFA or its receptors VEGFR1 
or VEGFR2 suffer from renal agenesis and die before birth (Fong et al., 1995; Shalaby et al., 
1995; Eremina et al., 2003).  Heterozygous knockouts die early from renal disease due to 
abnormal vasculature (Eremina et al., 2003), and where VEGFA is ablated just in one cell 
population (podocytes) the mice do not produce mesangial cells and die early (Eremina et 
al., 2006). 
Playing a complementary role to VEGFA and its receptors are the angiopoietins.  During 
development angiopoietin 1 (Ang1) is thought to stabilise blood vessels by making them 
leak-resistant, whereas angiopoietin 2 (Ang2) is an antagonist to Ang1 and has the opposite 
effect (Maisonpierre et al., 1997).  Ang1 is expressed from the start of metanephric 
development in the mesenchyme, and developing tubules and podocytes, alongside its 
receptor Tie2 which is found in the interstitial and glomerular capillaries (Yuan et al., 1999; 
Kolatsi-Joannou et al., 2001; Satchell et al., 2002).  Ang1-/- mutant mice are embryonically 
lethal due to the failure of normal vascular remodelling during development (Suri et al., 
1996).  Close cooperation between VEGFA and Ang1 is needed to maintain the integrity of 
the glomerular endothelial cell barrier (Satchell et al., 2004). 
Also crucial for the development of the renal vasculature is platelet derived growth factor 
(PDGF).  PDGF is essential during the development of the glomerular capillary loops.  PDGF-
/- mutant mice are embryonically lethal and form only a single capillary loop (Leveen et al., 
1994), whilst mice with a PDGF ablation in endothelial cells only live into adulthood but 
have glomerular abnormalities such as dilated capillary loops and fewer mesangial cells 
(Bjarnegard et al., 2004). 
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1.5 Kidney physiology 
Mammals have two kidneys and in most mammals including humans and sheep these are 
bean-shaped organs located retroperitoneally.  The kidney is divided into two distinct 
regions, with an outer cortex and an inner medulla. The cortex is surrounded by the renal 
capsule.  
The kidney functions as a regulatory and endocrine organ as well as an excretory organ.  It 
excretes waste products from the body which are end-products of metabolism, such as 
urea and creatinine, along with metabolites of hormones, and foreign substances such as 
drugs.  The kidney has a vital role in the function of the cardiovascular system by regulating 
the volume of body fluid and blood pressure, and also in controlling the osmolality of body 
fluids to maintain normal cell volume (Koeppen and Stanton, 2007).  Additionally the kidney 
regulates electrolyte balance by adjusting the level of excretion of electrolytes such as 
potassium, sodium and chloride to take account of the amount ingested, and also has a role 
in maintaining the correct acid-base balance for normal metabolic functions (Bray et al., 
1999).  In its role as an endocrine organ the kidney produces and secretes erythropoietin, 
renin and 1,25-dihydroxyvitamin D3 (Koeppen and Stanton, 2007).  
The functional unit of the kidney is the nephron, and each kidney in a human can contain 
over a million nephrons (Keller et al., 2003).  The number of nephrons is generally related 
to the size of the animal (Kunkel, 1930).  Figure 1.2E shows a diagram of a nephron, and 
Figure 1.4 a renal corpuscle.  Blood enters the nephron through the afferent arteriole and 
into the glomerulus where the pressure is relatively high, and this drives water, amino 
acids, glucose and other small molecules such as sodium, chloride and potassium through 
the basement memďƌĂŶĞŝŶƚŽƚŚĞŽǁŵĂŶ ?ƐĐĂƉƐƵůĞ(O'Callaghan, 2009).   
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Figure 1.4: Diagram of a renal corpuscle 
A  W renal corpuscle; B  W proximal tubule, C  W distal convoluted tubule, D  W juxtoglomerular apparatus; 1  W 
basement membrane; 2  W ŽǁŵĂŶ ?ƐĐĂƉƐƵůĞ ?ƉĂƌŝƌĞƚĂůůĂǇĞƌ ? ?Ă W podocyte foot processes; 3b  W podocytes; 4  W 
ŽǁŵĂŶ ?ƐƐƉĂĐĞ ? ?Ă W mesangium, intraglomerular cell; 5b  W mesangium, extraglomerular cell; 6 - 
juxtaglomerular cells; 7  W macula densa; 8  W myocytes; 9  W afferent arteriole; 10  W glomerular capillaries; 11  W 
efferent arteriole.  Copyright-free image from Wiki Commons. 
 
Larger cells such as red blood cells and most proteins are too large to pass through and 
continue through the glomerulus and out into the efferent arteriole (O'Callaghan, 2009).  
The filtrate ƚŚĂƚƉĂƐƐĞĚƚŚƌŽƵŐŚŝŶƚŽƚŚĞŽǁŵĂŶ ?ƐĐĂƉƐƵůĞĞŶƚĞƌƐƚŚĞƉƌŽǆŝŵĂůĐŽŶǀŽůƵƚĞĚ
tubule where most of the water is reabsorbed, along with glucose, amino acids, and 
electrolytes such as sodium, chloride, potassium and phosphate through the epithelial cells 
and into the interstitial tissues, before being transported back into the blood in the 
surrounding vessels (Bray et al., 1999).  The filtrate passes into the Loop of Henle, where 
more water and electrolytes are reabsorbed, and then into the distal convoluted tubule 
where sodium and chloride are actively transported through the epithelial cells before the 
filtrate is delivered to the collecting duct (Bray et al., 1999).  The concentrated urine enters 
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the papilla, then through the calyces before reaching the renal pelvis and finally the ureter 
(Solomon et al., 2004).  The amount of water reabsorbed through the collecting ducts is 
largely dependent on vasopressin (or anti-diuretic hormone, ADH) which is released by the 
posterior pituitary gland in response to high blood osmolarity, and makes the collecting 
duct permeable to water so it can be reabsorbed and retained in the body (Koeppen and 
Stanton, 2007).  
1.6 Developmental Origins of Health and Disease 
The Developmental Origins of Health and Disease (DOHaD) hypothesis proposes that events 
that occur in utero programme susceptibility to chronic adult diseases, such as type II 
diabetes (Hales and Barker, 1992) and coronary heart disease (Barker, 1995).  Early in the 
development of the fetal origins hypothesis it was suggested that limiting nutrient supply to 
the fetus was an important programming factor (Barker, 1992).  dŚĞƚĞƌŵ “ĨĞƚĂů
ƉƌŽŐƌĂŵŵŝŶŐ ?ƌĞĨĞƌƐƚŽƚŚĞĐŽŶĐĞƉƚƚŚĂƚĂŶŝŶƐƵůƚŽƌƐƚŝŵƵůƵƐĂƚĂĐƌŝƚŝĐĂůpoint during fetal 
development leads to a long-ƚĞƌŵĞĨĨĞĐƚ ?dŚŝƐ ‘ƉůĂƐƚŝĐŝƚǇ ?ŽĨĨĞƚĂůĚĞǀĞůŽƉŵĞŶƚŵĞĂŶƐƚŚĂƚ
developing tissues can adapt to their current circumstances by altering gene expression in 
response to the prenatal environment (Langley-Evans, 2006).  If this occurs during critical 
developmental periods, the availability of nutrients could therefore have permanent effects 
on tissue structure and function (Barker et al., 1993). 
From an evolutionary point of view a human only needs to be able to live long enough to 
reproduce, so fetal development should ideally provide adaptations that ensure short-
medium term survival in the prevailing environment.   Therefore such modifications may 
ŶŽƚďĞƐŽĂĚǀĂŶƚĂŐĞŽƵƐŝŶƚŚĞůŽŶŐƚĞƌŵ ?dŚĞ ‘dŚƌŝĨƚǇWŚĞŶŽƚǇƉĞ,ǇƉŽƚŚĞƐŝƐ ?(Hales and 
Barker, 1992) proposes that the nutrient-restricted fetus adapts to thrifty circumstances by 
making adaptations that allow it to make more efficient use of limited energy substrates 
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available.  This is a survival advantage if the postnatal environment remains poor, but a 
disadvantage if the postnatal environment is nutrient-rich (Hales and Barker, 1992).   
1.6.1 Epidemiological Evidence for DOHaD 
Epidemiological evidence supports the theory that nutritional factors during fetal 
development can have long-term implications for the health of the offspring.  If an insult 
takes place during a critical period of development for the fetus then growth may be 
restrained, and the resulting low birth weight may be a predictor of disease later in life 
(Barker, 1998).  In a cohort of men and women born in Hertfordshire between 1911 and 
1930 death rates from coronary heart disease were twice as high for those who weighed 
less than 5.5 lb at birth compared with those who weighed between 8.5 and 9.5 lb 
(Osmond et al., 1993).  Birth weight is, however, only one measure of events during 
intrauterine development, and responses to a sub-optimal fetal environment may lead to 
other permanent changes in tissue structure and function.  
In addition, epidemiological studies have provided evidence that the timing of the 
nutritional insult is also crucial, and depending on the stage of gestation at which the insult 
occurs there are different long-term effects depending on the organ systems developing at 
that time point.  For example, longitudinal evidence has been collected from a cohort of 
individuals exposed to famine in utero during the Dutch Famine at the end of World War II.  
At the peak of the famine, during the winter of 1944  W 1945, mean energy intake was 
reduced from 6.3 to 1.6 - 3.2 MJ/day (Roseboom et al., 2001).  As middle-aged adults, those 
individuals exposed to famine during early gestation had higher LDL:HDL cholesterol ratios 
(Roseboom et al., 2000) and higher risk of obesity and coronary heart disease (Roseboom et 
al., 2006),  than the control group who were not exposed to famine in utero.  Those 
exposed to famine mid-gestation had evidence of programmed changes to blood pressure 
and an increased incidence of coronary heart disease (Roseboom et al., 1999), and also 
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indices of early-stage renal disease such as microalbuminuria (Painter et al., 2005).   
Exposure to famine in late gestation led to poorer glucose tolerance compared to those 
who were not exposed (Ravelli et al., 1998).   These delayed developmental effects were 
largely unrelated to size at birth but rather to factors marking the quality of fetal growth or 
maternal macronutrient balance (Roseboom et al., 1999).  
Studies have shown a link between low birth weight and increased blood pressure (Barker, 
1992; Mackenzie and Brenner, 1995) and this may be to be due to a deficit in nephron 
number in the kidney (Brenner et al., 1988; Manalich et al., 2000).  In a retrospective 
analysis of autopsies of accident victims those with chronic hypertension had significantly 
fewer nephrons then the control group (Keller et al., 2003), and a direct linear relationship 
between birth weight and nephron number has also been observed with a predicted 
increase of 250,000 nephrons per extra kg birth weight (Hughson et al., 2003).  Birth weight 
has also been demonstrated to be inversely correlated with mean glomerular volume (Hoy 
et al., 2005) as it appears that glomeruli hypertrophy to compensate for having fewer 
nephrons.  This hypertrophy leads to hyperfiltration in the remaining nephrons, and 
increased pressure in the capillaries (Hershkovitz et al., 2007), and ultimately to 
glomerulosclerosis, proteinuria and reduced glomerular filtration rate (Brenner et al., 
1996).  Nephron number has also been shown to vary by sex and race, with males tending 
to have about 10% more nephrons than females, and Australian Aborigines having around 
30% fewer than non-Aboriginal Australians (Hoy et al., 2005). 
1.6.1.1 Limitations of epidemiological studies 
Epidemiological studies can highlight new and potentially important aetiologies of a multi-
factorial disease like chronic kidney disease.  However, epidemiological studies have been 
criticised on a number of other fronts, including weaknesses in terms of cohort selection 
and failure to correct for all confounding factors.  A meta-analysis of 55 studies that 
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reported an inverse relationship between birth weight and systolic blood pressure (typically 
2  W 4 mmHg increase in systolic blood pressure per 1 kg increase in birth weight) found that 
the larger studies generally showed a weaker association, and many studies were not 
appropriately adjusted for confounding factors (Huxley et al., 2002).  Once the studies were 
adjusted the relationship between birth weight and blood pressure was largely attenuated, 
and there was no conclusive evidence to support the link.   
Additionally, not all epidemiological studies show evidence that maternal diet affects birth 
weight or the risk of chronic disease later in life.  In a study of Northampton women, birth 
ǁĞŝŐŚƚĂŶĚŝŶĨĂŶƚƐ ?ƉƌŽƉŽƌƚŝŽŶƐǁĞƌĞŶŽƚĂĨĨĞĐƚĞĚby dietary intake during pregnancy 
(Langley-Evans and Langley-Evans, 2003), nor were the babies of a cohort of women from 
Portsmouth (Mathews et al., 1999).   However, it may be that these studies both carried 
out in a westernised country with a high availability of food do not reflect a severe enough 
reduction in nutrient intake to see obvious effects on birth weight. 
Another limitation of epidemiological studies in the area of DOHaD is that many are 
historical; the cohorts are not contemporary and may not reflect current lifestyles and 
diets.  These limitations mean that animal studies  W with their tightly controlled 
environments - have been crucial to demonstrating the biological plausibility of the 
programming effects of prenatal nutrition, and are now a valuable tool for investigating the 
mechanisms involved.  
1.6.2 Animal models 
Several animal models have been utilised for demonstrating the biological plausibility of the 
fetal programming of adult disease.   The advantage of animal models when considering the 
effects of programming is that unlike human studies where there are many confounding 
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factors, the environment can be strictly controlled, so that the only difference between the 
control and experimental groups is the intervention.   
Experimental models of intrauterine growth restriction (IUGR) can use interventions in 
either the mother, the placenta or the fetus.  The most commonly used interventions for 
demonstrating programming effects are surgical models, glucocorticoid treatment or 
dietary interventions in the mother.  These models have been used in several species, most 
commonly in rats and mice (around 70% of studies), but also in sheep, pigs, guinea pigs, 
monkeys, and chick embryos (Vuguin, 2007; Schroder, 2003).  The selection of an 
appropriate model has several considerations.  Shorter gestation and life expectancy makes 
rodent models attractive, and this also has financial implications for animal trials, as 
keeping larger animals with longer gestation and life expectancies to adulthood is time 
consuming and expensive. 
Mammals share many common features at a biological level, for example with similar genes 
and biochemical pathways.  However, there are also differences, which make selection of 
an appropriate model dependent on the variables being studied.  For example, rodents are 
altricial which means they are born without their organs being fully developed, and a 
significant amount of maturation and development takes place during a short period after 
birth.  Although human babies are also altricial, many of their internal organs are more 
mature, so sometimes a precocial animal model may be a more appropriate choice, 
depending on the organ or system being studied.  Also, litter-bearing mammals, such as 
rodents and pigs, may have variations in the amounts of nutrient supply to different fetuses 
within the same litter.  As humans usually have only one or two offspring, a model such as 
sheep may be more relevant, and indeed the sheep is a long-standing model for considering 
placental-fetal interactions (Fowden et al., 2006). 
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When considering kidney development, a sheep model is particularly appropriate.   
Nephron development in the kidney is complete at birth in humans and sheep, and no new 
nephrons are formed postnatally.  However in some other mammals, such as rats, mice and 
pigs nephrogenesis continues for a short period after birth (see Table 1.3).    
Table 1.3: Mesonephric and metanephric kidney development in several species 
Species Gestation length (days) Mesonephros present   
(% of gestation) 
Metanephric development     
(% of gestation) 
Mouse 20 0.50  W 0.65 0.55  W 1.13 
Rat 21 0.57  W 0.81 0.57  W 1.38 
Pig 112 0.13  W 0.21 0.18  W 1.10 
Sheep 147 0.11  W 0.38 0.18  W 0.90 
Human 268 0.10  W 0.40 0.12  W 0.90 
Table adapted from Brace et al., 1998; Moritz and Wintour, 1999 
 
The mesonephric and metanephric stages of kidney development are almost parallel in 
sheep and humans.  Mesonephric development takes place between 10 to 40% of human 
gestation and 11 to 38% of sheep gestation (Table 1.3).  This compares to a far shorter 
window of development in pigs (13  W 21% of gestation) and a much later developmental 
window in the more frequently used laboratory animals, rats (57  W 81%) and mice (50  W 
65%).  Similarly the period of metanephric development is analogous between human and 
sheep (12  W 90% gestation and 18  W 90% gestation respectively), whereas the in the pig it 
starts at the same time period, but extends postnatally, and in rats and mice it starts later 
and also extends postnatally (57  W 138% of gestation in rats, and 55  W 113% gestation in 
mice). 
Unlike humans and most other mammals, a sheep does not appear to have a rudimentary 
pronephros, but instead develops a giant glomerulus at the end of what later becomes the 
mesonephros (Davies, 1951).  However, the development of the metanephros, which 
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develops into the fully functioning adult kidney, is the same in both sheep and humans, 
thus justifying the use of sheep as an appropriate animal model with respect to renal 
aspects of the DOHaD paradigm. 
One limitation of using sheep as a model for the human condition is that sheep are 
ruminants unlike humans who are monogastric, however this does not affect the functional 
physiology and anatomy of the kidney which are extremely similar between the species.  
Sheep have primarily been used in global restriction models rather than individual nutrient 
restriction models.  However, even with a global nutrient restriction the digestive 
differences still apply, so it is important that any study considers this, and whether or not 
the results observed apply just to the sheep, or whether they may have a comparative 
aspect to humans or all mammals.    
1.6.2.1 Surgical models 
There are several models of fetal programming which are surgical in nature, and are used to 
generate hypoxia and intrauterine growth restriction.  One commonly used method in 
sheep is carunclectomy, in which the majority of endometrial caruncles are removed from 
the uterus; this reduces the number of cotyledons that are responsible largely for the 
placental mass later in pregnancy (Schroder, 2003).   
Studies have reported reduced gene expression of insulin-like growth factor 2 (IGF-2) and 
its receptors  IGF-1R and IGF-2R in fetal hearts (Wang et al., 2011) and, in the liver, a 
reduction in IGF-1 mRNA and increased levels of hydroxysteroid dehydrogenase like 1, 
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and 
phosphoenolpyruvate carboxykinase 2 (Gentili et al., 2009).   
More commonly used as models for kidney development are sub-total maternal 
nephrectomy or placental embolisation models.  One study (Brandon et al., 2008) showed a 
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reduction in mean glomerular volume in offspring whose mothers had undergone sub-total 
nephrectomy, although there was no change in kidney weight or nephron number.  In 
addition the same research group (Brandon et al., 2009) reported a reduction in renal 
function from 6 months of age in the same experimental group.   
WůĂĐĞŶƚĂůĞŵďŽůŝƐĂƚŝŽŶŝŶǀŽůǀĞƐŝŶũĞĐƚŝŶŐƐŵĂůůŵŝĐƌŽƐƉŚĞƌĞƐ ? ? ?ʅŵŝŶĚŝĂŵĞƚĞƌ )ŝŶƚŽƚŚĞ
placenta, where they block small capillaries and thus reduce surface area for transferring 
oxygen and nutrients to the fetus (Morrison, 2008).  Three studies which all carried out 
placental embolisation during the third trimester of pregnancy have shown inconsistent 
results, highlighting the variability inherent in the technique.  In one (Zohdi et al., 2007) 
there was a 24% reduction in nephron number in offspring whose mothers underwent 
embolisation compared to the control group, although there was no change in kidney 
weight or renin-angiotensin system (RAS) gene expression.  However, in another study 
(Mitchell et al., 2004) there was no change in nephron number, despite the same 
intervention, although there was a 34% reduction in the bodyweight of the fetuses at day 
140 gestation.  Furthermore, a small reduction in blood pressure (4 mmHg) was reported in 
young lambs (Louey et al., 2000). 
1.6.2.2 Glucocorticoid treatment 
Glucocorticoid treatment during pregnancy has been associated with lower birth weight 
and adult disease in both humans and animals (Reinisch et al., 1978; Moss et al., 2001; 
Newnham, 2001).  In animal models artificial glucocorticoids (dexamethasone or 
betamethasone) have been given, as one-off doses (Dodic et al., 2001; Volk et al., 2010) or 
as a course over time (Malaeb et al., 2009), and various effects have been described in a 
range of organs and cell types in both rodent and large animals.  In sheep, an increase in 
adult blood pressure (10 mmHg) in those offspring exposed to a glucocorticoid injection at 
day 27 gestation was observed (Dodic et al., 2001).  In addition, in this model, nephron 
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number was reduced and mean glomerular volume increased (Wintour et al., 2003) when 
exposed to maternal dexamethasone at the same time point.   
It has been suggested that changes in the relative ratio of angiotensin receptors in the 
kidney may explain these observations as after maternal betamethasone injection at day 80 
of gestation, there was an increase in  angiotensin II receptor type I (AGTR1) and a decrease 
in angiotensin II receptor type II (AGTR2) (Gwathmey et al., 2011). 
1.6.2.3 Nutritional models 
Many different dietary interventions have been studied in animal models, and they may 
provide useful insights into the challenges faced by pregnant women in developing 
countries, as well as for those women in westernised societies who do not have balanced 
diets or for those who suffer from hyperemesis gravidarum. 
The main two dietary interventions used are global nutrient restriction (i.e. a reduction in 
caloric content of the diet, across all macronutrients) or a low protein diet which is 
isocaloric.  Other diets have also been studied, and indeed similar programming effects are 
sometimes observed regardless of the intervention, which suggests that some common 
mechanisms may be involved.  For example, hypertension has been reported in rats 
exposed prenatally to high fat (Khan et al., 2003), low iron (Crowe et al., 1995), and low 
protein diets (Langley and Jackson, 1994). 
1.6.2.3.1 Global Nutrient Restriction 
Many studies have utilised global nutrient restriction diets.  The calorie/energy restriction 
may be mild, moderate or severe, and the timing of the restriction has also been varied, 
from pre-conception to early, mid and late gestation. 
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A summary of nutritional models in sheep is shown in Table 1.4.  The majority of the studies 
ƵƚŝůŝƐĞƐŽŵĞĨŽƌŵŽĨĐĂůŽƌŝĐƌĞƐƚƌŝĐƚŝŽŶ ?^ŽŵĞƐƚƵĚŝĞƐŚĂǀĞƚŚĞĞǁĞ ?ƐĚŝĞƚĂƐƚŚĞŽŶůǇ
ŝŶƚĞƌǀĞŶƚŝŽŶǁŚĞƌĞĂƐƐŽŵĞŽƚŚĞƌƐŚĂǀĞĂ ‘ĚŽƵďůĞŚŝƚ ? ?ǁŝƚŚĂƌĞƐƚƌŝĐƚĞĚŵĂƚĞƌŶĂůĚŝĞƚ
ĨŽůůŽǁĞĚďǇĂĨƵƌƚŚĞƌŝŶƚĞƌǀĞŶƚŝŽŶŝŶƚŚĞůĂŵďƐ ?ĚŝĞƚůĂƚĞƌŝŶ life. 
Several studies have considered the effect of an energy restricted diet on the hypothalamic-
pituitary-adrenal (HPA) axis.  One study (Long et al., 2010) which used a moderate 
restriction (50% of metabolisable energy, ME) during mid-gestation found little effect on 
the HPA axis, although fertility was reduced compared to the control group.  Other studies 
with the same dietary restriction in the first 30 days of gestation reported a 50% increased 
cortisol: adrenocorticotrophic hormone (ACTH) area under the curve in females only (Poore 
et al., 2010) and an increase in the HPA axis in females only (Chadio et al., 2007).  However, 
the latter study found no significant differences when the dietary restriction was later in 
pregnancy (day 31  W 100).  A severe restriction (down to 3% ME) for 10  W 20 days at the 
start of the third trimester resulted in a 35% increase in (ACTH) output in response to a 
challenge (Bloomfield et al., 2003).  
A number of studies have considered the effect of energy restriction on metabolism and 
energy balance.  These have tended to show fairly consistent results, with a reduction in 
glucose tolerance in the offspring at 8  W 10 months of age, whether the intervention was 
prior to conception and in early gestation (Todd et al., 2009) or in mid gestation (Ford et al., 
2007).  In addition, insulin sensitivity was reduced whether the dietary intervention was 
early in gestation (Poore et al., 2007), mid-late (Rhodes et al., 2009) or confined to late 
gestation (Gardner et al., 2005).  However, two studies have showed little to no effect on 
glucose metabolism and energy balance (Sebert et al., 2009; Hyatt et al., 2011). 
Changes in ME (either a reduction or an increase) along with a high selenium diet have 
been demonstrated to reduce microvascularity in the fetal jejunum (Neville et al., 2010), 
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decrease mitochondrial activity and VO2max (Jorgensen et al., 2009), and increase birth 
weight and perirenal fat at six months of age (Vonnahme et al., 2010).   A 50% ME diet early 
in gestation resulted in increased fetal blood pressure  of 3  W 8 ± 2.5 mmHg (Edwards et al., 
2002), increased pulse pressure  of 5 ± 1 mmHg at one year of age (Gardner et al., 2004), 
increased blood pressure (10 ± 2 mmHg) at three years (Gopalakrishnan et al., 2004), and 
reduced renal function at one year (Williams et al., 2007).   
A milder energy restriction where ewes were fed 70% ME resulted in increased renal IGF-1 
(MacLaughlin et al., 2010).  However, one study (Braddick et al., 2011) showed no effect on 
nephron number or kidney weight for either days 1  W 31 or 104  W 127 gestation, and 
although a study with the period of restriction in mid-gestation (Gopalakrishnan et al., 
2005) reported a 40% decrease in nephron number, this did not have a detrimental effect 
on blood pressure at six months of age; indeed, there was a trend for the nutrient 
restricted group to have lower blood pressure. 
1.6.2.3.2 Low protein 
Using a maternal low protein diet that is isocaloric to the control diet is a commonly used 
dietary intervention in rodent models.  It is perhaps more relevant than the global 
restriction model for westernised populations, where a mismatch of nutrients is more 
common than a deficiency in energy intake. 
There is strong evidence from animal studies that certain organs, such as the kidney, are 
particularly vulnerable to structural changes in response to adverse conditions in utero.  
Low protein diets in rat studies have been demonstrated to result in smaller kidneys with 
fewer nephrons (Langley-Evans et al., 1999), misshapen kidneys that are shorter and wider 
(Nwagwu et al., 2000) and fewer nephrons (Vehaskari et al., 2001) and hypertension 
(Langley and Jackson, 1994).  Fetal programming is also associated with altered renal 
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function.  Maternal low protein rat offspring have been found to have lower creatinine 
clearance, and higher blood urea and urinary albumin excretion (Nwagwu et al., 2000), 
reduced glomerular filtration rate (Woods et al., 2001), and  increased urinary excretion of 
vasoactive prostaglandins (Sherman et al., 1999).  
Although the low protein model is well established in rats, such dietary interventions have 
been rarely used in large animal studies.  A low protein diet throughout gestation in the pig 
resulted in increased genes in lipid transport, glucose and fatty acid metabolism, and 
apoptosis pathways in adipose tissue (Sarr et al., 2010).  Also in pigs, a low protein diet 
early in gestation led to lower expression of housekeeping genes with reduced histone 
modifications in the kidney (Denisenko et al., 2011).  In cows, a low protein diet in the third 
trimester led to altered leptin and IGF receptors in adipose tissue (Micke et al., 2011a) and 
increased cross sectional areas in longissimus dorsi muscle (Micke et al., 2011b).  However, 
no studies to date have currently considered the effect of a maternal low protein diet in 
sheep. 
1.6.2.3.3 Other diets 
Less commonly, other dietary interventions have been used but these tend to show similar 
programming effects.  A high salt diet in ewes led to reduced vasopressin and increased 
aldosterone (Digby et al., 2010) and over nutrition (150% ME) to decreased insulin 
signalling to longissimus dorsi muscle at 22 months of age (Yan et al., 2011).  A methyl 
deficient diet in pregnant sheep (for 56 days prior to conception to day six of gestation) also 
led to reduced insulin sensitivity in males only, and to an increase in blood pressure of 11 ± 
2 mmHg (Sinclair et al., 2007).  Ethanol administration in ewes from days 95  W 133 gestation 
resulted in increased cardiomyocyte and left ventricular volumes in day 133 fetuses (Goh et 
al., 2011) and also to an 11% reduction in nephron number, although there was no change 
in kidney weight, nor in renin angiotensin system (RAS) gene expression (Gray et al., 2008). 
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Therefore maternal malnutrition is more significant than any specific deficit, and it is the 
lack of ideal balance of nutrients that is more important than whether it is caused by a 
reduction in energy, protein, etc., or even an increase in energy, salt, or ethanol.  The wide 
range of different maternal diets in sheep and the effects observed are shown in Table 1.4. 
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Table 1.4: Studies of nutritional models in sheep 
Reference Experimental diet Timing Results: effects on offspring 
Nutritional models: ewe intervention only   
Yan et al, 2011 Ewe: 150% ME -60  W 121 postnatal A?ĚŽǁŶƐƚƌĞĂŵŝŶƐƵůŝŶƐŝŐŶĂůůŝŶŐŝŶlongissimus dorsi muscle at 22 months 
 
Todd  et al, 2009 Ewe: 10-15% weight loss -61 to 30 days gestation A?ŐůƵĐŽƐĞƚŽůĞƌĂŶĐĞĂƚ ? ?ŵŽŶƚŚ 
Hernandez et al, 2009 Ewe: 10-15% weight loss -61 to 30 days gestation altered behavioural responses 
Edwards et al, 2002 Ewe: 70% ME -60 to 7 days gestation n  fetal blood pressure (3 - 8 r 2.5 mmHg) 
Sinclair et al, 2007 Ewe: Methyl deficient diet -56 to 6 days gestation A?ŝŶƐƵůŝŶƐĞŶƐŝƚŝǀŝƚǇ ?ŵĂůĞƐ )Ăƚ ?Ǉƌ ?n  Blood pressure (11 ± 2 mmHg) 
Maclaughlin et al, 2010 Ewe:70% ME -42  W 7 days gestation n renal IGF1 
Smith et al,  2010 Ewe:70% ME -28  W 7 days gestation No effect on adrenal function; changes in GTT response in males at 10 weeks 
Neville et al, 2010 
Ewe: High selenium; 
40% or 140% ME 
-21  W 147 days gestation 
64  W 147 days gestation A?ŵŝĐƌŽǀĂƐĐƵůĂƌŝƚǇŝŶƚŚĞĨĞƚĂůũĞũƵŶƵŵ 
Torrens et al, 2009 Ewe: 50% ME -20  W 15 days gestation n vasoconstrictor response in some arteries, but not in others 
Chadio et al, 2007 Ewe: 50% ME 
0 to 30 days gestation 
31 - 100 
n HPA axis  in female vs. Male 
Little to no effect 
Vonnahne et al, 2010 
Ewe: High selenium; 
40% or 140% ME 
0  W 147 days gestation 
50  W 147 days gestation n birth weight and perirenal fat at 6 months for high selenium groups 
Meyer et al, 2010 
Ewe: High selenium; 
40% or 140% ME 
0  W 147 days gestation 
50  W 147 days gestation Little or no effect at day 21 
Digby et al, 2010 Ewe: high salt 0  W 147 days gestation A?sW ?n aldosterone 
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Reference Experimental diet Timing Results: effects on offspring 
Gardner et al, 2004 Ewe: 50% ME 1 to 30 days gestation n  adult pulse pressure at 1 yr (5 ± 1 mmHg) 
Gardner et al, 2006 Ewe: 50% ME 1 to 30 days gestation A?ďĂƌŽƌĞĨůĞǆƐĞŶƐŝƚŝǀŝƚǇ 
Braddick et al, 2011 Ewe: 50% ME 
1  W 31 days gestation 
104  W 127 days gestation No effect on nephron number or kidney weight 
Gopalakrishnan et al, 2004 Ewe: 50% ME 1 to 95 days gestation n  adult blood pressure at 3 yr (10 ± 2 mmHg) 
Erhard et al, 2004 Ewe: 50% ME 1 to 95 days gestation altered behavioural responses 
Ford et al, 2007 Ewe: 50% ME 28 to 78 days gestation A? ? 锃? ?A? )ŐůƵĐŽƐĞƚŽůĞƌĂŶĐĞĂƚ ?ŵŽŶƚŚ 
Long et al, 2010 Ewe: 50% ME 28 to 78 days gestation >ŝƚƚůĞĞĨĨĞĐƚŽŶ,WĂǆŝƐ ?A?ĨĞƌƚŝůŝƚǇ 
Gopalakrishnan et al, 2005 Ewe: 50% ME 28 to 80 days gestation A?ůŽŽĚƉƌĞƐƐƵƌĞ (at 6 mth , 8 ± 3 mmHg).     A? ? ? ?A䘀  ? ?A? )ŶĞƉŚƌŽŶŶƵŵďĞƌ 
Sharkey et al, 2009 Ewe: 50% ME 
28  W 80 days gestation 
110 -147 days gestation 
Changes in adipose tissue inflammatory profile at 6 months 
Hyatt et al, 2011 Ewe: 50% ME 30  W 80 days gestation Little to no effect on glucose metabolism and energy balance 
Dwyeret al, 2003 Ewe: 65% ME 28 to 147 days gestation A?ĞǁĞ-lamb bonding behaviour at birth 
Eckersall et al, 2008 Ewe: 70% ME 65 to 125 days gestation A?ŝŵŵƵŶĞƌĞƐƉŽŶƐĞƚŽǀĂĐĐŝŶĂƚŝŽŶ 
Goh et al, 2011 Ewe: ethanol administration 95  W 133 days gestation n cardiomyocyte & left ventricular volume in fetuses 
Grey et al, 2008 Ewe: ethanol administration 95  W 133 days gestation A? ? ? ?A? )ŶĞƉŚƌŽŶŶƵŵďĞƌ ?ŶŽĐŚĂŶŐĞŝŶZ^ŐĞŶĞĞǆƉƌĞƐƐŝŽŶŽƌŬŝĚŶĞǇweight 
Bloomfield et al, 2003 Ewe: 3% ME 105 to 125 days gestation n (35%) ACTH output to challenge 
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Reference Experimental diet Timing Results: effects on offspring 
Smith et al, 2009 Ewe: propylene glycol 110 to 147 days gestation n birth weight (5%) plasma glucose and postnatal growth rates up to 12 weeks 
Sebert et al, 2011 Ewe: 60% ME 110 to 147 days gestation n insulin; A?ƚƌŝŐůǇĐĞƌŝĚĞƐ 
Gardner et al, 2005 Ewe: 50% ME 110 to 147 days gestation A? ?ĨŝƌƐƚƉŚĂƐĞ )ŝŶƐƵůŝŶƐĞŶƐŝƚŝǀŝƚǇĂƚ ?Ǉear 
Nutritional models: ewe and lamb intervention   
Poore et al, 2007 
Ewe: 50% ME  
Lamb: 85% growth  
0  W 30 days gestation 
3  W 6 months  A? ? ? ?A? )ŝŶƐƵůŝŶƐĞŶƐŝƚŝǀŝƚǇ 
Poore et al, 2010 
Ewe: 50% ME  
Lamb: 85% growth  
0  W 30 days gestation 
3  W 6 months  n (50%) cortisol:ACTH AUC  in females 
Cleal et al, 2007 
Ewe: 50% ME  
Lamb: 85% growth  
0  W 30 days gestation 
3  W 6 months n RAAS response (5  W 8 ± 2mmHg) to  furosemide at 2.5yr 
Jorgensen et al, 2009 
Ewe: 50% ME  
Lamb: high-fat  
0  W 30 days gestation 
0  W 6 months A? ? ? ?A? )ŵŝƚŽĐŚŽŶĚƌŝĂůĂĐƚŝǀŝƚǇ ?sK2max 
Lloyd et al, 2012 
Ewe: 50% protein 
Lamb: 1.5 ME  
0  W 65 gestation 
18  W 24 months  A?ƌĞŶĂůĨƵŶĐƚŝŽŶĂƚ ?Ǉƌ ?A?ĂŶŐŝŽŐĞŶŝĐĨĂĐƚŽƌƐŝŶĨĞƚƵƐ 
Williams et al, 2007 
Ewe: 50% ME  
Lamb: Ad lib  
1  W 75 days gestation 
3  W 12 months A?ƌĞŶĂůĨƵŶĐƚŝŽŶĂƚ ?Ǉƌ 
Chan et al, 2009 
Ewe: 50% ME  
Lamb: Ad lib  
1  W 75 days gestation 
3  W 12 months n ƚƌŝŐůǇĐĞƌŝĚĞŝŶůĞĨƚǀĞŶƚƌŝĐůĞ ?A? ?WWZɶ ?&W ?Ăƚ Ǉƌ 
Sebert et al, 2009 
Ewe: 50% ME  
Lamb: Ad lib  
1  W 75 days gestation 
3  W 12 months Subtle effects on energy balance 
Sebert  et al, 2010 
Ewe: 50% ME  
Lamb: Ad lib  
30  W 80 days gestation FTO gene n ŚǇƉŽƚŚĂůĂŵƵƐA?ŚĞĂƌƚĂŶĚŶŽĐŚĂŶŐĞŝŶůŝǀĞƌ ?ŬŝĚŶĞǇ ?ƉĂŶĐƌĞĂƐĂƚ
7 days or 1yr 
Rhodes et al, 2009 
Ewe: 70% ME  
Lamb: 1.5ME  
65  W 147 gestation 
18  W 24 months n peak insulin to GTT at 1.5yr 
ACC, acetyl coenzyme A; ACTH, adrenocorticotrophic hormone; AUC, area under the curve; AVP, arginine vasopressin; FABP3, fatty acid binding protein 3; FTO, fat mass and obesity 
associated; GTT, glucose tolerance test; HPA, hypothalamic-pituitary axis; IGF1, insulin-like growth factor 1; ME, metabolisable energy; PPARɶ ?ƉĞƌŽǆŝƐŽŵĞƉƌŽůŝĨĞƌĂƚŽƌ-activated receptor 
gamma;  RAS, renin-angiotensin system   
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1.7 Mechanisms of programming 
The processes of proliferation and differentiation within a developing fetus require oxygen 
and nutrients, and restricting nutrient intake may lead to fewer cells within a particular 
tissue or changes in the balance between cell types (Gopalakrishnan et al., 2005).  This can 
cause disruption of, or changes to, organ size and function, and metabolic and/or endocrine 
control (Barker, 1998).  Inadequate nutrition may lead to increased demands on functional 
units such as nephrons and although demand may be met initially, this may be at the cost 
of dysfunction later in life.  Altered signalling between cell types could disturb homeostatic 
mechanisms, and changes in gene expression could lead to changes in cell types which are 
unable to respond appropriately to the adult environment (Langley-Evans, 2006).  Under-
nutrition may also lead to permanent changes in gene expression via epigenetic 
mechanisms, which may programme altered endocrine or physiological function in later life 
(Barker, 1998; Langley-Evans, 2006).  
The mechanisms and systems involved in programming are likely to be multi-factorial and 
some brief examples are set out in the following paragraphs. 
1.7.1 Hormones and growth factors 
1.7.1.1 Angiogenic factors 
A traditional early marker for CKD (i.e. before overt clinical signs are present) is 
microalbuminuria, which can robustly predict future CKD (Fox et al., 2010).  A reduced 
filtration barrier, allowing small amounts of albumin into the urine, is likely to be due 
initially to effacement of the podocyte foot processes, the integrity of which is supported 
by a number of factors, but primarily VEGF (Eremina et al., 2008a).  VEGF is an important 
signalling protein that regulates endothelial cell growth and differentiation and is crucial for 
initiation of angiogenesis (Breier et al., 1992).  For example, obesity leads to local hypoxia in 
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adipose tissue as the adipocytes expand and become distanced from the microvasculature 
and it has been shown that obesity leads to a tissue specific increase in VEGF, to support 
development of the new vascular network (Wood et al., 2009).  In obese sheep, the 
increased adipose tissue mass around the kidneys has been shown to be positively 
associated with increased intra-renal endoplasmic stress, a potential early prognostic 
marker for CKD (Sharkey et al., 2009a).   
The glomerular filtration barrier is comprised of endothelial cells, the basement membrane 
and visceral epithelial cells called podocytes, and is supported by mesangial cells (Rask-
Madsen and King, 2010).  The endothelial cells contain fenestrae through which plasma and 
small molecules can pass (Bray et al., 1999). The filtrate then passes across the glomerular 
basement membrane and through the slit diaphragm which is formed by interlinked foot 
processes from the podocytes (O'Callaghan, 2009). VEGFA is highly expressed in podocytes 
and plays an important role in both establishing and maintaining this barrier (Eremina et al., 
2003).  Mouse knockout models that are homozygous for podocyte-specific VEGFA die 
within a day of birth due to an absence of endothelial or mesangial cells in the mature 
glomeruli (Eremina et al., 2006).  Heterozygous conditional knockout mice have proteinuria 
and ESRD by 12 weeks of age (Eremina et al., 2003).  The cause of this dysfunction is 
multifactorial and includes a loss of endothelial cell fenestrations, a reduction in podocyte 
foot processes, and loss of mesangial cells (Eremina et al., 2003; Eremina et al., 2006). 
Another study showed that mice treated with a VEGF receptor inhibitor for 1  W 3 weeks had 
significant regression of small capillaries in multiple organs, and in addition, those that 
remained had fewer fenestrations (Kamba et al., 2006).  Within a week of stopping the 
administration of the inhibitor, VEGF levels increased and capillaries began to repair.  
A similar finding has been observed in humans who were treated with bevacizumab, which 
is an anti-VEGF monoclonal antibody used to treat various types of cancer through reducing 
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angiogenesis (Ferrara, 2004).  A study identified patients on this drug who suffered from 
the side effects of proteinuria, hypertension and renal failure, and through examination of 
renal biopsies they found thrombosis in capillaries and arterioles due to endothelial injury 
(Eremina et al., 2008). Taken in conjunction with the rodent studies above it would appear 
that VEGF is not only involved in angiogenesis and formation of the vascular structure in the 
developing kidney (Tufro et al., 1999), but it also is critical for maintenance and repair later 
in life. 
Many other factors such as basic FGF and angiopoietin have complementary roles in 
vascular development (see 1.4.4).  Other fetal nutritional studies have also demonstrated 
reduced VEGFA in response to a prenatal sub-optimal diet in non-human primates (Cox et 
al., 2006; Nijland et al., 2007); therefore angiogenic factors may have an important 
programming role. 
1.7.1.2 Glucocorticoids 
Glucocorticoids are involved in many key processes including gluconeogenesis,  the 
regulation of gene expression and the renin-angiotensin system, and are thought to 
mediate some of the effects of maternal diet on the developing organs of the fetus 
(Edwards et al., 1993).   
The glucocorticoid cortisol is about 1000 times higher in maternal circulation than in fetal 
circulation, despite being able to diffuse freely across the placenta (Langley-Evans, 2006). 
The placental enzyme 11-beta hydroxysteroid dehydrogenase ( ? ?ɴ-HSD) is thought to play 
a key role in protecting the fetus from overexposure to maternal cortisol (Bertram et al., 
2001; Whorwood et al., 2001).  In the rat, the effects of a maternal low protein diet led to 
reduced birth weight, hypertension and metabolic dysfunction and are thought to be 
ŵĞĚŝĂƚĞĚďǇƚŚĞŝŶŚŝďŝƚŝŽŶŽĨƉůĂĐĞŶƚĂů ? ?ɴ-HSD (Langley-Evans and Nwagwu, 1998; 
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Bertram et al., 2001).  However, these effects may be sex-specific.  One study (McMullen 
and Langley-Evans, 2005a) observed that offspring of maternal low protein rats had higher 
systolic blood pressure at 4 weeks of age than the control group, however, this appeared to 
be dependent on glucocorticoids in males but not females.   
1.7.2 Renin-angiotensin system 
The RAS regulates long-term blood pressure and the volume of extracellular fluid, through 
the actions of renin, angiotensin I and II, and aldosterone (Bray et al., 1999).  This system 
has been studied extensively as it plays a potential role in the mechanisms underlying the 
programming of hypertension in animal models. Angiotensin II is considered to be the main 
effector hormone of the RAS, promoting vascular smooth muscle growth and inflammation, 
vasoconstriction, and sodium reabsorption (Ruiz-Ortega et al., 2000).  Angiotensin II works 
through cell surface receptors called AT1 and AT2, and current evidence suggests an 
alteration in the balance between these receptors may be involved in the programming 
effects of maternal diet on postnatal renal function and blood pressure control (McMullen 
and Langley-Evans, 2005b).  In addition, the deletion of any genes involved in RAS leads to 
offspring with kidney abnormalities (Matsusaka et al., 2002), and in fetal sheep the RAS 
system is essential for the maintenance and regulation of fetal GFR (Lumbers, 1995). 
1.7.3 Inflammatory factors 
Whilst angiotensin II and AT1/AT2 receptors are well characterised regulators of blood 
pressure, emerging evidence suggests their involvement in the inflammatory process too. 
One common feature of renal disease is monocyte infiltration (Ruiz-Ortega et al., 2000). 
Angiotensin II has a direct role in the inflammatory response by activation of Nuclear Factor 
Kappa B (NF-ʃ )ŝŶƚŚĞŬŝĚŶĞǇǀŝĂƚŚĞd1 and AT2 receptors, and increases degradation of 
/ʃ-ɲ ?ǁŚŝĐŚŝƐĂŶŝŶŚŝďŝƚŽƌŽĨE&-ʃ(Ruiz-Ortega et al., 2000).  AT1 also regulates monocyte 
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chemoattractant protein-1 (MCP-1) via the NF-ʃƉathway (Esteban et al., 2004).  Some 
studies have demonstrated interactions between NF-ʃ ?/ʃ-ɲĂŶĚDW-1.  Angiotensin II 
ĂĐƚŝǀĂƚĞƐE&ʃĚŝƌĞĐƚůǇǀŝĂd1 and AT2 receptors and indirectly via its metabolite 
angiotensin IV, which results in increased MCP-1 (Esteban et al., 2005).  Vascular injury in 
mice resulted in increased NF-ʃĂŶĚDW- ?ĂŶĚĂĚĞĐƌĞĂƐĞŝŶ/ʃ-ɲ(Gao et al., 2007), and 
ŝŶŚƵŵĂŶƐǁŝƚŚĚŝĂďĞƚŝĐŶĞƉŚƌŽƉĂƚŚǇƚŚĞƌĞǁĂƐĂƐƚƌŽŶŐƉŽƐŝƚŝǀĞĐŽƌƌĞůĂƚŝŽŶďĞƚǁĞĞŶE&ʃ-
B and MCP-1 levels (Mezzano et al., 2004).  Nutritional intervention studies have shown a 
reduction in the innate inflammatory response in the kidney (Sharkey et al., 2009b) and 
altered the adipose tissue inflammatory profile (Sharkey et al., 2009c). 
1.7.4 Apoptosis 
The process of programmed cell death, or apoptosis, is a normal part of tissue development 
and maintenance.  However, evidence shows that programming may result in an 
abnormally increased level of apoptosis.  Intrauterine growth restriction in rats resulted in 
altered mRNA levels for apoptosis-related proteins, increased renal apoptosis and reduced 
nephron number (Pham et al., 2003).  A  maternal low protein diet in rats reduced nephron 
number, increased systolic blood pressure and increased apoptosis in kidneys at eight 
weeks of age, despite the kidneys looking morphologically normal (Vehaskari et al., 2001).  
In fetal kidneys an increase in apoptosis in rat kidneys at embryonic day 13 was observed 
for those fed a low protein diet (Welham et al., 2002).  
1.7.5 Epigenetics 
Epigenetic modifications result in functional changes to the genome without any change in 
the underlying nucleotide sequence and are initiated by, for example, DNA methylation or 
histone acetylation (Ozanne and Constancia, 2007). 
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The methionine-homocysteine pathway and concomitant generation of 1C methyl groups is 
dependent on an adequate provision of amino acids, plus the vitamins B6, B12 and folic 
acid being provided through the diet (Geissler and Powers, 2011).  Rats exposed to a MLP 
diet plus 1 mg/kg folic acid (to offset the dietary reduction) had lower glucocorticoid 
receptor and PPAR gene methylation and higher mRNA levels than the control group 
(normal protein plus 1 mg/kg folic acid; (Lillycrop et al., 2005).  A further group was 
subjected to the low protein diet but with 5 times the amount of folic acid, and there was 
no difference between this group and the controls, suggesting that the additional folic acid 
ameliorated the effects of the low protein diet. A further study (Sinclair et al., 2007), which 
restricted folate, B12 and methionine during the periconceptual period, concluded that this 
modest dietary restriction led to adult offspring with altered immune responses to 
antigenic challenge, decreased insulin sensitivity and elevated blood pressure, and that 
these changes were more evident in males. 
 
1.8 Aims and Hypotheses 
1.8.1 Aims 
This programme of work aims to characterise the effect of a low protein maternal diet 
during early or late gestation on the ewe, the fetus at day 65 gestation, and the offspring at 
two years of age, through assessment of metabolic variables, kidney development and 
renal function.  A further aim is to determine if any changes observed in the fetus or 
offspring are sex-specific. 
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1.8.2 Hypotheses 
1. A maternal low protein diet will have little or no effect upon the nutritional status 
of the ewe. 
2. Restriction of maternal protein intake during early or late gestation will impact 
upon fetal renal development resulting in a reduced nephron endowment.   
3. The different timing of the low protein diet during gestation will lead to different 
phenotypes. 
4. Later in life a nephron deficit coupled with an obesogenic environment will leave 
the adult offspring with a functionally compromised kidney. 
5. Fetal programming of renal disease in the sheep is sex-specific. 
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2. Methods and Materials 
2.1 Summary 
All methods were carried out solely by Louise Lloyd unless acknowledged otherwise below: 
x The diet was formulated by Dr Stewart Rhind, Macauley Institute, Aberdeen. 
x Animal care and sample collection for the first 18 months of study 1 were carried 
out by Dr Rhind and his team, and for the period from 18  W 24 months by Dr David 
Gardner and Phillip Rhodes at the University of Nottingham.  At 24 months Louise 
Lloyd assisted Dr Gardner with gamma scintigraphy as part of a Physiological 
Society summer studentship. 
x Dr David Gardner was responsible for animal care and sample collection for Study 
2. Professor Kevin Sinclair and Louise Lloyd assisted at post mortem. 
Further details of study design and animal procedures are found at section 2.2. 
x Urine and plasma metabolites and protein were measured using an autoanalyser 
and colormetric assay kits (section 2.3) 
x Maternal and fetal plasma amino acids were analysed by Louise Lloyd, but the 
amniotic fluid was measured by Dr Dongfang Li, University of Nottingham (sections 
2.3.3  W 4) 
x Histological stains were used to examine kidney sections for morphological 
differences (section 2.5) 
x Manual and automated immunohistochemistry methods were used to determine 
protein localisation (section 2.6) 
x TUNEL staining (with assistance from Tom Foster) was used to detect DNA 
fragmentation, as an indicator of apoptosis (section 2.7) 
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x Lectin staining was carried out to try to identify endothelial cells in kidney sections 
(section 2.8) 
x Image analysis software was used to quantify glomerular area, TUNEL and 
immunohistochemical staining (section 2.9) 
x Nephron number, total and mean glomerular volume were estimated 
stereologically (section 2.10), and a range of mammalian nephron numbers 
analysed to predict a value for sheep (section 2.11) 
x Gene expression was measured using Quantitative PCR (section 2.12) 
x Corrosion casts were made at post mortem of fetuses in Study 2 by Dr David 
Gardner and Professor Kevin Sinclair.  Weights were measured by Louise Lloyd, and 
surface area and volume were quantified using a CT scanner operated by Craig 
Sturrock, University of Nottingham (section 2.13) 
x Osmolality was measured using a cryoscopic osmometer (section 2.14) 
x Power calculations and statistical analysis were performed using Genstat v13 
(section 2.15). 
2.2 Study Design 
All procedures were performed in accordance with the UK Animals (Scientific Procedures) 
Act, 1986 and were approved by the relevant local ethical review committees of the 
Macaulay Research Institute and the University of Nottingham.  
All chemicals, reagents and equipment were purchased from Fisher Scientific, 
Loughborough, UK unless stated otherwise. 
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2.2.1 Study 1 
2.2.1.1 Macauley Institute, Aberdeen: 0 ʹ 1.5 years of age 
One month prior to mating Scottish Blackface ewes were barn housed in order to improve 
and align their body condition scores.  Two weeks prior to mating a progesterone sponge 
was inserted into the vagina to induce estrus, and removed the day before mating with 
Scottish Blackface rams.  Maternal weight and body condition score was measured 12 
times; four times before mating and eight times during pregnancy.  Thirty-eight pregnant 
Scottish Blackface ewes carrying singleton fetuses were randomly assigned to one of three 
diet groups fed either a control diet providing adequate protein (control protein, CP; n = 
15), a low protein diet during early gestation from day 0 - 65 (low protein early, LPE; n = 17) 
or a low protein diet during late gestation from day 65 to term, 147 d (low protein late, LPL; 
n = 6).  The protein and energy content of the diets are shown in Table 2.1 below. 
Table 2.1: Energy and protein composition of the diets 
Diet Protein (g.kg-1 
crude protein) 
Energy (MJ.kg-1 
DM) 
Protein:energy ratio 
(g.kg.MJ DM-1) 
CP 180 10.6 16.9 
LPE 80 9.2 8.7 
LPL 80 9.2 8.7 
CP, control protein; LPE, low protein early, day 0  W 65 gestation; LPL, low protein late, day 65  W term, DM, dry 
matter 
On an as fed basis, the diets were isocaloric with the effective level of protein restriction 
being 8.7 vs. 17 g crude protein.MJ-1 ME (metabolic energy).  At day 65 gestation (chosen to 
coincide with the mid-point of nephrogenesis in the sheep) a randomly selected sub-group 
of CP (n = 9) and LPE (n = 10) ewes were euthanized (Study 1A, Figure 2.1), and fetal kidneys 
snap frozen in liquid nitrogen and stored at - ? ?ȗ for further analysis.  The remainder (CP, n 
= 6; LPE, n = 7; LPL, n = 6) carried to term and the offspring were delivered naturally (Study 
1B, Figure 2.1). 
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After birth, ewes were offered 1.5 kg of feed and unlimited hay, to ameliorate the effects of 
the diet during gestation on milk quality during lactation.  All male lambs were castrated.  
At two weeks of age the lambs were vaccinated and then lambs and ewes were put to 
pasture.  Ewes were fed 1 kg.day-1 feed pellets (North Eastern Farmers, Aberdeen, UK) for 4 
weeks, and then 0.6 kg.day-1 until weaning at ten weeks of age.  Every three weeks, weights 
and body condition scores were recorded for both ewe and lamb, and a blood sample taken 
from the jugular vein of the lambs.  The sheep were at pasture with the feed supplement 
until euthanised (ewes; a lethal dose of sodium pentobarbital followed by exsanguination) 
or transferred to the Sutton Bonington Campus of the University of Nottingham at 1.5 years 
of age (offspring).  
2.2.1.2 University of Nottingham, Sutton Bonington: 1.5 ʹ 2 years of age 
On arrival at the University of Nottingham, the offspring were weighed and had their body 
condition score assessed.  After a brief period of acclimatisation of four weeks the sheep 
were exposed to an obesogenic environment, specifically designed to encourage weight 
gain, being fed to 150% ME requirements, and barn housed to restrict physical activity, and 
reduce energy expenditure needed for thermogenesis.  All animals were weighed weekly to 
monitor the weight gain, and the endpoint was an approximately 50% weight gain, as this 
represented a theoretical gain in body mass index (BMI) from 22.5 to 32.5 kg.m-2, i.e. from a 
normal to an obese BMI  (World Health Organisation, 2000).  After six months (at two years 
of age) in vivo renography was performed on all animals, with the sheep being 
subsequently euthanized (one week later) by electrocortical stunning with exsanguination.  
Urine was sampled from the bladder at post mortem.  The right kidney was snap frozen in 
liquid nitrogen and stored at - ? ?ȗand the left fixed in neutral buffered formalin (NBF), 
rinsed in 0.02 M phosphate buffered saline (PBS) for 24 h and then stored in 70% ethanol at 
room temperature. 
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Figure 2.1: Experimental design for Study 1 
 CP, control protein; LPE, low protein early; LPL, low protein late. 
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2.2.2 Study 2 
Fifty-six Scottish Blackface ewes were weighed, body condition scored (1 = very thin to 5 = 
obese) and gradually acclimatised to the environment at Sutton Bonington over a one-
month period, prior to a baseline blood sample being taken by venepuncture.  Over this 
period, sheep were fed 600 g concentrate with unlimited hay being available.  Ewes were 
oestrus synchronised using progesterone sponges and after 14 days were artificially 
inseminated by laparoscopy with semen from a Scottish Blackface ram.  This was 
designated as day 0 of pregnancy and at this time, an equal number of ewes were randomly 
allocated to a control or low protein diet.  The sheep were fed these diets (900 g pellets 
with 100 g hay) until day 65 gestation.  On two occasions (days 17 and 18) pregnancy was 
confirmed by measurement of progesterone (Ridgeway Science, UK) and non-pregnant 
ewes were returned to stock.  Ewe weights, body condition score and blood samples were 
collected on four further occasions to day 65.  
From 56 ewes, seven were found to be non-pregnant, and upon completion of the study 
and retrieval of the products of conception it was found that 18 ewes carried either triplet 
or singleton pregnancies.  Only twin-bearing ewes (n = 31) were entered into the study for 
analysis.  Hence, thirty-one pregnant Scottish Blackface ewes carrying twin fetuses (n = 62 
fetuses) were randomly assigned to one of two diet groups fed either a control diet 
providing adequate protein (control protein, CP; n = 15), or a low protein diet during early 
gestation from day 0 - 65 (low protein early, LPE; n = 16).  The study design is summarised 
in Figure 2.2.  The protein and energy content of the diets are shown in Table 2.1 above. 
Blood samples were taken from the ewe prior to mating, and at days 28, 42 and 65 of 
pregnancy.  The blood was withdrawn into K+-EDTA tubes, centrifuged at 3000 rpm (800 g) 
for 10 min, and the resulting plasma taken and stored at -20°C.  At day 65 of gestation the 
sheep were euthanized by barbiturate overdose and the twin fetuses retrieved.  Fetal blood 
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samples were withdrawn from the umbilical artery into K+-EDTA tubes, centrifuged and the 
plasma removed and stored at -20°C. Amniotic fluid was sampled from each fetus and 
stored at -20° C.  One twin from each pair was corrosion cast (CP, n = 6 males and n = 8 
females; LPE, n = 8 males and n = 7 females), and from the other twin (CP, n = 8 males and n 
= 8 females; LPE, n = 9 males and n = 8 females) the right kidney was snap frozen in liquid 
nitrogen and stored at - ? ?ȗand the left fixed in 4% w/v paraformaldehyde, rinsed in 0.02 
M PBS for 24 h and then stored in 70% ethanol at room temperature.  
 
Figure 2.2: Experimental design for Study 2 
CP, control protein; LPE, low protein early 
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2.3 Blood and Urine Analysis 
2.3.1  Urine Analysis 
Urine from adult offspring at two years of age was collected from the bladder at post-
mortem and albumin (g.l-1) and creatinine (µmol.l-1) were measured using a Randox Rx 
Imola autoanalyser and quantitative colorimetric assay kits (Randox Laboratories, Co 
Antrim, UK).   
2.3.1.1 Albumin 
Albumin levels were determined using a Randox albumin kit.  Albumin has the ability to 
bind to bromocresol green in a quantitative manner.  The albumin-bromocresol green 
complex can then be detected as it absorbs maximally at 578 nm. 
2.3.1.2 Creatinine 
Creatinine levels were determined enzymatically using a Randox creatinine kit.  Creatinine 
deaminase converts creatinine and H2O to N-Methylhydantoin and ammonia.  Glutamate 
dehydrogenase catalyses ammonia and ɲ-ketoglutarate in the presence of NADPH to form 
glutamate and NAD+.  The absorbance decrease (at 340 nm) due to NADPH reduction is 
proportional to the concentration of creatinine.  
2.3.2 Plasma Analysis: Randox Imola 
All two-year old offspring plasma samples from Study 1 were defrosted and analysed for 
sodium, potassium and chloride using a Randox Rx Imola autoanalyser and quantitative 
colorimetric assay kits (Randox Laboratories, Co Antrim, UK).  All maternal plasma samples 
from Study 2 were defrosted and analysed for glucose, non-esterified fatty acids (NEFA), 
triglycerides, albumin, total protein, urea, lactate and D-3-hydroxybutarate.  Fetal plasma 
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samples from Study 2 were defrosted and analysed for glucose and lactate only.  All 
concentrations were measured in mmol.l-1 unless stated otherwise. 
2.3.2.1 Sodium 
Sodium concentrations were determined enzymatically using a Randox sodium kit.  O-
nitrophenol-ɴ-D-galactopyranoside (OPNG) is added to the plasma.  Ȳ-galactosidase 
hydrolyses sodium + OPNG to form o-nitrophenol, which is yellow.  The absorbance of the 
yellow product is measured at 405 nm.  
2.3.2.2 Potassium 
Potassium was determined enzymatically using a Randox potassium kit.  Pyruvate kinase 
reacts with phosphoenolpyruvate to yield pyruvate.  The pyruvate reacts with NADH in the 
presence of lactate dehydrogenase to form lactate and NAD.  This causes a decrease in 
absorbance at 340 nm which is proportional to the concentration of potassium. 
2.3.2.3 Chloride 
Chloride concentrations were determined using a Randox chloride kit, using a thiocyanate 
method.  Mercurious thiocynate reacts with the chloride ions to form mercury perchlorate 
and thiocyanate.  The thiocyanate forms a red complex with ferric chloride and the 
absorbance of the red dye is measured at 500 nm. 
2.3.2.4 Glucose 
Glucose concentrations were determined using a Randox glucose kit, which uses the 
hexokinase method.  The action of the hexokinase enzyme results in D-glucose being 
phosphorylated with an ATP molecule to form glucose-6-phosphate.  Glucose-6-phosphate 
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dehydrogenase catalyses G6P in the presence of NADP, to form 6-phosphogluconate and 
NADPH.  The absorbance of NADPH is measured at 340 nm. 
2.3.2.5 NEFA 
NEFA concentrations were determined using a Randox NEFA kit.  The enzyme acyl-CoA 
synthetase is added to plasma and allows NEFA to form thiol esters of coenzyme A (acyl-
CoA) in the presence of adenosine triphosphate (ATP), magnesium cations and CoA.  
Hydrogen peroxide is produced when Acyl-CoA is oxidised by acyl WCoA oxidase.  Peroxidase 
enzymes then catalyse 3-methylN-(hydroxyethylanaline) with 4-aminoantipyrine in the 
presence of hydrogen peroxide to form a purple coloured adduct which is maximally 
absorbed at 550 nm. 
2.3.2.6 Triglycerides 
Triglyceride concentrations were determined using a Randox triglyceride kit, which utilises 
the GPO-PAP method.  The triglycerides undergo enzymatic hydrolysis using lipases.  
Peroxidase then catalyses hydrogen peroxide, 4-aminophenazone and 4-chlorophenol to 
produce quinoneimine, which is maximally absorbed at 540 nm. 
2.3.2.7 Albumin 
Albumin levels were determined using a Randox albumin kit, see 2.3.1.1.   
2.3.2.8 Total protein 
Total protein concentration was determined using a Randox total protein kit, and was 
measured in g.l-1.  The kit uses the Biuret method: under alkali conditions peptides form a 
violet-coloured complex with copper ions.  The intensity of the colour, and therefore the 
absorption at 540 nm, is directly proportional to the concentration of protein. 
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2.3.2.9 Urea 
Urea concentration was determined using a Randox urea kit, utilising a kinetic method.  The 
urea is hydrolysed in the presence of water and the enzyme urease to form ammonia and 
CO2.  Glutamate dehydrogenase catalyses the ammonia to react with a-oxoglutaric acid and 
NADH2, to form glutamic acid and NAD+.  The absorbance decrease (at 340 nm) due to 
NADH2 reduction is proportional to the concentration of urea.  
2.3.2.10 Lactate 
Lactate concentration was determined using a Randox L-Lactate kit.  The kit uses an 
enzymatic method, where lactate oxidase catalyses the oxidation of L-lactate to form 
pyruvate and H2O2.  The H2O2 is catalysed with a peroxidase to form a purple dye.  The 
intensity of the dye (absorbed at 550 nm) is proportional to the lactate content. 
2.3.2.11 D-3-hydroxbutyrate 
D-3-hydroxybutyrate concentration was determined using a Randox ranbut 
(hydroxybutyrate) kit.  This is a kinetic enzymatic method.  The enzyme 3-Hydroxybutyrate 
dehydrogenase oxidises D-3-hydroxybutyrate to form acetoacetate.  Concurrently NAD+ is 
reduced to NADH and the associated change of absorbance at 340 nm can be directly 
correlated with the D-3-hydroxybutyrate concentration. 
2.3.2.12 Quality control 
Experimental samples were run in duplicate, and each run contained the same two quality 
control (QC) samples.  Inter-assay variation was calculated from the variance from the QC 
samples, and intra-assay variation from the variance of the duplicate experimental samples.  
Intra-assay variance ranged from 0.35  W 3.52, and inter-assay from 3.23  W 7.07.   
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2.3.3 Plasma Analysis: Amino acids 
Amino acids were isolated from maternal and fetal plasma and derivatised using the 
 PĨĂĂƐƚ ?ŵŝŶŽĐŝĚ<ŝƚ ?WŚĞŶŽŵĞŶĞǆ ?DĂĐĐůĞƐĨŝĞůĚ ?h< )ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ
protocol.   
2.3.3.1 Amino acid extraction 
&ŝĨƚǇʅůŽĨƉůĂƐŵĂĂŶĚ ? ? ?ʅůŽĨŝŶƚĞƌŶĂůƐƚĂŶĚĂƌĚƐŽůƵƚŝŽŶ ? ? ?ŶŵŽůŶŽƌǀĂůŝŶĞ )ǁĂƐƉŝƉĞƚƚĞĚ
into a preparation vial, and then passed very slowly throƵŐŚĂƚŝƉĐŽŶƚĂŝŶŝŶŐ PĨĂĂƐƚ ?ƐŽůŝĚ
ƉŚĂƐĞĞǆƚƌĂĐƚŝŽŶƐŽƌďĞŶƚƵƐŝŶŐĂƐǇƌŝŶŐĞ ?EĞǆƚ ? ? ?ʅůŽĨǁĂƐŚŝŶŐƌĞĂŐĞŶƚ ?ƐŽĚŝƵŵ
ĐĂƌďŽŶĂƚĞ )ǁĂƐƉĂƐƐĞĚƚŚƌŽƵŐŚƚŚĞƐŽƌďĞŶƚƚŝƉ ?ďĞĨŽƌĞ ? ? ?ʅůĞůƵƚŝŶŐŵĞĚŝƵŵ ?ƉƌŽƉƌĂŶŽů
and sodium hydroxide) was drawn up into the tip and then expelled along with the sorbent 
ĐŽŶƚĂŝŶŝŶŐƚŚĞĂŵŝŶŽĂĐŝĚƐŝŶƚŽĂĐůĞĂŶǀŝĂů ?&ŝĨƚǇʅůŽĨĐŚůŽƌŽĨŽƌŵĂŶĚŝƐŽŽĐƚĂŶĞǁĞƌĞ
sequentially added to derivatise the amino acids and the resulting organic layer was 
recovered.  The organic layer containing the amino acids was dried down using nitrogen, 
ĂŶĚƚŚĞƐĂŵƉůĞƌĞĚŝƐƐŽůǀĞĚŝŶ ? ? ?ʅůŝƐŽ-octane:chloroform (4:1 v/v).  Where necessary the 
amino acids were stored at -20°C for up to 12 hours whilst other samples were prepared. 
Amino acid standards were prepaƌĞĚƵƐŝŶŐƚŚĞƐĂŵĞŵĞƚŚŽĚ ?ǁŝƚŚ ? ?ʅůŽĨ PĨĂĂƐƚ
ƐƚĂŶĚĂƌĚƐŽůƵƚŝŽŶƐ ?ĂŶĚ ?ĂĚĚĞĚƚŽ ? ? ?ʅůŝŶƚĞƌŶĂůƐƚĂŶĚĂƌĚ ?ƐƚĂŶĚĂƌĚǁĂƐƌƵŶĞǀĞƌǇ ? ?
samples, to check for consistency. 
2.3.3.2 Gas Chromatography ʹ Mass Spectrometry 
 One µl of each amino acid sample was injected in splitless mode (split closed for 10s) using 
an AS3000 autosampler (Thermo, Manchester, UK).  The injector of the Trace GC Ultra gas 
chromatograph (Thermo) was kept at 250°C, with a starting oven temperature of 90°C 
which was increased to 320°C at the rate of 20°C min-1 (transfer line from the oven to mass 
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spectrometer was 300°C).  Helium (8 psi) was used as the carrier gas to elute the amino 
acids from the ZB-AAA column (10 m x 0.25 mm ID).  
The DSQ II mass spectrometer (Thermo) was operated in selected ion mode recording ions 
84, 101, 114, 116, 130, 144, 146, 155, 156, 158, 172, 180, 184, 243 and 244 with a dwell 
time of 0.03s.  To calibrate the data the peak areas for the amino acids in the standards and 
samples were adjusted for variation in the peak area of the internal standard. 
2.3.4 Amniotic Fluid: Amino Acids 
Dr Dongfang Li carried out this analysis on behalf of the study.  In brief, 980 µl of the plasma 
sample and 20 µl internal standard norleucine were added to a conical centrifuge tube 
containing 60 mg of solid 5-sulphosalicylic acid (SSA), immediately mixed and allowed to 
stand for 1 hour at 4°C.  Next the mixture was centrifuged for 15 minutes at 4°C in a high 
speed centrifuge to spin down the precipitate, and the supernatant was removed and 
filtered through a 0.2 µm filter.  Standard solutions of amino acids were prepared in the 
same way.  Finally, 20 µl of treated standards or sample were injected to a Biochrom 20 
amino acid analyser (Pharmacia LKB, Biochrom Ltd, Cambridge, UK) and peak integration 
was performed using EZChrom Elite software.  This method successfully measured 19 out of 
the 20 amino acids. 
2.4 Gamma Scintigraphy 
This work was carried out during a Physiological Society summer studentship in 2007. 
Adult sheep were restrained and stood underneath a gamma camera, and a radioactive 
nuclide 100 megabecquerels (MBq) technetium-99 diethylenetriaminepentaacetic acid 
(Tc99m-DTPA) was injected (i.v. 0.5 ml-1 0.9% NaCl) into the jugular vein.  Sixty frames were 
captured over a 20 min period and a dynamic renogram (adjusted for movement artefact, 
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background and bolus deconvolution) was produced for the left and right kidney. Specific 
measurements of interest were: 
x time to peak (min), i.e. how quickly the maximum amount of Tc99m-DTPA is 
detected in the kidney 
x upslope (counts per minute, cpm): the slope upwards as the radioactive nuclide 
increases towards its peak 
x  downslope (cpm): the downward slope as the nuclide leaves the kidney 
x transit-time (min): a composite of all previous measurements, which measures the 
time the Tc99m-DTPA takes to pass through the kidney. 
The time to peak and upslope are indicative of the rate of uptake of tracer into the kidney, 
whereas the downslope is indicative of the rate of tracer clearance.  
In addition, at 3, 4 and 5 h after injection, 5 ml venous blood was drawn from the 
contralateral jugular cannula, centrifuged in heparinised tubes, and plasma collected.  This 
was used to determine the glomerular filtration rate (GFR) using the method described by 
(Gleadhill et al., 1999).  In brief, duplicate 1 ml plasma aliquots, along with timed control 
samples were measured on a gamma counter and the GFR determined by the decline in 
radioactivity over time. 
2.5 Histology 
2.5.1 Sample preparation 
Random samples were taken from the NBF or paraformaldehyde-fixed tissues and 
processed (Tissue processor TP1020, Leica, Germany) by increasing concentrations of 
ethanol to dehydrate the tissue, followed by clearing with Histoclear, and impregnating 
with paraffin wax (Table 2.2).  
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Sections were embedded at random orientations (Paraffin Embedding Center EG1160, 
Leica) in cassettes containing paraffin wax.  All cassettes were given a code unrelated to the 
animal number so all analyses were blinded.  Sections were cut using a microtome 
(Microtome RM2255, Leica) at 5 µm thick and mounted onto Menzel polysine slides (Fisher 
Scientific, Loughborough, UK). 
Table 2.2: Protocol for processing tissues 
Step Chemical Time 
1 70% ethanol 60 min 
2 80% ethanol 60 min 
3 95% ethanol 60 min 
4 100% ethanol 30 min 
5 100% ethanol 30 min 
6 100% ethanol 30 min 
7 100% ethanol 30 min 
8 Histoclear 60 min 
9 Histoclear 60 min 
10 Histoclear 60 min 
11 Paraffin wax 60 min 
12 Paraffin wax 90 min 
 
2.5.2 Haematoxylin and Eosin Staining 
Sections were stained with Haematoxylin and Eosin (H&E), using a standard protocol.  In 
brief, the sections were dewaxed in histoclear (2 x 5 min), then rehydrated through a series 
of ethanol baths (100%, 95% and 70% ethanol) for 2 min each, and then rinsed in tap water.  
They were stained in Harris haematoxylin for 2 min (adult kidney tissue) and 1 min (fetal 
tissue).  After differentiation in 1% alcohol (2 dips) and bluing in ammoniated water  (2 dips) 
the sections were counterstained in eosin (VWR, Lutterworth, UK) for 4 min (adult tissue) or 
3 min (fetal), before being dehydrated back through the series of ethanol baths, and 
cleared in xylene (2 x 5 min).  The sections were mounted with glass coverslips using DPX 
mountant (Sigma-Aldrich, Dorset, UK).  
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2.5.3 WĞƌŝŽĚŝĐĐŝĚ^ĐŚŝĨĨ ?ƐZĞĂŐĞŶƚ^ƚĂŝŶŝŶŐ 
Adult kidney sections were dewaxed in histoclear (2 x 5 min), then rehydrated through a 
series of ethanol baths (100%, 95% and 70% ethanol) for 2 min each, and then rinsed in tap 
water.  They were oxidised in 0.5% periodic acid solution (VWR, Lutterworth, UK) for 5 min.  
EĞǆƚƚŚĞƐĞĐƚŝŽŶƐǁĞƌĞƌŝŶƐĞĚŝŶǁĂƚĞƌďĞĨŽƌĞďĞŝŶŐƐƚĂŝŶĞĚǁŝƚŚ^ĐŚŝĨĨ ?ƐƌĞĂŐĞŶƚ ?stZ ?
Lutterworth, UK) for 15 min, and then rinsed in tap water for 8 min.  The sections were 
counterstained in haematoxylin for 1 min.  After differentiation in 1% alcohol (2 dips) and 
bluing in ammoniated water (2 dips) the sections were dehydrated back through the series 
of ethanol baths, and cleared in xylene (2 x 5 min).  The sections were mounted with glass 
coverslips using DPX mountant. 
2.5.4 Trichrome Staining 
Adult kidney sections were dewaxed in histoclear (2 x 5 min), rehydrated through a series 
of ethanol baths (100%, 95% and 70% ethanol) for 2 min each and then rinsed in tap water.  
dŚĞǇǁĞƌĞƐƚĂŝŶĞĚŝŶ,ĂƌƌŝƐ ?ŚĂĞŵĂƚŽǆǇůŝŶĨŽƌ ? ?ŵŝŶ ?ĨƚĞƌĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶŝŶ ?A?ĂůĐŽhol (2 
dips) and bluing in ammoniated water (2 dips) the sections were placed in  
phosphomolybdic acid for 2.5 min, then into Orange G  for 5 min, before being rinsed in tap 
water.  The sections were  put in 1% acetic acid for 2 min, and then in Fast Green for 5 min 
before being returned to the 1% acetic acid for a further 3 min.  The sections were rinsed in 
95% ethanol before being dehydrated back through 95% and 100% ethanol baths (3 min 
each), and cleared in xylene (2 x 5 min).  The sections were mounted with glass coverslips 
using DPX mountant.  
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2.6 Immunohistochemistry 
2.6.1 VECTASTAIN Elite ABC System 
Immunohistochemistry (IHC) was carried out using The VECTASTAIN Elite ABC system 
(Vector Labs, Peterborough, UK).  All steps were carried out at room temperature unless 
stated otherwise.  Antibody dilutions are given in the individual experimental chapters. 
Random samples were taken from NBF (Study 1) or paraformaldehyde (Study 2) fixed 
tissues, embedded in paraffin and sectioned at 5 µm (Microtome RM2255, Leica) onto 
Menzel polysine slides.  Slides were coded to allow for blinded analysis. 
Slides were de-waxed in xylene (2 x 5 min) and rehydrated through a series of ethanol baths 
(100%, 95%, 70%) and into distilled water for 5 min each.  Next the slides were equilibrated 
in PBS (Invitrogen Life Technologies, Paisley, UK) for 2 x 5 min.  The slide surrounding the 
sample was carefully dried (taking care to keep the sample hydrated), the sample was 
circled with a hydrophobic barrier pen (ImmEdge pen, Vector Labs, Peterborough, UK) and 
the slides were placed onto a shelf in a humidity chamber.  Endogenous peroxidises were 
inactivated using 3% H2O2 for 15 min, then rinsed in PBS for 2 x 5 min.   An avidin-biotin 
blocking kit (Vector Labs, Peterborough, UK) was used to block endogenous biotin, with 
avidin applied for 15 min, rinsed in PBS, then blocked with biotin for 15 min, before being 
rinsed in PBS again.  Non-specific binding was prevented by applying a block of 20% normal 
goat serum (diluted in PBS) for 30 min.  Primary antibodies were diluted in PBS + 0.05% 
Tween 20 (Sigma Aldrich, Gillingham, UK) and incubated in a fridge overnight at 4°C.  The 
next day unbound antibody was removed by rinsing slides in PBS for 2 x 5 min, before 
incubating with the secondary antibody (Biotinylated Goat anti-rabbit IgG, Vector Labs) 
diluted 1:200 in PBS + 0.05% Tween for 30 min.  This was followed by 2 x 5 min washes in 
PBS to remove the unbound secondary antibody.  Next the samples were incubated with 
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Vectastain® Elite ABC Reagent (Vector Labs) for 30 min, before rinsing in PBS (2 x 5 min). 
The staining was visualised using a  ? ? ? ?ĚŝĂŵŝŶŽďĞŶǌŝĚŝŶĞ ?A? )ƐƵďƐƚƌĂƚĞkit (Vector 
Labs).  To 2.5 ml distilled water, one drop of buffer, two drops of DAB substrate, and 1 drop 
of H2O2 were added.  This was applied to each tissue section and developed for 2 min (fetal 
tissue) and 4 min (adult tissue).  When the appropriate intensity of stain was achieved, 
slides were immersed in running tap water and rinsed for 5 min.  The samples were then 
counterstained using haematoxylin and mounted as described previously (see 2.5.2).   
Negative controls were omission of primary antibody, and rabbit IgG.  Positive controls for 
each experiment are listed in the experimental chapters. 
2.6.2 BondMax System 
Random samples were taken from NBF-fixed tissues, embedded in paraffin and sectioned at 
5 µm (Microtome RM2255, Leica) onto Menzel polylysine slides.  Slides were coded to allow 
for blinded analysis. 
Samples were stained using the Leica BOND-Dy ?ĂƵƚŽŵĂƚĞĚƐǇƐƚĞŵ ?ƵƐŝŶŐReady-to-use 
ŽŶĚ ?ƌĞĂŐĞŶƚƐ ?>ĞŝĐĂ ?tĞƚǌůĂƌ ?'ĞƌŵĂŶǇ ).  Sections were dewaxed and then antigen 
retrieval performed for 10 min using EDTA pH9.  Protocol X was selected, with a peroxidise 
block, followed by incubation with primary antibodies diluted in Bond Primary Antibody 
Diluent at room temperature for 30 min.  The secondary antibody, polymer and DAB were 
applied sequentially for 10 min each.  The specimens were counterstained with 
haematoxylin, then rehydrated with ethanol and cleared with Xylene before being mounted 
using DPX mountant. 
Negative controls were omission of primary antibody, and rabbit IgG.  Positive controls are 
listed in the relevant experimental chapters. 
 62 
2.6.3 Vascular Endothelial Growth Factor A 
The ovine VEGFA protein sequence was checked against the sequences of other large 
mammals using the CLUSTAL 2.1 multiple sequence alignment tool (European 
Bioinformatics Institute, 2012) and had high homology (99% with bovine, 96% porcine, 95% 
equine and 93% human).  The VEGFA antibody is a rabbit polyclonal IgG with epitope 
mapping at the N-terminus of human VEGFA which is identical to ovine VEGFA in that 
region (see Table 2.3). 
Table 2.3: Clustal 2.1 sequence alignment for ovine and human VEGFA 
Accession 
Number 
Species Amino acids 
gi|3228693 
gi|3719221 
Ovis aries 
Homo sapiens 
MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGG-QKPHEVMKFMDVYQRS 
MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRS 
********************************* *: ***:********* 
gi|3228693 
gi|3719221 
Ovis aries 
Homo sapiens 
FCRPIETLVDIFQEYPDEIEFIFKPSCVPLMRCGGCCNDESLECVPTEEF 
YCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCSNDEGLECVPTEES 
:*:*****************:***************.***.******** 
gi|3228693 
gi|3719221 
Ovis aries 
Homo sapiens 
NITMQIMRIKPHQSQHIGEMSFLQHNKCECRPKKDKARQENPCGPCSERR 
NITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQENPCGPCSERR 
*************.*********************:************** 
gi|3228693 
gi|3719221 
Ovis aries 
Homo sapiens 
KHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 
KHLFVQDPQTCKCSCKNTHSRCKARQLELNERTCRCDKPRR 
******************.********************** 
 
2.6.4 CD31 and CD34 
CD31 and CD34 were selected for their properties as markers of endothelial cells.  
However, the ovine CD31 and CD34 protein sequences are not available.  In such cases it is 
conventional to use bovine sequences as they tend to have greater homology to ovine.  
Using the CLUSTAL 2.1 multiple sequence alignment tool (European Bioinformatics 
Institute, 2012) the homology between bovine CD31 and CD34 and that of other mammals 
was 100% (human, mouse, pig, horse), therefore  it is likely that these proteins are highly 
conserved between species.  As there were no published papers using CD31 or CD34 
antibodies in sheep at this time, four antibodies were trialled, for which details are given in 
Table 2.4. 
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Table 2.4: Antibody details for CD31 and CD34 
Antibody Abcam ref Polyclonal or 
monoclonal 
Epitope mapping 
(amino acid number) 
Dilutions 
CD31 ab32457 Polyclonal  600  W 700 1:100, 200, 500, 1000, 2000 
CD31 ab83959 Polyclonal 700  W C-terminus 1:50, 100, 250, 500, 1000 
CD34 ab63985 Polyclonal 1 - 100 1:50, 100, 250, 500, 1000 
CD34 ab81289 Monoclonal C-terminus 1:25, 50, 100, 250, 500, 1000 
 
2.7 TUNEL Staining 
&ĞƚĂůŬŝĚŶĞǇƐĞĐƚŝŽŶƐǁĞƌĞƐĞĐƚŝŽŶĞĚĂƚ ?ʅŵƚŚŝĐŬ ?ĂŶĚƚhe presence of apoptotic nuclei 
was determined using a terminal deoxynucleotidyl transferase dUTP nick-end labelling 
(TUNEL) kit (dĚd&ƌĂŐ> ?EĨƌĂŐŵĞŶƚĂƚŝŽŶĚĞƚĞĐƚŝŽŶŬŝƚ; Calbiochem, Nottingham, UK) 
ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů ?All steps were undertaken at room temperature, 
and slides were rinsed between stages with 1x TBS (20 mM Tris pH 7.6, 140 mM NaCl) 
unless stated otherwise.  
Sections were deparaffinised in xylene, and then rehydrated through a series of 100%, 90%, 
80% and 70% ethanol baths.  The slides were rinsed briefly in 1x TBS, and then the samples 
circled with a paraffin pen (ImmEdge hydrophobic barrier pen; Vector Labs, Peterborough, 
UK).  EĞǆƚƚŚĞƐĂŵƉůĞƐǁĞƌĞƉĞƌŵĞĂďŝůŝƐĞĚǁŝƚŚ ?ŵŐ ?ŵů-1 Proteinase K diluted 1:100 in 10 
mM Tris pH8 for 20 min, before endogenous peroxidises were inactivated with 3% H2O2 for 
5 min.  
Samples were equilibrated with 1x TdT Equilibration buffer for 10 min, before the excess 
was blotted, and then incubated with TdT enzyme diluted 1:20 with TdT Labeling Reaction 
Mixture Ăƚ ? ?ȗĨŽƌ ? ? ?ŚŽƵƌƐŝŶĂŚƵŵŝĚŝĨŝĞĚĐŚĂŵďĞƌ ? The reaction was terminated using 
Stop Solution for 5 min.  Next, blocking buffer was applied for 10 min, then the excess was 
blotted and samples incubated with 1x conjugate for 30 min in a humidified chamber.  
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Apoptotic nuclei were detected after 10 min incubation with  ? ? ? ?ĚŝĂŵŝŶŽďĞŶǌŝĚŝŶĞ (DAB) 
solution.  After rinsing in dH2O, the samples were counterstained with methyl green for 3 
min, rehydrated through a series of ethanol baths, cleared with Xylene and mounted with 
DPX.  
Omission of primary antibody was used as a negative control.  A mixture of HL60 cells 
incubated with 0.5 ʅg/ml actinomycin D for 19 hours to induce apoptosis was used as a 
positive control. 
2.8 Lectin Staining 
Surface carbohydrates on vascular endothelial cells act as ligands for mammalian lectins 
(Rhodes and Milton, 1998).  Griffonia simplicifolia lectin 1 isolectin B4 (GSL1B4) was selected 
as this binds to murine endothelial cells and most species apart from humans (Laitinen, 
1987).   
Sections were deparaffinised in xylene and then rehydrated through a series of 100%, 95%, 
and 70% ethanol baths.  The slides were placed in distilled H2O for 5 min and then in PBS for 
5 min.  The samples were circled with a paraffin pen, and endogenous peroxidises were 
inactivated using 3% H2O2 for 5 min before being rinsed in PBS (2 x 5 min).   
An avidin-biotin blocking kit (Vector Labs, Peterborough, UK) was used to block endogenous 
biotin (15 min with avidin, rinsed with PBS, then 15 min with biotin) and then the samples 
were covered with Carbo-free blocking solution (Vector Labs, Peterborough, UK) for 30 min 
to prevent non-specific binding.   
The excess solution was tipped off, then the samples were incubated with biotinylated 
Griffonia (Bandeiraea) simplifolia lectin 1 isolectin B4 (Vector Labs, Peterborough, UK). 
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Next the samples were incubated with Vectastain® Elite ABC Reagent (Vector Labs) for 30 
min, before rinsing in PBS (2 x 5 min).  The staining was visualised using a  ? ? ? ?
diaminobenzidine (DAB+) substrate kit (Vector Labs).   To 2.5 ml distilled water, one drop of 
buffer, two drops of DAB substrate, and 1 drop of H2O2 were added.  This was applied to 
each tissue section and developed for 5 min.  When the appropriate intensity of stain was 
achieved, slides were immersed in running tap water and rinsed for 5 min.  The samples 
were then counterstained using haematoxylin and mounted as described previously (see 
2.4.2).   
Omission of primary antibody and 500 mM galactose (a competing sugar) were used as 
negative controls.  Bovine ovary was used as a positive control. 
2.8.1 Optimisation 
GSL1B4 ǁĂƐĚŝůƵƚĞĚĂƚ ? ? ? ? ? ? ?ĂŶĚ ? ?ʅů ?ŵů-1, and incubated for either 2 hours at room 
temperature, or overnight at 4°C.  These variations were tried both with and without 
antigen retrieval.  Antigen retrieval was carried out after the sections were rehydrated 
through xylene and a series of ethanol baths.  A pressure cooker containing 1x citrate buffer 
was used, with the samples immersed in the pressure cooker for 2 min 30 sec, before the 
steam was released and the samples left to cool for 30 min.  Next the samples were rinsed 
in PBS twice for 5 min, before carrying on with the peroxidise blocking step shown in 2.8. 
Other optimisation steps included increasing blocking steps to try to remove non-specific 
staining, and decreasing the incubation time with the DAB substrate. 
 66 
2.9 Image Analysis 
Image Analysis was carried out using ImagePro MC 6.0 software, to quantify 2D glomerular 
area, immunohistochemical staining, and TUNEL staining.  Macros were written to 
automate the processes.  
2.9.1 Quantification of glomerular area 
Sections stained with H&E were used to assess mean glomerular area  ?ʅŵ3) of the adult 
kidneys.  Using a light microscope (Leica, Germany) and x200 magnification, twenty 
glomeruli were randomly selected per adult animal and photographed.  The glomerular 
area for each glomeruli was calculated using Image Pro MC 6.0 software.  Figure 2.3 shows 
the process, whereby each glomerulus is identified (A), then circled (B), before the circled is 
filled and the black area measured.  Each measurement was automatically exported to an 
Excel spreadsheet, and the mean from 20 glomeruli per animal calculated. 
 
Figure 2.3: Quantification of 2D glomerular area on Image Pro MC 6.0 
Microphotographs were taken (A) and glomeruli outlined in green (B).  The region outlined was filled in (C) and 
the software calculated the area. 
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2.9.2 Quantification of Immunohistochemical staining 
Sections stained as per the methods described in 2.6.1 or 2.6.2 were used to assess the 
amount of antibody staining.  Using a light microscope (Leica, Germany) and x200 
magnification, twenty images of random areas were photographed.  The amount of staining 
was calculated using Image Pro MC 6.0 software.  For each field of view, brown DAB 
staining was picked up by the software and its percentage area relative to the whole picture 
calculated.  Each measurement was automatically exported to an Excel spreadsheet, and 
the mean from 20 fields of view per animal calculated.  For quality control purposes three 
100 x 100 µm sections were counted by eye and compared with the automated results.  
Variation was <5% between the methods. 
2.9.3 Quantification of TUNEL positive cells 
Sections stained as per the method described in 2.7 were used to assess the amount of 
TUNEL positive cells. Using a light microscope (Leica, Germany) and x200 magnification, 
twenty images of random areas were photographed. The number of TUNEL positive cells 
was calculated using Image Pro MC 6.0 software.  For each field of view the number of cells 
stained brown with DAB was counted by the software, along with the number of cell nuclei 
stained blue with haematoxylin.  Each measurement was automatically exported to an 
Excel spreadsheet, and percentage of TUNEL positive cells was calculated using the formula: 
Number of TUNEL positive cells ÷ Total number of cells x 100 
The mean from 20 fields of view per animal was calculated.  For quality control purposes 
three 100 x 100 µm sections were counted by eye and compared with the automated 
results.  Variation was <5% between the methods. 
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2.10 Stereology 
Sheep kidneys were previously halved and snap frozen, then defrosted and fixed in NBF. 
The volume of the total kidney was calculated using water displacement. 
2.10.1 Random systematic sampling 
Figure 2.4 details the random systematic sampling method.  First, each half kidney was cut 
into 3 mm slices (Figure 2.4A).  Depending on the size of the kidney this meant a range of 8-
12 slices.  Next a dice was rolled to select a random starting point (in this case number 3), 
and the dice rolled again (again, number 3); hence, every third slice was taken for sampling, 
starting with the third section (Figure 2.4B). 
Each randomly selected slice was then cut vertically into 5 mm strips, and horizontally every 
10 mm (range 6 -18 segments).  A dice was rolled again (randomly selecting number 5), 
hence every 5th piece was taken (from the random start point of 3 previously selected) 
counting from left to right, top to bottom then moving to the next slice until 6 samples 
were obtained from each animal (Figure 2.4C).  The six samples were processed (see 2.5.1), 
and then embedded (Paraffin Embedding Center EG1160, Leica) at random orientation in 
cassettes containing paraffin wax.  All cassettes were given a code unrelated to the animal 
number so all analysis was carried out blind.  
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Figure 2.4: Random, systematic sampling method 
A, the kidney is cut into 3 mm slices; B, every third slice is selected; C, every fifth segment is selected, until six in 
total are collected. 
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2.10.2 Cortex:medulla ratio 
Sections were cut using a microtome (Microtome RM2255, Leica) at 5 µm thick and 
mounted onto polysine slides and stained using H&E (see 2.5.2). 
Using a slide box (PathScan Enabler IV, Electron Microscopy Sciences) the whole of each 
section was photographed at high resolution and was used to estimate the ratio of the 
cortex to medulla, using the Cavalieri Principle which gives an unbiased volume estimate 
based upon reference areas on sections.  First a point-counting method was applied which 
is considered to be the most efficient method for estimating the area of cut surfaces of 
tissue (Gundersen, 1986).  A point counting grid containing 200 points (20 x 10) was used 
(Figure 2.5A), and the volumes of cortex and medulla were worked out using the formula: 
Volume fraction(cortex) = no of points hitting cortex/no of points hitting the kidney 
Volume fraction(medulla) = no of points hitting medulla/no of points hitting the kidney 
The volume fraction of the cortex and medulla were multiplied by the volume of the kidney 
to give the volumes of the cortex and medulla. 
2.10.3 Nephron Number 
Two die were rolled and the total was used to select a random starting point  W 7  W and  
every 7th  ?ƚŚĞ “ƌĞĨĞƌĞŶĐĞ ? )ĂŶĚ ?th ƉĂŝƌ ?ƚŚĞ “ůŽŽŬ-ƵƉ ? )ǁŝƚŚĂĚŝƐƚĂŶĐĞŽĨ ? ?A?ŵďĞƚǁĞĞŶ
were selected for the physical dissector, and were mounted adjacent on slides.  The block 
was serially sectioned until five dissector pairs had been acquired.   Six blocks were cut per 
animal, so a total of 30 dissector pairs per animal were obtained.  Next, the slides were 
stained with H&E (2.5.2) so the glomeruli could be easily identified. 
9 9 9 
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Photographs were taken using the slidebox scanner (PathScan Enabler IV, Electron 
Microscopy Sciences) and an unbiased counting frame measuring 2 mm x 2 mm was placed 
on the reference and look-up sections in the same position.  Glomeruli were counted if they 
appeared in the reference section but not in the look-up section and were not hit by the 
solid line (glomeruli were counted if they hit the dotted line).  In the example illustrated in 
Figure 2.5D only the glomeruli indicated by the black arrows were counted.  To double the 
efficiency of this process the same pictures were counted in the reverse direction, i.e. 
counting glomeruli that appeared in the look-up section but not in the reference section 
(white arrows, Figure 2.5D).  To ensure consistency, where the cross was not fully within 
the glomeruli, it was counted whenever the top right intersection (Figure 2.5C) was on the 
glomeruli.  The mean numerical density of glomeruli (N/V) was calculated: 
N/V(glomeruli) = ɇQ-(glomeruli) / A x d 
Where ɇQ- is the total no of glomeruli counted in the reference section, d is the distance 
between the planes and A is the area of the unbiased counting frame. The results were 
multiplied by the cortex volume to give a nephron number per kidney. 
Glomerular volume density (Vv) was calculated using a point counting grid containing 200 
points (20 x 10) was used (Figure 2.5B), and the volume of glomeruli was calculated using 
the formulae: 
Vv (glomeruli) = no of points hitting glomeruli/no of points hitting the cortex 
Total glomerular volume = Vv (glomeruli) x cortex volume 
Mean glomerular volume = total glomerular volume/Nv (glomeruli) 
For quality control purposes, three animals had their nephrons recounted on a different 
day.  The difference between results was < 5%. 
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Figure 2.5: Stereological counting method 
A point counting grid was used to estimate cortex:medulla ratio (A) and glomeruli:cortex ratio (B), whereby 
crosses hitting the item of interest were counted in relation to the total number of crosses.  As crosses 
sometimes are only partly on an item of interest, it was counted wherever the top right hand corner of the cross 
lay (C).   Glomeruli were counted if they appeared in the reference section but not in the look-up section and 
were not hit by the solid line (D).  To double the efficiency of this process the same pictures were counted in the 
reverse direction, (white arrows) 
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2.11 Estimation of mammalian nephron number 
Relevant studies were identified using computerised searches of the online electronic 
databases PubMed (MEDLINE) and ISI Web of Science from inception up to 30 June 2009.  
Data for as many different mammalian species as possible were included, where body 
weight and nephron number had been reported.  These data were added to the data 
provided in an earlier study (Kunkel, 1930) and using log10 data for published values of 
nephron number from a mouse weighing 20 g to an elephant weighing 3700 kg generated 
an equation of y = 0.613x + 3.116.  This was used to predict the nephron number for sheep. 
2.12 Quantitative PCR 
All procedures carried out used RNase-free water, tubes and pipette tips. All steps were 
carried out at room temperature unless otherwise stated. 
2.12.1 RNA Extraction 
2.12.1.1 Study 1 
Total RNA was extracted using an RNeasy Mini Kit (Qiagen, Crawley, UK), in accordance 
ǁŝƚŚƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? Kidney samples were ground to a fine powder under 
ůŝƋƵŝĚŶŝƚƌŽŐĞŶŝŶĂŶĂƵƚŽĐůĂǀĞĚƉĞƐƚůĞĂŶĚŵŽƌƚĂƌ ?ƚŚĞŶ ? ? ?ʅŐŽĨƚŚĞƉŽǁĚĞƌǁĂƐĂĚĚĞĚ
to lysis buffer RLT + 1% 2-mercaptoethanol in a cooled Eppendorf tube and homogenised 
by passing through a 19-gauge needle ten times.  The homogenate was centrifuged at 
12,000 x g for 3 min, and the supernatant transferred to a new RNase-free tube.  One 
volume of 70% ethanol was added to each tube and mixed by pipetting.  A maximum of 700 
ʅůŽĨƚŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĂĚĚĞĚƚŽƚŚĞƐƉŝŶĐŽůƵŵŶ ?ĂŶĚĐĞŶƚƌŝĨƵŐĞĚĂƚ ? ? ? ? ?ǆŐ for 15 sec 
at room temperature.  The flow-through collected in the collection tube underneath was 
discarded and the spin column reinserted in the same collection tube. 
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Buffer RW1 was added to the spin column and centrifuged at 8,000 × g for 15 sec to wash 
the spin column.  The spin column was placed into a new Collection Tube, buffer RPE 
added, and centrifuged at 8,000 × g for 15 sec. Buffer RPE was added a second time, and 
then centrifuged at 8,000 × g for 2 min to dry the membrane, then the spin column was 
ƉůĂĐĞĚŝŶƚŽĂĐŽůůĞĐƚŝŽŶƚƵďĞ ?dŚŝƌƚǇʅůŽĨZEĂƐĞ-Free Water was added to the centre of 
base of the spin column and centrifuged for 1 min at 8,000 × g.  This step was repeated 
using the eluted RNA to put it through the centre of the spin column again.  The purified 
RNA was stored in a -80ȗC freezer.   
2.12.1.2 Study 2 
Total RNA was extracted using WƵƌĞ>ŝŶŬ ? Mini Kit (Invitrogen, Paisley, UK), in accordance 
ǁŝƚŚƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ?Kidney samples were ground to a fine powder under 
ůŝƋƵŝĚŶŝƚƌŽŐĞŶŝŶĂŶĂƵƚŽĐůĂǀĞĚƉĞƐƚůĞĂŶĚŵŽƌƚĂƌ ?ƚŚĞŶ ? ? ?ʅŐŽĨƚŚĞƉŽǁĚĞƌǁĂƐĂĚĚĞĚ
to lysis buffer + 1% 2-mercaptoethanol in a cooled eppendorf and homogenised by passing 
through a 19-gauge needle ten times.  The homogenate was centrifuged at 12,000 × g for 2 
minutes, and the supernatant transferred to a new RNase-free tube.  One volume of 70% 
ethanol was added to each tube and vortexed to disperse any visible precipitate.  A 
ŵĂǆŝŵƵŵŽĨ ? ? ?ʅůŽĨƚŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĂĚĚĞĚƚŽƚŚĞƐƉŝŶĐĂƌƚƌŝĚŐĞ ?ĂŶĚĐĞŶƚƌŝĨƵŐĞĚĂƚ
12,000 × g for 15 seconds at room temperature.  The flow-through was discarded and the 
spin cartridge reinserted in the same collection tube. 
Wash Buffer I was added to the spin cartridge and centrifuged at 12,000 × g for 15 seconds.  
The spin cartridge was placed into a new collection tube, Wash Buffer II added, and 
centrifuged at 12,000 × g for 15 seconds.  This step was repeated. 
Next the spin cartridge was centrifuged at 12,000 × g for 1 min to dry the membrane and 
ƚŚĞŶƚŚĞƐƉŝŶĐĂƌƚƌŝĚŐĞǁĂƐƉůĂĐĞĚŝŶƚŽĂƌĞĐŽǀĞƌǇƚƵďĞ ?&ŝĨƚǇʅůŽĨZEĂƐĞ-Free Water was 
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added to the centre of the base of the spin cartridge and incubated at room temperature 
fŽƌ ?ŵŝŶ ?dŚŝƐǁĂƐĐĞŶƚƌŝĨƵŐĞĚĨŽƌ ?ŵŝŶĂƚA? ? ? ? ? ?A g.  This step was repeated using the 
eluted RNA to put it through the centre of the spin cartridge again.  The purified RNA was 
stored in a -80ȗC freezer.   
2.12.1.3 Quality Control 
The quality of the RNA was checked using a Nanodrop (Fisher Scientific, Loughborough, 
h< ) ?dŚĞƉĂƌĂŵĞƚĞƌƐƐĞƚǁĞƌĞƚŚĂƚZEǇŝĞůĚǁĂƐA? ?  ?ŶŐ.ʅů-1, and the 260/280 
absorbance ratio was between 1.90 and 2.10. 
2.12.2 CDNA Synthesis 
CDNA was synthesised using an Omniscript reverse transcriptase kit (Qiagen, Crawley, UK) 
ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů ? RNA was thawed and kept on ice, and all other 
kit components were thawed at room temperature and then kept on ice during the 
protocol.  First the RNA was treated by DNase to remove any DNA contamination prior to 
cDNA synthesis, using a RQ1 RNase-ĨƌĞĞEĂƐĞŬŝƚ ?WƌŽŵĞŐĂ ?^ŽƵƚŚĂŵƉƚŽŶ ?h< ) ?dǁŽʅůŽĨ
RNA was added to an Eppendorf tube containing RNase-free DNase, buffer and water and 
incubated in a water bath at 37°C for 30 min.  Next RQ1 DNase stop was added to 
terminate the reaction and the solution denatured at 65°C in a heat block for 10 min to 
inactivate the DNase. 
A mastermix was prepared containing 10x RT buffer, random primers, Dntp, RNase 
inhibitor, Omniscript and RNase-free water. This was added to each tube and incubated in a 
ǁĂƚĞƌďĂƚŚĂƚ ? ? ?ĨŽƌ ?Ś ?&ŝŶĂůůǇ ?ƚŚĞƐĂŵƉůĞƐǁĞƌĞĚŝůƵƚĞĚŝŶ ? ? ?ʅůZEĂƐĞ-free water, 
and stored in the -20°C freezer until used for qPCR. 
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2.12.3 Primer Design 
Primers were designed using NCBI Primer-BLAST (Table 2.5), and purchased from Eurofins 
MWG (Ebersberg, Germany).  ^ƚŽĐŬƉƌŝŵĞƌƐ ? ? ? ?ƉŵŽů ?ʅů-1 )ǁĞƌĞĚŝůƵƚĞĚƚŽ ?ƉŵŽů ?ʅů-1 in 
RNase-free H2O. 
Table 2.5: Primer details for Quantitative PCR 
Primer ^ĞƋƵĞŶĐĞ ? ? ?  ? ŶŶĞĂůŝŶŐƚĞŵƉ ?ȗ ? 
Angiopoietin 1 
F GGGTCACACTGGGACAGCAGG 
58 
R TGGGCCACAGGCATCAAACCA 
ATF4
 F AGATGACCTGGAAACCATGC 
52 
R AGGGGGAAGAGGTTGAAAGA 
ATF6
 F AACCAGTCCTTGCTGTTGCT 
52 
R CTTCTTCTTGCGGGACTGAC 
Bax
 F CAGGATGCATCCACCAAGAAGC 
56 
R TTGAAGTTGCCGTCGGAAAACATT 
Beta actin
 F TGTGCGTGACATCAAGGAGAA 
55 
R CGCAGTGGCCATCTCCTG 
BMP 7 
F GCCACTTCCTCACCGACGCC 
58 
R CAGCTGCAGTCACGGCCTCC 
CD68
 F GTCCTGCTACCACCACCAGT 
52 
R GCTGGGAACCATTACTCCAA 
Cyclophilin 
F CATACAGGTCCTGGCATCTTGTC 
56 
R TGCCATCCAACCACTCAGTCT 
DDIT3
 F AGGACCACCAGAGGTCACAC 
56 
R TGCCACTTTCCTTTCGTTTT 
bFGF 
F CTTTCCCGCCCGGCCACTTT 
58 
R GTCGCTCTTCTCGCGGACCC 
GAPDH
 F TCCGTTGTGGATCTGACCTG 
55 
R TGCTTCACCACCTTCTTGATCTC 
GRP78
 F TGAAACTGTGGGAGGTGTCA 
52 
R TCGAAAGTTCCCAGAAGGTG 
iNOS 
F TGATGCAGAAGGCCATGTCA 
52 
R TCTCCCTGTCTCTGTTGCAAAG 
MCP-1 
F CAAGACCATCCTGGGCAAA 
52 
R GTCCTGGACCCATTTCAGGTT 
PDGF 
F CAAGACGCGCACGGAGGTGT 
58 
R GCGGTTGTTGCAGCAGCCAG 
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Primer  ^ĞƋƵĞŶĐĞ ? ? ?  ? ŶŶĞĂůŝŶŐƚĞŵƉ ?ȗ ? 
SPARC 
F CGAGGTACCCGTGGGAGCCA 
58 
R CAAACTCGCCGATGGGGGCA 
d'&ɴ ? F GGAGTTGTGCGGCAGTGGCT 58 
R AAGGGCCGGTTCATGCCGTG 
Thrombospondin 
F TGCTGTGCGGGCGGAGAAAG 
58 
R TGCCCGCCTTGCCATTGGAG 
Tie-2 
F CAGCAGACCTCGGAGGCAGGA 
58 
R TGCCCTCTTCAGCTGCAGCATG 
VEGFA
 F GGATGTCTACCAGCGCAGC 
56 
R TCTGGGTACTCCTGGAAGATGTC 
VEGFR1
 F TGGATTTCAGGTGAGCTTGGA 
52 
R TCACCGTGCAAGACAGCTTC 
VEGFR2
 F CTTCCAGTGGGCTGATGACC 
52 
R GCAACAAACGGCTTTTCATGT 
All primers were designed using NCBI Primer-BLAST; ATF, Activating Transcription Factor; BMP 7, Bone 
Morphogenic Protein 7; DDIT3, DNA Damage Inducible Transcript 3; bFGF, basic Fibroblast Growth Factor; 
GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; iNOS, inducible Nitric Oxide Synthase; GRP78, 78 kDa 
Glucose-regulated Protein ; MCP1, Monocyte Chemotactic Protein 1; PDGF, Platelet-derived Growth Factor; 
SPARC, Secreted Protein, Acidic, Cysteine-ƌŝĐŚ ?d'&ɴ- ? ?dƌĂŶƐĨŽƌŵŝŶŐ'ƌŽǁƚŚ&ĂĐƚŽƌɴ-1; VEGF, Vascular 
Endothelial Growth Factor.  
2.12.4 QPCR 
2.12.4.1 Study 1 
QPCR was performed using QuantiTect SYBR Green RT-PCR Kit (Qiagen, Crawley, UK) on a 
Roche Lightcycler® 480 (Roche Diagnostics, Burgess Hill, UK). 
&ŽƌĞĂĐŚƌĞĂĐƚŝŽŶ ? ?ʅůŽĨĚŝůƵƚĞĚĐEǁĂƐĂĚĚĞĚƚŽ ? ?ʅů^zZ'ƌĞĞŶ ? ? ? ? ?ʅůĞĂĐŚŽĨ
forward and reverse primers and  ? ? ?ʅůZEĂƐĞ-ĨƌĞĞǁĂƚĞƌ ?ŵĂŬŝŶŐ ? ?ʅůǀŽůƵŵĞƉĞƌǁĞůůŽŶ
a 96-well plate (Roche Diagnostics, Burgess Hill, UK).  The protocol for the Roche Lightcycler 
is shown in Table 2.6. 
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Table 2.6: PCR protocol for QuantiTect SYBR Green 
Program name Cycles Analysis mode 
Pre-incubation 1 None 
Amplification 40  W 45* Quantification 
Melting curve 1 Melting curves 
Cooling 1 None 
Pre-incubation    
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) Acquisitions (per ȗC) 
95 None 00:15:00 4.4  
 
Amplification     
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) 
ȗ
Acquisitions (per ȗC) 
95 None 00:00:20 4.4  
55* None 00:00:20 2.2  
72 Single 00:00:20 4.4  
 
Melting curve    
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) Acquisitions (per ȗC) 
95 None 00:00:05 4.4  
72 None 00:01:00 2.2  
95 Continuous  0.11 5 
 
Cooling     
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) Acquisitions (per ȗC) 
40 None 00:00:30 2.2  
*primer dependent 
Melting curves were used to confirm reaction specificity (example in Figure 2.7).  MRNA 
quantities were normalised to three housekeeping genes (2.12.5) using Roche Lightcycler® 
480 advanced relative quantification software. 
 79 
2.12.4.2 Study 2 
QPCR was performed using a Roche SYBR Green kit (Roche Diagnostics, Burgess Hill, UK) on 
a Roche Lightcycler® 480 ?&ŽƌĞĂĐŚƌĞĂĐƚŝŽŶ ? ?ʅůŽĨĚŝůƵƚĞĚĐEǁĂƐĂĚĚĞƚŽ ? ?ʅů^zZ
'ƌĞĞŶ ? ?ʅůĞĂĐŚŽĨĨŽƌǁĂƌĚĂŶĚƌĞǀĞƌƐĞƉƌŝŵĞƌƐĂŶĚ ?ʅůZEĂƐĞ-ĨƌĞĞǁĂƚĞƌ ?ŵĂŬŝŶŐ ? ?ʅů
volume per well on a 96-well plate (Roche Diagnostics). The protocol for the Roche 
Lightcycler is shown in Table 2.7. 
Table 2.7: PCR protocol for Roche SYBR Green 
Program name Cycles Analysis mode 
Pre-incubation 1 None 
Amplification 40  W 45* Quantification 
Melting curve 1 Melting curves 
Cooling 1 None 
 
Pre-incubation    
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) Acquisitions (per ȗC) 
95 None 00:10:00 4.4  
 
Amplification     
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) 
ȗ
Acquisitions (per ȗC) 
95 None 00:00:10 4.4  
55* None 00:00:10 2.2  
72 Single 00:00:10 4.4  
 
Melting curve    
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) Acquisitions (per ȗC) 
95 None 00:00:05 4.4  
65 None 00:01:00 2.2  
97 Continuous  0.11 5 
 
Cooling     
Target ȗC Acquisition mode Hold (hh:mm:ss) Ramp rate (ȗC/s) Acquisitions (per ȗC) 
40 None 00:00:10 1.5  
*primer dependent 
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Figure 2.6: Example of a melt curve 
DĞůƚĐƵƌǀĞĚĞŵŽŶƐƚƌĂƚŝŶŐƚŚĞƉƌŝŵĞƌ ?ƐƐƉĞĐŝĨŝĐŝƚǇǁŝƚŚĂůůƐĂŵƉůĞƐŚĂǀŝŶŐƚŚĞƐĂŵĞŵĞůƚĐƵƌǀĞĂŶĚƚŚĞ blanks 
flat along the bottom of the graph 
 
Melt curves were used to confirm reaction specificity (example in Figure 2.6).  MRNA 
quantities were normalised to housekeeping genes (2.12.5) using Roche Lightcycler® 480 
advanced relative quantification software. 
2.12.5 Housekeeping genes 
Beta-actin, cyclophilin and glyceraldehyde-3 phosphate dehydrogenase (GAPDH) were 
selected as housekeeping genes. Crossing points for the CP, LPE and LPL groups were 
compared to confirm that the housekeeping genes were not significantly different between 
groups, and therefore suitable to be used in this context. Results for all genes of interest 
were normalised relative to all three housekeeping genes and all significant results stood 
whichever housekeeping gene was used.  The results for beta actin are shown in this thesis, 
as this was the housekeeping gene expressed at levels closest to the genes of interest. 
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2.12.6 Quality Control 
All standards were done in triplicate and samples in duplicate.  Intra-assay variation was set 
at 5%, although most duplicates and triplicates had less than 1% variation between them.  
Inter-assay agreement was also validated, for example, VEGFA run on two different plates 
on different days had an R2 value of 99.1. 
2.13 Corrosion Casting  
ŽƌƌŽƐŝŽŶĐĂƐƚŝŶŐǁĂƐĐĂƌƌŝĞĚŽƵƚƵƐŝŶŐĂƚƐŽŶ ?ƐEŽ ? ? ?WůĂƐƚŝĐZĞƉůŝĐĂĂŶĚŽƌƌŽƐŝŽŶ<ŝƚ
 ?WŽůǇƐĐŝĞŶĐĞƐ/ŶĐ ?ƉƉĞůŚĞŝŵ ?'ĞƌŵĂŶǇ )ŝŶĂĐĐŽƌĚĂŶĐĞǁŝƚŚƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů ?ƚŽ
visualise and quantify the gross vasculature of the fetus. 
2.13.1 Resin casting  
First 2 - 4 ml of the catalyst was added to 10 ml of the base solution A, and left to stand at 
room temperature.  To a further 10 ml of base solution A, 2 - 4 drops of promoter C were 
added, and the solution mixed slowly.  After combining the two preparations, 7 ml of the 
resulting solution was injected slowly into the umbilical artery of the fetus using a fine-
gauge (21G) needle.  The perfusion-fixed fetus was stored on ice for 2 - 3 h whilst the resin 
set, to aid the polymerisation process, and to prevent expansion and distortion of the 
specimen. 
2.13.2 Maceration 
Once the specimen was set, it was immersed in maceration solution (20% potassium 
hydroxide) for 12 - 18 h at 50°C to remove the surrounding soft tissue.  After all the tissue 
was dissolved, the remaining vascular cast was rinsed in water, dried gently and stored at 
room temperature in a protective plastic container. 
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2.13.3 Micro CT Analysis 
The surface area and volume of the resin casts of each kidney were quantified using a 
Nanotom® high resolution computed tomography (CT) scanner (GE Sensing and Inspection 
Technologies, Wunstorf, Germany) operated by Craig Sturrock, University of Nottingham. 
X-ƌĂǇƐůŝĐĞƐǁĞƌĞƚĂŬĞŶĞǀĞƌǇ ? ?ʅŵƚŚƌŽƵŐŚŽƵƚƚŚĞĐĂƐƚ ?ĂǀĞraging 2000 slices per fetus. 
Using the Nanotom® software, these images were stacked and reconstructed to provide 
quantitative volumetric data and to calculate the surface area of each cast. 
2.14 Osmolality 
Osmolality of plasma samples was measured using an OSMOMAT 030 automatic cryoscopic 
osmometer (Gonotec, Berlin, Germany).   
Fifteen µl of each sample was pipetted into a measuring vessel and then pushed onto the 
measuring vessel holder.  The holder was moved down onto the lower cooling system and 
the osmolality was measured automatically. 
The system was calibrated by performing measurements with distilled H2O and a calibration 
standard of 300 mOsmol.kg-1 (Gonotec, Berlin, Germany).   For quality control purposes all 
samples were measured in duplicate and all results presented had < 5% coefficient of 
variation. 
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2.15 Statistics   
2.15.1 Power calculations 
For Study 1, renal functional outcomes were considered to be subject to the most 
measurement error, based upon a previous study (Williams et al., 2007).  Intra-renal transit-
time represents an important variable that condenses many aspects of adult renal function.  
Genstat v13 (VSNi, UK) was used to perform the power calculations, using a split-plot 
design with diet as the whole plot and sex as the sub plot.  Significance was set at 0.05, and 
within animal variance (residual mean square, SD2) was 0.005 min and between animal 
variance 0.016 min.  For this study it was estimated that there was 91% power to detect a 
20% effect size for renal transit-time in the adult, with at least 3 male and 3 female animals 
per group (three groups; CP, LPE and LPL; n = 19 total). 
For Study 2, amino acid concentrations were considered to be the main outcome of 
interest.  For example, the study had 86% power to detect a change of 10% in ornithine 
concentrations.  Genstat v13 was used to perform the split-plot design with diet as the 
whole plot and sex as the sub plot. Significance was set at 0.05 and diet variance was 166 
µmol and sex variance 25 µmol, with at least 4 male and female animals per group (two 
groups; CP and LPE; n = 31 total). 
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Figure 2.7:Distribution and residual checking 
Examples shown of A, normal distribution; B, gamma distribution; C, normal distribution of residuals; D, fitted-
value plot; E, normal plot; F, half-normal plot 
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2.15.2 Distribution 
The distributions of the data were checked for normality using a Shapiro-Wilks test (Genstat 
v13).  Figure 2.7 shows examples of variables that were either normally distributed (A) or 
had a skewed distribution (B).  Where there was a skewed distribution, the data were log-
transformed.  The models were checked to ensure the residuals had a normal distribution 
(C), and the fitted-value plot (D) shows no tendency of the residuals to increase or decrease 
with the fitted values.  This ensures that the constant variance assumption in the model is 
satisfied (Petrie and Sabin, 2009).  The normal and half-normal plots (E and F) should show 
a linear relationship between the residuals and expected values. 
2.15.3 Univariate Analysis 
The data (unless stated below) were analysed using General Linear Models (GLM; Genstat 
v13).   
All data were first checked for normality (or otherwise) of the distribution and appropriate 
GLM statistical models used with or without data transformation (log-link functions).  Fixed 
effects were diet, sex and a diet.sex interaction.  For the fetal experiments where data was 
included from both twins, the ewe was added as a random effect, and therefore a residual 
maximum likelihood (REML) model was used as this is capable of taking into account both 
fixed and random effects (Galwey, 2006). 
All data are presented as predicted means ± SEM.  Data with a gamma distribution was log 
transformed for statistical analysis and the means and SEM back transformed for 
presentation purposes.  Whilst P < 0.05 was accepted as indicating statistical significance, 
values of P from 0.05 - 0.09 are also presented to indicate effects falling close to the 
arbitrary significance boundaries.   
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The albumin:creatinine ratio data did not fit usual distribution patterns, therefore was 
analysed by the Wilcoxon rank sum test, a non-parametric test that does not depend upon 
assumptions about distribution (Petrie and Sabin, 2009). 
The data for the developmental stage of the fetal kidneys was assessed using a Chi-squared 
test, as this is appropriate for categorical data (Petrie and Sabin, 2009). 
ŽƌƌĞůĂƚŝŽŶƐǁĞƌĞƉĞƌĨŽƌŵĞĚƵƐŝŶŐWĞĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶĐŽĞĨĨŝĐŝĞŶƚƐ ? 
2.15.4 Multivariate analysis 
Amino acid concentrations are not all independent of each other, therefore GLM analysis is 
not necessarily the best statistical method, and a multivariate discriminant analysis was 
also carried out (Genstat v13) in addition to GLM analysis of each individual amino acid.  
This is a type of linear discriminant analysis whereby one or two numerical values (linear 
descriptors called canonical variate 1 and canonical variate 2) capture the majority of 
variation for all non-independent variables (Altman, 1991).  Furthermore, combining 
related variables in this way improves the power and precision of the analysis and offers a 
more objective interpretation of the physiology.  Data are presented as canonical variates 
plot with group means enclosed by circles representing 95% confidence of the mean. 
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3. Study 1: The effect of a maternal low protein diet on the 
ewe and her fetus 
3.1 Introduction 
The incidence of non-communicable diseases such as CVD, type II diabetes and CKD rises 
with both age and degree of obesity (Wilson et al., 1998; Calle et al., 1999; Wahba and 
Mak, 2007; Danaei et al., 2009).  Whilst some risk factors are unavoidable (age, sex), others 
are lifestyle-related (e.g. obesity, smoking) and can be modified to reduce the risk of such 
chronic diseases.  In 2005, 396 million people worldwide were estimated to be obese (Kelly 
et al., 2008); in 2008, 28-35% of the US and UK population were hypertensive (Egan et al., 
2010) and in 2010, 285 million people were estimated to have type II diabetes (Diabetes 
UK, 2009).  With each disease predicted to increase significantly in frequency over the next 
few decades, the global burden of ƚŚĞƐĞ ‘ůŝĨĞƐƚǇůĞ ?ĚŝƐĞĂƐĞƐ is a major public health issue.   
However, the risk of these diseases is not dependent on one factor alone, but rather on a 
combination of genetics, diet, lifestyle and other environmental influences.  Unlike genetics 
and some environmental influences, an individual living in a country where food is freely 
available usually has control over their diet.  A 16-year long study of female nurses in the 
USA (Hu et al., 2001) identified that a diet high in fibre and polyunsaturated fat and low in 
trans-fats and glycaemic load leads to the lowest risk of type II diabetes, even after 
adjustment for BMI.  Another study of the same cohort showed similar results for coronary 
heart disease (CHD), with the least risk of death or non-fatal infarctions in those who ate a 
diet high in fibre, n-3 fatty acids and folate, and low in trans fats and glycaemic load 
(Stampfer et al., 2000).  In addition, other studies of men and women have shown an 
inverse relationship between dietary folate intake and risk of stroke and CVD (Bazzano et 
al., 2002), and a Mediterranean diet (high in monosaturates, fruit, vegetables, fish and 
unrefined cereals) led to a decreased risk of CVD (Knoops et al., 2004).  Furthermore, a 
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huge increase in CHD mortality in Beijing between 1984 and 1999 was attributed to rises in 
ƚŽƚĂůĐŚŽůĞƐƚĞƌŽůĂƐĂƌĞƐƵůƚŽĨĂŶŝŶĐƌĞĂƐŝŶŐůǇ ‘ǁĞƐƚĞƌŶŝƐĞĚ ?ƚǇƉĞŽĨĚŝĞƚ(Critchley et al., 
2004).  Changes in diet are, therefore, a potentially easily achievable way of reducing some 
of the risk of non-communicable disease in the population. 
/ŶĐƌĞĂƐĞĚĨŽĐƵƐŽŶĚŝĞƚĚƵƌŝŶŐĂǁŽŵĂŶ ?ƐƌĞƉƌŽĚƵĐƚŝǀĞǇĞĂƌƐ ?ƉĂƌƚŝĐƵůĂƌůǇĚƵƌŝŶŐƉƌĞŐŶĂŶĐǇ
and lactation, has been stimulated by the Developmental Origins of Health and Disease 
hypothesis (Barker and Osmond, 1986; Gluckman et al., 2008).  The response of the fetus to 
maternal diet has been demonstrated to increase the risk of those offspring developing 
hypertension (Huang et al., 2010; Stein et al., 2006), coronary dysfunction (Crispi et al., 
2010), type II diabetes (Whincup et al., 2008) and kidney disease (Amann et al., 2006; 
Woods et al., 2004) later in life.  Increased focus on kidney disease is particularly pertinent 
as nephrogenesis is complete by term in humans and non-litter bearing mammals (Wintour 
and Moritz, 1997) and is therefore particularly sensitive and vulnerable to maternal 
malnutrition.  For example, nephron endowment has been shown to be reduced by 
maternal diets low in protein (Langley-Evans et al., 1999), low in iron (Crowe et al., 1995), 
high in glucose (Nehiri et al., 2008) or high in fat (Khan et al., 2003).  
The inclusion of pregnant women in experimental trials has major ethical and legal 
considerations, with the potential to cause harm to both the woman and the developing 
fetus.  In addition, the need to follow the offspring through to middle or old age makes a 
trial extremely time-consuming and expensive; hence most such studies have tended to be 
retrospective rather than prospective.  Other major limitations of human dietary studies 
are a lack of accurate recall regarding diet, and many confounding factors.  Taken together, 
these difficulties mean that animal studies - with their tightly controlled environments and 
short life-spans  W provide an ideal opportunity to study the effect of maternal diet during 
pregnancy on the mother, the developing fetus and the offspring later in life. 
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Research into the nutrition of sheep has been ongoing for more than 60 years.  Initially this 
was focused on discovering the optimal nutrition for ewes during pregnancy in order to 
maximise offspring weight, reduce lamb mortality and increase the number of live twin 
births (Blaxter, 1957; Louca et al., 1974; Quirke et al., 1978).  However, in the last two 
decades sheep have increasingly been used as a model for the effect of diet during 
pregnancy on fetal development due to similarities between human and ovine 
development in utero.  
Most fetal programming studies in sheep have focused on a global restriction model in 
which total energy (and all other macro/micronutrients) is restricted.  These studies have 
shown a range of metabolic and cardiovascular effects (see Table 1.4).  However, in 
Westernised countries a lack of energy intake is rarely a problem for pregnant women, due 
to the high availability of energy dense foodstuffs.  More common is an imbalance of 
nutrients such that a greater proportion of energy is consumed relative to, for example, the 
proportion of protein leading to a mismatch of food groups.  In addition, the timing of any 
nutritional insult is important, as particular organs develop at different rates and periods 
during gestation.  Organogenesis proceeds first by a priority of cell differentiation, then 
proliferation and finally by maturation of these cells.  Therefore differing effects of 
undernutrition will be observed depending on the relative priority of cellular processes 
being undertaken at the time of a given nutritional perturbation.   
Hence, this study has considered two periods of nutrient restriction, one up to day 65 of 
gestation (chosen to coincide with the peak period of nephrogenesis) and one from day 65 
to full term (~147 days) and has specifically considered the effect of a low protein (but 
adequate energy) diet compared with a control ruminant diet (i.e. one providing 9% protein 
vs. 18% protein).  The protein content of 18% more than adequately meets the protein 
requirements of a pregnant ewe, and indeed such an animal has no additional 
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requirements compared with a non-pregnant ewe during early to mid-gestation (Robinson 
and Forbes, 1967).  Although similar percentages of protein have also been used in 
programming studies of rats (Langley-Evans et al., 1999; Brawley et al., 2003), these figures 
were set independently as 18% is a normal protein intake for a sheep at pasture, whereas 
9% is considered to be equivalent to that available to ewes reared on a heather-dominant 
pasture.  The latter situation may occur in many hill areas in the UK where increased 
consumption of tannins (for example in heather) limit amino acid availability to the ewe.   
To summarise, this chapter considers the effect of a low protein diet both on the ewe 
throughout gestation and on the fetus at day 65 (or 0.44 gestation).  The investigation 
characterises the effect of a low protein maternal diet on maternal gestational weight gain 
and body condition score.  In addition it investigates the effect on the developing fetus in 
terms of renal development, at both a morphological and molecular level. 
3.2 Materials and Methods 
3.2.1 Study Design  
Full details are given in Chapter 2.  A brief summary of the experimental design is as 
follows: 
All procedures were performed in accordance with the UK Animals (Scientific Procedures) 
Act, 1986 and were approved by the relevant local ethical review committees of the 
Macauley Institute and the University of Nottingham.  Thirty-seven pregnant Scottish 
Blackface ewes carrying singleton fetuses were randomly allocated to one of three diet 
groups fed either a control diet (CP; n = 15) providing adequate protein from day 0 of 
gestation to term (term ~147 days), or a protein-restricted diet during either early (LPE, 
days 0  W 65 gestation; n = 16) or late gestation (LPL, day 66  W term; n = 6).  KŶĂŶ ‘ĂƐĨĞĚ
ďĂƐŝƐ ? ?ƚŚĞĚŝĞƚƐǁĞƌĞŝƐŽĐĂůŽƌŝĐǁŝƚŚƚŚĞĞĨĨĞĐƚŝǀĞůĞǀĞůŽĨƉƌŽƚĞŝŶƌĞƐƚƌŝĐtion being 8.7 vs. 17 
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g crude protein.MJ ME (metabolic energy).  At day 65 gestation, chosen to coincide with 
peak nephrogenesis in the sheep (Wintour and Moritz, 1997), a proportion of CP (n = 9) and 
LPE (n = 9) ewes were euthanised and the fetal kidneys snap frozen in liquid nitrogen and 
stored at - ? ?ȗ for further analysis. The remaining ewes carried to term and are reported in 
Chapter 4.  
Maternal weight and body condition score was measured prior to and up to day 65 in the 
group that were euthanised at this time point, and to term in the other group, and data for 
the whole pregnancy is reported in this chapter.  All fetal data presented in this chapter 
relates to the group that were euthanised at day 65 gestation. 
3.2.2 Renal histology  
One kidŶĞǇĨƌŽŵĞĂĐŚĨĞƚƵƐǁĂƐƐĞĐƚŝŽŶĞĚƚƌĂŶƐǀĞƌƐĞůǇ ?ƐƚĂŝŶĞĚǁŝƚŚƉĞƌŝŽĚŝĐĂĐŝĚ^ĐŚŝĨĨ ?Ɛ
reagent (section 2.5.3) and assessed for morphological differences between the diet 
groups.   
3.2.3 Renal immunohistochemistry 
Renal sections were analysed for abundance of VEGFA (SC-152; Santa Cruz Biotechnology, 
Santa Cruz, USA) using a biotinylated ABC kit (Vector Labs, Peterborough, UK).  The full 
method is given in section 2.6.1. 
The primary and secondary antibodies were both diluted 1:200.  Appropriate negative 
controls were included for the primary antibody (i.e. omission of primary antibody) and for 
non-specific binding of the secondary antibody (i.e. using a rabbit IgG; Vector Labs, 
Peterborough, UK).  Adult sheep kidney was used as a positive control. 
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3.2.4 Detection of apoptosis  
The presence and extent of apoptotic nuclei was determined using a TUNEL kit 
(Calbiochem, Nottingham, UK).  The full method is described in section 2.7.  Omission of 
TdT enzyme and reaction mixture was used as a negative control, and a mixture of HL60 
cells incubated with 0.5 ʅg/ml actinomycin D for 19 hours to induce apoptosis (provided by 
the manufacturer) was used as a positive control. 
3.2.5 Quantitative PCR 
Total RNA was extracted using RNeasy Mini Kit (Qiagen, Crawley, UK) and cDNA was 
synthesised using an Omniscript reverse transcriptase kit (Qiagen, Crawley, UK).  QPCR was 
performed using QuantiTect SYBR Green RT-PCR Kit (Qiagen, Crawley, UK) on a Roche 
Lightcycler® 480.  Melt curves were used to confirm reaction specificity and cyclophilin, 
beta actin and GAPDH were used as housekeeping genes. Negative controls were H2O, and 
samples with Omniscript omitted.  MRNA quantities were normalised to housekeeping 
genes using Roche Lightcycler® 480 advanced relative quantification software.  Full details 
of the method are described at sections 2.12.1.1, 2.12.2, 2.12.3, 2.12.4.1 and 2.12.5. 
3.2.6 Statistical Analysis 
All data apart from the qualitative scoring of kidney maturity were analyzed using a General 
Linear Model (GLM) or general linear mixed model approach where appropriate (Genstat 
v13, VSNi, UK) after checking for normality (or otherwise) of the error distribution.  Data 
with skewed errors were log transformed before analysis.  Estimated marginal means are 
presented with SEM, or s.e.d. as indicated, to represent the measurement error.  P < 0.05 
was accepted as indicating statistical significance.  For the qualitative scoring of kidney 
maturation, scores for each treatment group were assessed by F2. 
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3.3 Results 
3.3.1 Maternal weight and body condition score 
Maternal weight was not significantly different between diet groups neither before 
pregnancy, at conception, nor during gestation.  As would be expected, weight increased 
during the course of gestation in all groups, from 61.3 ± 0.94 kg at conception up to 75.6 ± 
0.94 kg at day 124 of gestation (average for all groups; data for individual groups shown in 
Figure 3.2).  However, there was no diet*sex interaction and the effects of time on weight 
gain were seen equally in all groups.  
Body condition score (BCS) was similar at conception, increased slightly during early 
pregnancy and declined toward the end of gestation (Figure 3.1).  The LPE group tended to 
have lower BCS (2.60 ± 0.04 LPE vs 2.65 ± 0.05 CP and 2.66 ± 0.04 LPL; P = 0.06), however 
the changes observed were very small, with LPE having only a 1.8% reduction compared 
with controls.  
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Figure 3.1: Maternal weight and body condition score of ewes during pregnancy. 
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3.3.2 Fetal organ weights 
At post mortem only sex of the fetus, but not maternal diet, had a significant effect on fetal 
body weight, liver, and heart weights which were all significantly higher in males.   Kidney 
weights tended to be higher in males although this did not reach statistical significance (P = 
0.09) and brain and lung weights were not different between the sexes (Table 3.1).  
 
Data are predicted means ± S.E.M. for ewes (CP, n = 8; LP, n = 10) fed a control protein diet (CP fetuses, male, n 
= 4; female, n = 4) or a low protein diet to day 65 gestation (LP fetuses, male, n = 4; female, n = 6). Data were 
analysed by general linear model for the fixed effects of treatment (control vs. low protein), sex (male vs. 
female) or their interaction using Genstat v13 (VSNi, UK). Statistical significance was accepted at P < 0.05, NS, 
not significant.  
 
Table 3.1: Effect of maternal low protein diet on  fetal weights at 65 days gestation 
 
  Sex P value 
 Diet male female  Diet Sex Diet*Sex 
Body weight (g) CP 111 ± 4 89 ± 5 
NS 0.004 NS 
LP 110 ± 9 95 ± 3 
Brain weight (g) CP 3.46 ± 0.08 3.32 ± 0.15 
NS NS NS 
LP 3.55 ± 0.15 3.52 ± 0.04 
Liver weight (g) CP 8.42 ± 0.39 6.92 ± 0.51 
NS 0.007 NS 
LP 9.02 ± 0.37 7.30 ± 0.52 
Heart weight (g) CP 0.97 ± 0.08 0.90 ± 0.09 
NS 0.040 NS 
LP 1.17 ± 0.06 0.90 ± 0.07 
Lung weight (g) CP 5.32 ± 0.45 4.79 ± 0.79 
NS NS NS 
LP 5.88 ± 0.99 4.76 ± 0.42 
Kidney weight (g) CP 1.77 ± 0.22 1.43 ± 0.11 
NS NS NS 
LP 1.66 ± 0.16 1.50 ± 0.07 
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3.3.3 Fetal kidney apoptosis  
The percentage of cells that were TUNEL positive (indicating DNA fragmentation resulting 
from apoptosis) was significantly higher in both the nephrogenic zone around the outer 
edge of the cortex, and throughout the whole kidney (Figure 3.2).  In the whole kidney 
there was a two-fold increase in the number of TUNEL positive cells in the low protein 
group compared with controls, however in the nephrogenic zone the difference was more 
pronounced, with an eight-fold increase in the LPE group. 
 
Figure 3.2: TUNEL positive staining and quantification in fetal tissue at day 65 gestation 
A  W the percentage of TUNEL positive cells in the whole of the fetal kidney section; B  W the percentage of TUNEL 
positive cells in the nephrogenic region; C  W a representative micrograph of the TUNEL staining (brown) with 
methyl green counterstain and arrows indicating TUNEL positive cells; D  W negative control; E- positive control 
(cells incubated with 0.5 ʅg/ml actinomycin D for 19 hours to induce apoptosis).  Data in graphs are predicted 
means ± S.E.M. for ewes (CP, n = 8; LP, n = 10) fed a control protein diet (CP fetuses, male, n = 4; female, n = 4) 
or a low protein diet to day 65 gestation (LP fetuses, male, n = 4; female, n = 6). Data were analysed by general 
linear model for the fixed effects of treatment (control vs. low protein), sex (male vs. female) or their interaction 
using Genstat v13 (VSNi, UK). Statistical significance was accepted at P < 0.05, NS, not significant. 
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Figure 3.3: VEGFA and receptors gene and protein expression in fetal tissue at day 65 gestation 
A  W representative micrograph of VEGFA staining (brown) with arrows indicating staining in collecting ducts; B & 
C quantification of staining in the whole sample and nephrogenic zone; D  W F, mRNA for VEGFA and its receptors 
VEGFR1 & 2; negative controls were G (omission of antibody) and H (IgG control); I, positive control, adult 
kidney.  Data in graphs are predicted means ± S.E.M. for ewes (CP, n = 8; LP, n = 10) fed a control protein diet 
(CP fetuses, male, n = 4; female, n = 4) or a low protein diet to day 65 gestation (LP fetuses, male, n = 4; female, 
n = 6). Data were analysed by general linear model for the fixed effects of diet,, sex  or their interaction using 
Genstat v13 (VSNi, UK). Statistical significance was accepted at P < 0.05, NS, not significant. 
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3.3.4 Vascular Endothelial Growth Factor 
VEGFA protein as measured by immunohistochemical staining was significantly lower in the 
LPE group compared to controls, in both the whole of the fetal kidney and the nephrogenic 
zone around the outer edge of the cortex (Figure 3.3 A-C).  In addition, for the whole 
kidney, males had around 50% more staining than females (P = 0.047).  However although 
the numerical mean for males was higher than for females in the nephrogenic zone, this 
was not statistically significant.  Furthermore, the difference between control and low 
protein VEGFA levels was more pronounced in males than females, which was also 
mirrored by the levels of mRNA for VEGFA (Figure 3.3 D) where there was a significant 
diet*sex interaction (P < 0.01). VEGFA mRNA was also reduced in the LPE group compared 
to controls (0.237 ± 0.009 vs 0.199 ± 0.008; P < 0.01).  The mRNA for the VEGF receptor 
VEGFR1 showed a strong trend (P = 0.052) towards reduced expression in the LPE group in 
both sexes, relative to controls (1.78 ± 0.12 vs. 2.23 ± 0.14 x 10-2 units).  VEGFR2 also 
tended to be lower in the LPE group compared to controls, but  this was not statistically 
significant (Figure 3.3 E - F).  However, as for the other variables, greater differences 
between treatment groups were observed in males.   
3.3.5 Other genes involved in the angiogenesis pathway 
There was no effect of diet or sex on transcript expression for angiogenesis promoters 
including angiopoietin 1 (Ang1), the Tie 2 receptor, basic fibroblast growth factor (bFGF), 
platelet-derived growth factor (PDGF) and transforming growth factor beta 1 (d'&ɴ ? ) ?
,ŽǁĞǀĞƌ ?ĨŽƌŶŐ ? ?dŝĞ ? ?ď&'& ?W'&ĂŶĚd'&ɴ ?ƚŚĞƌĞǁĂƐĂƐŝŐŶŝĨŝĐĂŶƚĚŝĞƚ ?ƐĞǆŝŶƚĞƌĂĐƚŝŽŶ ?
with lower mRNA levels in male LPE fetuses only (Figure 3.4).  
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Figure 3.4: Gene expression of angiogenic factors in fetal tissue at day 65 gestation 
Data are predicted means ± S.E.M. for ewes (CP, n = 8; LP, n = 10) fed a control protein diet (CP fetuses, male, n 
= 4; female, n = 4) or a low protein diet to day 65 gestation (LP fetuses, male, n = 4; female, n = 6). Data were 
analysed by general linear model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, 
UK). Statistical significance was accepted at P < 0.05; NS, not significant; PDGF, platelet-dervied growth factor; 
bFGF, basic fibroblast growth factor; TGFɴ1, transforming growth factor beta-1; TSP, thrombospondin. 
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Bone morphogenetic protein 7 (BMP7) was not different between groups (5.68 ± 0.34 x 10 -3 
CP, vs 6.13 ± 0.30 x 10-3 LPE), and neither was secreted protein, acidic, cysteine-rich (SPARC; 
7.83 ± 0.49 x 10-2 CP, vs 7.47 ± 0.46 x 10-2 LPE) an angiogenesis inhibitor.  However, one 
inhibitor of angiogenesis, thrombospondin (TSP) had a significant diet.sex interaction, with 
gene expression increased in female LPE fetuses but decreased in male LPE fetuses 
compared to controls (Figure 3.4). 
3.4 Discussion 
Protein-energy malnutrition (PEM) is highly prevalent in developing or emerging  countries 
with up to 20% and 8% children in India and China, respectively - which equates to over 130 
million individuals in these two countries alone - being affected (WHO, 2011).  Whilst PEM 
is less prevalent in developed Westernised societies e.g. (0.8% children in the USA) this still 
equates to ~2 million children (WHO, 2011).  In addition, the high incidence of pregnancy-
induced nausea and vomiting (75-90% of women) and in its extreme version hyperemesis 
gravidarum (1% of women) during early pregnancy means that many women (and 
therefore their fetuses) may experience some degree of macro/micronutrient deficiency at 
this time (Fejzo et al., 2009). 
/ŶƚŚŝƐƐƚƵĚǇƉƌŽƚĞŝŶƌĞƐƚƌŝĐƚŝŽŶĞĂƌůǇŽƌůĂƚĞŝŶŐĞƐƚĂƚŝŽŶŚĂĚŶŽĞĨĨĞĐƚŽŶƚŚĞĞǁĞ ?ƐǁĞŝŐŚƚ
gain during pregnancy, which is likely to reflect the isocaloric nature of the low protein and 
control diets.  Body condition score  W a subjective marker of overall fat mass - was slightly 
lower in the LPE group by the end of gestation but only by 2%.  These results indicate that 
the nutritional insult is mild, as the ewe is not detrimentally affected during gestation, with 
no clear indications of maternal malnutrition.  In contrast global nutrient restriction has 
been shown to affect maternal weight gain when given in mid gestation (Vonnahme et al., 
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2003) or late gestation (Chadio et al., 2007).  However, most studies fail to report the 
effects on the ewe and concentrate solely on the effects on the offspring.   
Fetal body weight and organ weights were not different between dietary groups, although 
there was an effect of sex, with males having higher total body and organ weights.  
However, the greater organ weights were a reflection of the higher overall body weight, 
and once adjusted for body weight the effects did not persist.  Interestingly, the difference 
in fetal weight for males and females at such an early stage in gestation (day 65 out of term 
147 days), is at a time when there is no exposure to secondary sex hormones, suggesting 
that differences in size between males and females are not entirely dependent on these 
hormones.  In contrast, another programming study of sheep (MacLaughlin et al., 2005) 
found no differences in fetal weight at d 53  W 56 gestation.  It may be that differences are 
only observed at particular time points during gestation, as fetal growth does not follow a 
linear course, but instead is a pulsatile process, and differences in fetal growth rates in 
humans have been shown to be sex-specific (Lampl and Jeanty, 2003). 
A further consideration is that larger animals like sheep and humans have a greater 
metabolic reserve capacity compared to smaller mammals and are therefore better able to 
cope with temporary nutritional deficits in protein intake.  However, because sheep are 
ruminants and the rumen contains microbes which are able to synthesise amino acids, a 
dietary deficit may not always lead to a deficit for the fetus.  This is considered further in 
Chapter 5 through experiments measuring the levels of amino acids in maternal and fetal 
plasma, and fetal amniotic fluid. 
The development of the kidney depends on the balance between survival factors 
promoting growth and factors promoting cell death.  The process of apoptosis, or 
programmed cell death, is a normal part of cellular development and maintenance and 
tight control of this process is crucial.  Dysregulation of apoptotic pathways is present in 
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many renal disease states.   An increase in apoptosis has been observed in diabetic 
nephropathies in mice (Susztak et al., 2006), rats (Zhang et al., 1997) and humans (Kumar et 
al., 2004).  Furthermore, higher levels of apoptosis have been found at different stages of 
disease progression in a rat model of experimental glomerulonephritis (Shimizu et al., 1996) 
and in human polycystic and dysplastic kidneys both pre- and post-natally (Woo, 1995; 
Winyard et al., 1996).  In addition, evidence shows that fetal programming may also result 
in an abnormally increased level of apoptosis. This current study found that apoptosis was 
increased in the LPE group at the midpoint of nephrogenesis, both in the whole of the 
kidney but also, crucially, in the nephrogenic zone, and this finding is replicated in other 
programming studies.  Intrauterine growth restriction in rats resulted in altered mRNA 
levels for apoptosis-related proteins, increased renal apoptosis and reduced nephron 
number (Pham et al., 2003).  Also a maternal low protein diet in rats reduced nephron 
number, increased systolic blood pressure and increased apoptosis in kidneys at 8 weeks of 
age, despite the kidneys looking morphologically normal (Vehaskari et al., 2001).  In rat 
fetal kidneys an increase in apoptosis in kidney condensing mesenchymal cells (i.e. nephron 
progenitors) and in loose mesenchymal cells (precursors of interstitial cells) at embryonic 
day 13 was observed for those fed a low protein diet (Welham et al., 2002).  
This study has also demonstrated decreased expression of important mediators of 
vasculogenesis (de novo vessel formation) and angiogenesis (sprouting of new vessels from 
existing vessels), which indicates potential for reduced renal vascular growth during fetal 
development.  Vascular development involves overlapping processes of formation, 
stabilisation, branching, remodelling and pruning, and specialisation (Jain, 2003).  VEGFA is 
a signalling protein that regulates endothelial cell growth and differentiation and is 
essential for vasculogenesis and angiogenesis in all organs (Breier et al., 1992; Tufro et al., 
1999).  VEGFA has many important biological roles which vary according to the stage of 
development and physiological function  in the organ in which it is expressed (Breen, 2007).  
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Initially VEGF was called vascular permeability factor (VPF), following its discovery as a 
protein in tumour ascites fluids that increased microvascular permeability (Senger et al., 
1983).  Independently of this work VEGF was identified as a potent mitogen for vascular 
endothelial cells from both small and large vessels (Leung et al., 1989), before it was 
realised that VEGF and VPF were in fact the same protein which had a variety of roles (Keck 
et al., 1989).  Transgenic mouse gene knockout models have been utilised to further prove 
the importance of VEGFA.  Homozygous deletions lead to perinatal lethality (Eremina et al., 
2003) and heterozygous deletions result in renal disease at a young age (Eremina et al., 
2003) due to abnormal formation of blood vessels (Carmeliet et al., 1996).  VEGFA is highly 
expressed in podocytes and plays an important role in both establishing and maintaining 
the glomerular barrier (Eremina et al., 2003).  Podocyte-specific heterozygous VEGFA 
knockouts also die early from renal failure and do not produce differentiated mesangial 
ĐĞůůƐ ?ƚŚƵƐƐŚŽǁŝŶŐs'& ?ƐƌŽůĞŝŶŵĞƐĂŶŐŝĂůĐĞůůĚĞǀĞůŽƉŵĞŶƚ(Eremina et al., 2006).  In 
the present study, VEGFA mRNA was reduced in the LPE group, although the effect was 
much more pronounced in males.  However, both sexes showed a more substantial 
reduction at the protein level, both in the whole of the kidney and  W critically  W in the 
nephrogenic zone, suggesting that VEGFA is the key angiogenic factor affected by the 
nutritional deficit of maternal dietary protein intake.  This has also been verified in other 
fetal studies involving a large mammal model, where reduced VEGFA in response to a 
prenatal sub-optimal diet in non-human primates has been demonstrated (Cox et al., 2006; 
Nijland et al., 2007).   
In this study VEGF staining was primarily found in the developing collecting ducts (see 
Figure 3.3), and very little was observed in the mature glomeruli, despite podocytes being a 
main source of VEGF expression (Rask-Madsen and King, 2010).  However, this pattern of 
staining has also been observed in other studies, which tend to find minimal staining in 
glomeruli when paraffin sections are used (Burt et al., 2007), and demonstrate evidence of 
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VEGF staining in the collecting ducts (Cooper et al., 1999; Gealekman et al., 2004). In later 
fetal life and mature kidneys VEGF is also expressed by other parts of the tubules (Tufro et 
al., 1999; Kang et al., 2001). 
In the fetal kidney peritubular capillaries have been shown using immunohistochemistry 
techniques to be positive for VEGF receptor proteins (Simon et al., 1998), therefore the 
VEGF in the collecting ducts may act through paracrine signalling via these nearby 
receptors.  In addition, VEGF receptors have been identified in non-endothelial cells and 
tissues, including the tubular cells of both fetal and adult kidneys, and it is hypothesised 
that VEGF may have both autocrine as well as paracrine effects.  For example, one study 
found a rat renal tubular epithelial cell line expressed VEGFR1 and VEGFR2 mRNA and 
protein, a finding that was replicated in vivo with sections of normal rat kidney (Kanellis et 
al., 2000).  In addition, when the cell line was exposed to VEGF it significantly stimulated 
their proliferation via VEGFR2 and the Akt signalling pathway, as well as protecting the cells 
from hydrogen peroxide-induced apoptosis.  Furthermore, another study revealed both 
autocrine and paracrine functions of VEGF (Villegas et al., 2005). Using three different cells 
lines (rat and mouse proximal tubular cells, and normal rat kidney cells) it was confirmed 
that all three secreted VEGF and this stimulated proliferation and survival of tubular 
epithelial cells via the VEGFR2 receptor in a paracrine manner.  In addition there was a 
paracrine effect through the VEGF acting to chemoattract and recruit endothelial cells 
when they were co-cultured. 
Further studies have shown the importance of the VEGF receptors, VEGFR1 and VEGFR2.  
Homozygous VEGFR1-deficient knockout mice form endothelial cells but these are arranged 
into abnormal vascular channels and the embryos die in utero (Fong et al., 1995).  
Homozygous VEGFR2-deficient mice fail to develop blood islands in the yolk sac and have 
no apparent organised blood vessels, and this is also embryonically lethal (Shalaby et al., 
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1995).  Therefore both of these receptors are critical for normal vascular development.  
This study showed a trend for decreasing VEGFR1 and VEGFR2 mRNA in the LPE fetuses, but 
this did not reach statistical significance (VEGFR1, P = 0.052; VEGFR2, P = 0.076).  Hence 
VEGFR1, having only just missed statistical significance was re-tested in a further fetal study 
(see Chapter 5). 
 In addition this study considered the effect of a low protein diet on key angiogenic factors 
by measuring gene expression of both promoters and inhibitors of angiogenesis.  Previous 
research has shown that whilst VEGFA is the main initiator of vasculogenesis and 
angiogenesis, other factors also have essential roles as the vasculature forms.  The primitive 
vessels initially consist of a tube of endothelial cells and as these mature they become 
stabilised through recruitment of mural cells (pericytes and vascular smooth muscle cells) 
and extracellular matrix (ECM); this varies according to whether they are specialising into a 
capillary, artery or vein (Jain, 2003).  At this stage of stabilisation and specialisation PDGF is 
secreted by endothelial cells to recruit mural cells, and through its receptor PDGFR-ɴ ?ǁŚŝĐŚ
is expressed on mural cells) it causes proliferation and migration of these cells (Hellstrom et 
al., 2001).   
d'&ɴ ?ĂůƐŽŚĂƐĂƌŽůĞĂƚƚŚŝƐƐƚĂŐĞŽĨvascular development, as it induces differentiation of 
mesenchymal cells to mural cells (Chambers et al., 2003), and Ang1/Tie 2 receptor assists in 
the stabilisation of the nascent vessels by making them leak-proof (Thurston et al., 1999).  
Overexpression of Ang1 in transgenic mice has been shown to lead to a higher number of 
blood vessels that are considerably larger and more highly branched (Suri et al., 1998), and 
ĂƚŚŝŐŚĚŽƐĞƐd'&ɴ ?ĂƉƉĞĂƌƐƚŽŝŶŚŝďŝƚĞŶĚŽƚŚĞůŝĂůĐĞůůĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ(Yancopoulos et al., 
2000), thus, like VEGFA, a tight control of these factors is needed in order to ensure normal 
development. 
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The present study showed that all the measured promoters of angiogenesis were 
decreased in the LPE group at 0.44 gestation, but only in males, suggesting that females 
may have some protective mechanisms.  This indicates reduced potential for intrarenal 
microvascular growth, which is explored further by measuring CD34, an endothelial cell 
marker, in the adult kidney (Chapter 4).  This study is the first to show sex-specific effects in 
a large animal model, although it is not uncommon in rodent  programming studies to find 
that males are more adversely affected than females (Kwong et al., 2000; Ozaki et al., 2001; 
Woods et al., 2005).  Furthermore, taken in conjunction with the increased proportion of 
apoptotic nuclei within the nephrogenic zone of the developing kidney it would appear that 
the dietary protein deficit in the maternal environment has an impact on the fetus, and 
specifically on those organs such as the kidney undergoing hyperplastic growth at that time.  
Although gross differences in the fetus such as a reduction in kidney weight were not 
observed between dietary groups, it appears that more subtle changes have occurred.   
Chapter 4 will consider the effects of the low protein diet on fetuses at full term and on 
their postnatal growth trajectories, alongside possible changes in the structure and function 
of the adult kidneys at two years of age, to see whether the subtle effects observed in the 
fetus have longer term effects. 
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4. Study 1: The effect of a maternal low protein diet on the 
offspring 
4.1 Introduction 
In the previous chapter, subtle yet significant changes were identified in the developing 
kidneys of the fetus, where diet was lower in protein during the first 65 days of gestation.  
Although there was no evidence of disturbance to the gross morphology of the kidneys at 
day 65, there were changes in the expression and translation of genes that mediate 
angiogenesis, including VEGFA, alongside increased apoptosis in the nephrogenic zone.   
The changes observed in the fetus are interesting per se, however the strength of this study 
lay in the opportunity to follow a cohort of sheep subject to the same experimental 
conditions (i.e. a maternal low protein diet over the first 65 days of gestation) to adulthood, 
and therefore to observe whether programming of the fetus translated into altered renal 
function in the adult.  In addition, there was the opportunity to consider whether the 
timing of a nutritional insult was important in the programming of renal function, as a 
further group were subjected to a low protein diet from day 65 through to the end of 
gestation (full term = ~147 days). 
The effect of a low protein maternal diet on nephron endowment is likely to be subtle.  It is 
unlikely to be solely responsible for compromised adult renal function but is considered to 
ďĞĂ ‘ĨŝƌƐƚ-Śŝƚ ? ?ŽƌƌĞŶŶĞƌ ?ƐŚǇƉŽƚŚĞƐŝƐ ?Brenner et al., 1988).  Fewer nephrons, coupled 
ǁŝƚŚĂ ‘ƐĞĐŽŶĚŚŝƚ ?ƐƵĐŚĂƐŽďĞƐŝƚǇ ?ƚǇƉĞ//ĚŝĂďĞƚĞƐ ?ŽƌŚǇƉĞƌƚĞŶƐŝŽŶ ?ŵĂǇĂĨĨĞĐƚƌĞŶĂů
ĨƵŶĐƚŝŽŶ ?ĂŶĚ ‘ŚĞĂůƚŚƐƉĂŶ ?ĐĂŶďĞƐŝŐŶŝĨŝĐĂŶƚůǇƌĞĚƵĐĞĚŝŶƚŚŽƐĞƉƌĞŶĂƚally compromised 
individuals (Griffin et al., 2008).   
The prevalence of obesity and its associated co-morbidities is rising rapidly.  In the UK in 
2010 65.8% of the population aged between 15 and 100 were overweight or obese with a 
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D/A? ? ? ? ?ŬŐ ?ŵ-2 (World-Health-Organisation-Global-InfoBase, 2010).  WHO statistics also 
show that in the USA the situation is even more pronounced, with 78.6% classified as 
overweight or obese.  The emerging nations such as India and China are also experiencing a 
rapid rise in the levels of obesity, with 22.5% and 38.5% respectively being overweight or 
obese in 2010.  As these two countries are the most populous in the world (India, 1.18 
billion; China, 1.33 billion; (United Nations Statistics Division, 2012) this equates to 266 
ŵŝůůŝŽŶĂŶĚ ? ? ?ŵŝůůŝŽŶŝŶĚŝǀŝĚƵĂůƐƌĞƐƉĞĐƚŝǀĞůǇǁŝƚŚĂD/A? ? ?ŬŐ ?ŵ-2. 
Overweight and obesity are associated with increased risk of mortality from kidney disease 
(Flegal et al., 2007).  The relative risk for end stage renal disease rises with each category of 
overweight, even after adjustment for other major risk factors such as smoking, 
hypertension and type II diabetes.  Compared with lean controls, the relative risk for 
overweight was 1.87 [95% CI 1.64  W 2.14]; for class I obesity, 3.57 [3.05  W 4.18]; for class II 
obesity, 6.12 [4.97  W 7.54]; and for class III obesity, 7.07 [5.37  W 9.31] (Hsu et al., 2006).  
Furthermore, ŵĞŶĂŶĚǁŽŵĞŶǁŝƚŚĂD/A? ? ?ŬŐ ?ŵ-2 at age 20, 40 and 60 had a 3-fold 
increased risk of CKD compared with those with a normal BMI (Ejerblad et al., 2006).   
The mechanisms through which obesity may cause renal disease are still poorly 
understood, although it is thought that inflammation, lipotoxicity and haemodynamic 
factors may play a role (for reviews, see Hall, 2003; Wahba and Mak, 2007). 
A traditional early marker for CKD (i.e. before there are any overt clinical signs) is 
microalbuminuria, which can reliably predict future CKD (Fox et al., 2010).  A reduced 
filtration barrier in the glomerulus allows small amounts of albumin to pass through into 
the urine, and is likely initially to be due to effacement of the podocyte foot processes.  The 
integrity of the foot processes is supported by a number of factors, but primarily by VEGFA 
(Eremina et al., 2008a).  Obesity leads to a tissue specific increase in VEGFA, to support the 
concomitant local hypoxia (Wood et al., 2009) and in obese sheep it has been shown to be 
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positively associated with increased intra-renal endoplasmic stress, a potential early 
prognostic marker for CKD (Sharkey et al., 2009a).  Maternal under-nutrition during fetal 
development may have subtle effects on nephron number, increased blood pressure and 
other metabolic variables; however, it is obesity later in life alongside the natural process of 
ageing that intensifies and exacerbates these effects and may lead to CKD. 
An important indicator of renal function is glomerular filtration rate (GFR) which is the rate 
of flow of filtered fluid through the kidney (O'Callaghan, 2009).  In humans it is most 
common to estimate GFR (eGFR), so as to avoid exposure to the radioactive nuclides that 
are needed to provide an exact measurement.  There are several methods of eGFR 
estimation, although most laboratories in the UK use the Modification of Diet in Renal 
Disease (MDRD) formula, which uses serum creatinine levels along with information on age, 
race and gender (Levey et al., 1999).  A criticism of this method is that it tends to 
underestimate GFR by around 6% in patients with CKD, but by around 29% in healthy 
individuals (Rule et al., 2004) when compared to GFR calculated by urinary clearance of I-
125-iothalamate.  However, it is more accurate then another estimation method called the 
Cockcroft-Gault equation (Levey et al., 2006).  Using an animal model and applying the 
radioactive isotope method means that greater accuracy can be ensured . 
A decline in GFR is an inevitable part of ageing, as nephrons cease to function.  Peak GFR is 
reached around the age of 18-20 years, and after that point there is a slow decline.  The 
rate of decline starts to increase after the age of 45, at an annual rate of around 8 ml.min-
1.1.73m-2 (Poggio et al., 2009).  Reduced nephron number leads to compensatory 
mechanisms so that, for example, a reduction of 50% of the nephrons  due to a 
nephrectomy only leads to around 20-30% reduction in function (Addis et al., 1924; Krohn 
et al., 1966; Fehrman-Ekholm et al., 2001). 
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Figure 4.1: Schematic graphs of glomerular filtration rate (GFR) during lifetime 
 A: normal GFR reaches peak during early adulthood, before declining with age; B: a shift in the line downwards 
(red line) means a failure to reach the peak and GFR falls below 60 ml.min-1.1.73m-2 (the cut off point for stage 
I chronic kidney disease) in late middle age, rather than in old age. C: The peak GFR is still reached, but there is a 
faster rate of decline (red line) and GFR declines below 60 ml.min-1.1.73m-2 around a decade earlier. D: a 
combination of B and C means that the peak is not reached, and also function declines at a faster rate, leading 
to CKD in early middle age. 
 
Figure 4.1A shows a schematic diagram of GFR with increasing age.  Although absolute GFR 
does not reach its peak until early adulthood, this is largely a reflection of body surface 
area.  When adjusted for this, the peak is reached much earlier (around 2-3 years of age; 
Wahl et al., 2003).  In Figure 1.4B, the red line shows a scenario where the peak reached is 
lower, perhaps due to a reduction in the nephron number at birth. This means that the 
natural decline observed later in life may lead to chronic kidney disease once the GFR falls 
below 60 ml.min-1.1.73m-2.  Alternatively, there may be a full nephron complement, but a 
failure to maintain functionality caused by either changes in utero, or through lifestyle as an 
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adult. This would lead to the same peak but a faster rate of decline, as shown by the red 
line in Figure 4.1C.  A combination of both scenarios might mean a lower peak and an 
increased rate of decline, as shown by the red line in Figure 4.1D.   
In Chapter 3, the fetal kidney exposed to a maternal low protein diet was clearly influenced 
by the dietary pattern.  The investigation in this chapter considers whether there is 
evidence for any of the scenarios in Figure 4.1, by looking at renal function, nephron 
complement, and other changes within the adult kidney at the molecular level. 
4.2 Materials and Methods 
4.2.1 Study Design  
Full details are given in Chapter 2.  A brief summary of the experimental design follows. 
All procedures were performed in accordance with the UK Animals (Scientific Procedures) 
Act, 1986 and were approved by the relevant local ethical review committees of the 
Macauley Institute and the University of Nottingham. 
Thirty-seven pregnant Scottish Blackface ewes carrying singleton fetuses were randomly 
allocated to one of three diet groups fed either a control diet (CP; n = 15) providing 
adequate protein from day 0 of gestation to term (term ~147 days), or a protein-restricted 
diet during either early (LPE, days 0  W 65 gestation; n = 16) or late gestation (LPL, day 66  W 
term; n = 6).  KŶĂŶ ‘ĂƐĨĞĚďĂƐŝƐ ? ?ƚŚĞĚŝĞƚƐǁĞƌĞŝƐŽĐĂůŽƌŝĐǁŝƚŚƚŚĞĞĨĨĞĐƚŝǀĞůĞǀĞůŽĨ
protein restriction being 8.7 vs. 17 g ĐƌƵĚĞƉƌŽƚĞŝŶ ?D:D ?ŵĞƚĂďolic energy).  Eighteen 
fetuses were killed on day 65 gestation (Chapter 3) and the remainder carried to term with 
the offspring delivered naturally.  All male lambs were castrated.  Lambs were vaccinated 
and put to pasture at two weeks of age and then weaned at 10 weeks.  Lamb weight and 
body condition score were measured every three weeks. 
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The offspring were transferred to the University of Nottingham at 18 months of age and 
barn housed to create an obesogenic environment.  At 24 months, in vivo renography was 
performed and then the sheep were euthanised, urine was sampled and the kidneys 
collected. 
4.2.2 Urine and plasma analysis 
Urine and plasma samples were analysed for a spot measurement of the urinary 
albumin:creatinine ratio (urine from the bladder) and  plasma electrolytes (Na+, K+ and Cl-) 
as described in sections 2.3.2.1, 2.3.2.2 and 2.3.2.3.  
4.2.3 Renal function 
Renal function was assessed using gamma scintigraphy.  Full details are given in section 2.4. 
4.2.4 Histology 
Random paraffin-embedded sections from each treatment group were stained with (H&E), 
Periodic-Acid Schiff Reagent (PAS) or a trichrome stain (sections 2.5.2, 2.5.3 and 2.5.4).  
These were examined to identify any obvious pathophysiological features such as monocyte 
infiltration, glomerular interstitial nephritis, glomerulosclerosis or basement membrane or 
mesangial cell thickening, the findings being confirmed by a consultant histopathologist. 
4.2.5 Mean glomerular area 
Mean glomerular area  ?ʅŵ3) was assessed on 20 randomly selected glomeruli per animal 
using ImagePro MC 6.0 (section 2.9.1). 
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4.2.6 Stereological estimation 
Kidney volume was measured using water displacement.  Cortex:medulla ratio, nephron 
number, total glomerular volume and mean glomerular volume were  estimated by 
unbiased stereology. The full method is explained in section 2.10. 
4.2.7 Estimation of mammalian nephron number 
A review of papers reporting estimates of nephron number in different mammalian species 
was carried out and the data used to predict nephron number in sheep as described in 2.11. 
4.2.8 Lectin staining 
Kidney sections were stained for lectin as a marker of endothelial cells.  The lectin staining 
method is described in 2.8.  Negative controls were omission of GSL1B4, and as a further 
negative control galactose (a competing sugar) was added to GSL1B4.  Bovine ovary was 
used as a positive control.   
4.2.9 Renal immunohistochemistry 
4.2.9.1 VEGFA 
Renal sections were analysed for abundance of VEGFA using the Leica BOND-Dy ?
automated system (full method is given in 2.6.2, and further details of the VEGFA protein 
sequence and antibody selection are given in 3.2.3.  Negative controls were omission of 
primary antibody and rabbit IgG, and mouse kidney was used as a positive control. 
4.2.9.2 CD31 and CD34 
CD31 and CD34 antibodies were tested on renal sections, using both the ABC system 
(section 2.6.1), and the BondMax automated system with and without antigen retrieval 
(section 2.6.2). 
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Negative controls were omission of primary antibody and rabbit IgG, and a multi-species 
microarray was used as a positive control. 
4.2.10 Quantitative PCR 
Total RNA was extracted using RNeasy Mini Kit (Qiagen, Crawley, UK) and cDNA was 
synthesised using an Omniscript reverse transcriptase kit (Qiagen, Crawley, UK).  QPCR was 
performed using QuantiTect SYBR Green RT-PCR Kit (Qiagen, Crawley, UK) on a Roche 
Lightcycler® 480.  Melt curves were used to confirm reaction specificity and cyclophilin, 
beta actin and GAPDH were used as housekeeping genes. Negative controls were H2O and 
samples with Omniscript omitted.  MRNA quantities were normalised to housekeeping 
genes using Roche Lightcycler® 480 advanced relative quantification software.  Full details 
of the method are described at sections 2.12.1.1, 2.12.2, 2.12.4.1 and 2.12.5. 
4.2.11 Statistical Analysis 
All data apart from the albumin:creatinine ratio (ACR) results were analysed using a General 
Linear Model (GLM) or general linear mixed model approach where appropriate (Genstat 
v13, VSNi, UK) after checking for normality (or otherwise) of the error distribution.  Data 
with skewed errors were log transformed before analysis.  Estimated marginal means are 
presented with SEM.  ZǁĂƐĂŶĂůǇƐĞĚƵƐŝŶŐƚŚĞtŝůĐŽǆŽŶ ?ƐƌĂŶŬƐƵŵƚĞƐƚĂŶĚƌĞƐƵůƚƐĂƌĞ
presented at median and interquartile range.  P < 0.05 was accepted as indicating statistical 
significance. 
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4.3 Results 
4.3.1 Maternal characteristics 
Maternal weight gain and body condition score is described at 3.3.1.  In brief, there was no 
significant difference in weight gain during pregnancy between dietary groups, although 
there was a small (1.8%) tendency for reduction in body condition score in the LPE group 
during gestation. 
4.3.2 Offspring: weights and growth rates 
Birth weight was significantly reduced in the LPL, but not LPE, group compared with 
controls (Figure 4.2 A), however there was no effect of sex, nor a diet.sex interaction.  The 
LPL group experienced a period of catch-up growth as there were no differences between 
dietary groups by the time of weaning at 12 weeks, or for weight at 18 months or 2 years of 
age (Figure 4.2 B-D), although by 2 years males tended to be heavier than females (male, 
77.6 ± 2.67; female 70.7 ± 2.53 kg; P = 0.076).   
At 1.5 years of age and at a similar weight (47.1 ± 0.7 kg, all groups) the offspring were 
reared in an obesogenic environment (barn housed to restrict exercise and decrease 
thermogenic loss, and fed ad libitum) for the following 35 weeks.   
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Figure 4.2: Weight of offspring at birth, weaning, 18 months and 2 years of age. 
Data are Means ± S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or a low protein diet during 
early gestation (days 0-65; LPE, n=7) or a low protein diet during late gestation (days 66-term; LPL, n=6). There 
were 3 males and 3 females in CP and LPL and 3 males and 4 females in LPE. Data were analysed by General 
Linear Model for the fixed effects of treatment, sex and their interaction with (Genstat v13, VSNi, UK). CP, 
control protein diet; LPE, low protein early diet; LPL, low protein late diet; * = P < 0.05. 
 
The purpose was to increase weight and body fat deposition to a point that corresponded 
to a theoretical gain in body mass index (BMI) from 22.5 to 32 kg.m-2, i.e. a change from a 
normal BMI to an obese one.  Figure 4.3 shows the weight gain during this period.  All 
groups gained weight at a similar rate, regardless of prenatal diet, although there was an 
effect of time because weight increased during the obesogenic period (P< 0.001) before 
stabilising at around 30 weeks of duration. 
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Figure 4.3: Weight gain of offspring during obesogenic period 
Sheep were barn housed and fed ab libitum to promote weight gain from age 18 months. Data are Means ± 
S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or a low protein diet during early gestation 
(days 0-65; LPE, n=7) or a low protein diet during late gestation (days 66-term; LPL, n=6). There were 3 males 
and 3 females in CP and LPL and 3 males and 4 females in LPE. Data were analysed by General Linear Model for 
the fixed effects of treatment, sex and their interaction with (Genstat v13, VSNi, UK). CP, control protein diet; 
LPE, low protein early diet; LPL, low protein late diet; NS, non-significant. 
 
There was no effect of diet or sex on the growth rate between birth and  weaning at 12 
weeks of age (CP, 272 ± 16.2; LPE, 235 ± 13.9; LPL 260 ± 14.6 g.day-1; Figure 4.4 A) nor 
between weaning and 18 months (CP, 35.9 ± 3.12; LPE, 41.5 ± 2.68; LPL, 35.4 ± 2.82 g.day-1; 
Figure 4.4 B).  Between 18 months and 2 years of age, the rate of growth increased 
compared to that observed between weaning and 18 months, although there were no 
statistically significant differences between dietary groups (CP, 84.77 ± 8.87; LPE, 96.96 ± 
7.61; LPL, 86.65 ± 8.00 g.day-1; Figure 4.4 C).  However, males tended to grow faster than 
females (males, 100.61±7.28 vs females, 82.03 ± 6.15 g.day-1; P = 0.075). 
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Figure 4.4: Growth rates of offspring 
Growth rates of offspring, from birth to weaning (A), weaning to 18 months (B) and in an obesogenic 
environment from 18 months to 2 years of age (C). Data are Means ± S.E.M. for offspring of ewes fed a control 
protein diet (CP, n = 6), or a low protein diet during early gestation (days 0-65; LPE, n = 7) or a low protein diet 
during late gestation (days 66-term; LPL, n = 6). There were 3 males and 3 females in CP and LPL and 3 males 
and 4 females in LPE. Data were analysed by General Linear Model for the fixed effects of treatment, sex and 
their interaction with (Genstat v13, VSNi, UK). CP, control protein diet; LPE, low protein early diet; LPL, low 
protein late diet;  
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4.3.3  Post mortem data 
Diet had no effect on the weights at post mortem of brain, heart, liver, kidneys, lungs or 
liver (Table 4.1).  Brain, liver and total kidney weight was significantly higher in males than 
females; however this was attenuated once adjusted for total body weight.  Other organs 
measured  W spleen, adrenal and pituitary glands  W were not significantly different in weight 
between groups.   
The heart left ventricular thickness was higher in the LPE groups compared to the LPL and 
control groups (CP, 15.39 ± 0.80; LPE, 17.86 ± 0.69; LPL 15.37 ± 0.72 cm).   
Various adipose tissue depots were also measured: total visceral fat, perirenal fat and 
omental fat were not different between groups. However, the amount of pericardial fat 
was significantly higher in the LPE group (CP, 5.29 ± 0.10; LPE, 5.53 ± 0.09; LPL, 5.15 ± 0.09 
g.kg-1 body weight). 
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Table 4.1: Organ weights at two years of age 
 
Data are means ± S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or a low protein diet during 
early gestation (days 0-65; LPE, n=7) or a low protein diet during late gestation (days 66-term; LPL, n=6). There 
were 3 males and 3 females in CP and LPL and 3 males and 4 females in LPE. Data were analysed by General 
Linear Model for the fixed effects of treatment, sex and their interaction with (Genstat v13, VSNi, UK). CP, 
control protein diet; LPE, low protein early diet; LPL, low protein late diet; NS, non-significant. 
 
  Sex P value 
Organ Diet male  female Diet Sex Diet*Sex 
Brain (g) CP 103 ± 3.63 91.1 ± 7.26 
NS <0.01 NS LPE 110 ± 5.14 91.0 ± 3.25 
 LPL 108 ± 7.26 91.1 ± 3.63 
Heart (g) CP 299 ± 33.7 271 ± 43.1 
NS NS NS LPE 313 ± 49.8 322 ± 32.4 
 LPL 303 ± 48.3 264 ±29.7 
Liver (g) CP 781 ± 47.3 640 ± 66.9    
 LPE 813 ± 66.9 684 ± 42.3 NS 0.018 NS 
 LPL 774 ± 66.9 663 ± 47.3    
Lungs (g) CP 660 ± 153 537 ± 176    
 LPE 682 ± 224 498 ± 103 NS NS NS 
 LPL 610 ± 200 376 ±  87    
Total kidney (g) CP 162 ± 10.3 128 ± 14.6    
 LPE 156 ± 14.6 117 ± 9.20 NS 0.010 NS 
 LPL 150 ± 14.6 131 ± 10.3    
Kidney (g.kg
-1
 weight) CP 2.15 ± 0.15 1.83 ± 0.22    
 LPE 1.90 ± 0.22 1.63 ± 0.14 NS NS NS 
 LPL 2.05 ± 0.22 1.86 ± 0.15    
Perirenal fat (kg) CP 2.31 ± 0.35 2.60 ± 0.50    
 LPE 2.57 ± 0.50 2.41 ± 0.31 NS NS NS 
 LPL 1.37 ± 0.50 2.57 ± 0.35    
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4.3.4 Urine and blood analysis 
4.3.4.1 Sodium, potassium, chloride 
Plasma sodium, potassium and chloride concentrations are shown in Figure 4.5. There was 
no significant effect of diet, sex or a diet.sex interaction on plasma sodium concentration 
(CP, 131.7 ± 4.95; LPE, 133.6 ± 4.24; LPL, 138.1 ± 4.46 mmol.L-1), although the 
concentrations observed were slightly below sheep reference values 142  W 160 mmol.L-1 
(Aitken, 2007).  Neither were any differences observed for chloride (CP, 93.6 ± 2.93; LPE, 
92.5 ± 2.51; LPL, 96.1 ± 2.64 mmol.L-1), which fell in the lower end of sheep reference values 
(Radostits et al., 2000). 
Potassium was not significantly different between diets (CP, 7.98 ± 0.39; LPE, 7.64 ± 0.33; 
LPL, 7.90 ± 0.35 mmol.L-1), but was reduced in males compared to females (7.23 ± 0.32 vs 
8.27 ± 0.27 mmol.L-1, P = 0.029).  These values were higher than the published reference 
range of 3.9  W 5.4 mmol.L-1 (Aitken, 2007) although it was not possible to check breed-
specific values.  However, haemolysis of plasma samples may lead to unreliable results with 
an incorrectly high level of potassium (Dimeski et al., 2005; Jeffery et al., 2009). Although 
precautions were taken to minimise the risk of haemolysis, i.e. minimal agitation of 
collection tubes and the immediate separation of plasma (Ismail et al., 2005), a visual 
inspection for haemolysis can be unreliable (Hawkins, 2002). In future studies, if potassium 
levels were as high as measured in this study a haemolyser index on an autoanalyser could 
be used to check definitively for haemolysis. 
4.3.4.2 Albumin:creatinine ratio 
The urinary albumin:creatinine ratio (ACR) was significantly increased in the LPE group 
compared with the controls and the LPL group (CP, 1.73 [1.71  W 2.67]; LPE, 8.88 [7.9-24.7]; 
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LPL, 2.49 [1.63-2.98] mg.µmol-1; P = 0.03, median [IQR]) and there was no effect of sex, nor 
a diet.sex interaction. 
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Figure 4.5: Sodium, potassium and chloride serum concentrations 
Data are Means ± S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or a low protein diet during 
early gestation (days 0-65; LPE, n=7) or a low protein diet during late gestation (days 66-term; LPL, n=6). There 
were 3 males and 3 females in CP and LPL and 3 males and 4 females in LPE. Data were analysed by General 
Linear Model for the fixed effects of treatment, sex and their interaction with (Genstat v13, VSNi, UK). CP, 
control protein diet; LPE, low protein early diet; LPL, low protein late diet; NS, non-significant 
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4.3.5 Renal function 
The upslope of the renogram (indicating the rate of uptake of the radioactive nuclide) was 
not significantly different between diets or between sexes (CP, 44.8 ± 11.40; LPE 37.4 ± 
6.76; LPL, 50.0 ± 6.76 cpm 99MTc-DPTA; Figure 4.6A).  The downslope (indicating the rate of 
clearance of the radioactive nuclide) was also not different between groups (CP, 10.30 ± 
3.04; LPE 6.08 ± 1.05; LPL, 8.18 ± 1.48 cpm 99MTc-DPTA; Figure 4.6B).  The time taken for the 
peak to be reached from injection to the peak concentration in the kidney was not different 
between males and females, however there was an effect of diet (CP, 2.98 ± 0.111; LPE 3.13 
± 0.071; LPL, 2.88 ± 0.065 min; P = 0.046; Figure 4.6C).  Transit time through the kidney (a 
composite measure of the other parameters and an indication of the whole kidney 
function) was greater in the LPE group compared to controls and the LPL group (CP, 1.07 ± 
0.076; LPE 1.27 ± 0.054; LPL, 0.97 ± 0.041 min; P < 0.001; Figure 4.6D).  Males had a slower 
transit time than females (1.028 min ± 0.0471 vs 1.164 ± 0.0407). 
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Figure 4.6: Gamma scintigraphy renogram results 
Renal function was assessed by renography using Tc99m-DTPA. The upslope (A) is defined as the positive slope 
of the renogram occurring before the peak and computed using the X and Y values of the renogram at 5 and 
90% of the peak Y; Time to peak (C) is from bolus injection to peak counts in the right kidney, the downslope is 
defined as the negative slope of the renogram occurring after the peak and computed using the X and Y values 
of the renogram at the peak and half-peak value on the downslope of the curve (B); transit-time is the mean 
time taken for tracer to pass through the kidney (D). Data are Means ± S.E.M. for offspring of ewes fed a control 
protein diet (CP, n=6), or a low protein diet during early gestation (days 0-65; LPE, n=7) or a low protein diet 
during late gestation (days 66-term; LPL, n=6). There were 3 males and 3 females in CP and LPL and 3 males and 
4 females in LPE. Data were analysed by General Linear Model for the fixed effects of treatment, sex and their 
interaction with (Genstat v13, VSNi, UK). CP, control protein diet; LPE, low protein early diet; LPL, low protein 
late diet; NS, non-significant, *P < 0.05, ***P < 0.001 
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Measurement of glomerular filtration rate (GFR)  indicated preservation of GFR in LPE 
animals in the longer-term (Table 4.2), as there were no differences between diet or sex, 
nor evidence of a diet.sex interaction. 
Table 4.2: Glomerular filtration rate (GFR) at two years of age 
 
Glomerular filtration rate was assessed through decay of Tc99m-DTPA in plasma samples collected after 3, 4 
and 5h post 100MBq I.V. bolus dose. Ewes were euthanized as per standard operating procedures and the wet 
weight of organs recorded. Data are Means ± S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or 
a low protein diet during early gestation (days 0-65; LPE, n=7) or a low protein diet during late gestation (days 
66-term; LPL, n=6). There were 3 males and 3 females in CP and LPL and 3 males and 4 females in LPE. Data 
were analysed by General Linear Model for the fixed effects of treatment, sex and their interaction with 
(Genstat v13, VSNi, UK). NS, not significant; CP, control protein diet; LPE, low protein early diet; LPL, low protein 
late diet; GFR, glomerular filtration rate. 
 
 
 
 
  Sex P value 
GFR Diet male female  Diet Sex Diet*Sex 
ml.ml
-1 
 
CP 146 ± 16 147 ± 23 
NS NS NS LPE 114 ± 23 150 ± 14 
 LPL 133 ± 23 139 ± 16 
ml.ml
-1
.g
-1
 kidney CP 0.97 ± 0.14 1.12 ± 0.22 
NS NS NS LPE 0.89 ± 0.21 1.32 ± 0.13 
 LPL 1.02 ± 0.21 0.98 ± 0.14 
ml.ml
-1
.kg
-1
 lean mass CP 3.21 ± 0.37 3.68 ± 0.53 
NS NS NS LPE 3.27 ± 0.53 3.78 ± 0.33 
 LPL 2.84 ± 0.53 3.63 ± 0.37 
 127 
4.3.6 Adult renal structure 
The general morphology of the kidneys was assessed by staining with a range of histological 
stains, details of which are shown in Table 4.3. 
Table 4.3: Histological stain details 
Stain Stain component Colour Structures stained 
H & E Haematoxylin Dark blue Cell nuclei 
 Eosin Pink                                      
Red 
Cytoplasm (pink)               
red blood cells (red) 
PAS Periodic acid-Schiff Magenta Basement membranes, 
tubule brush borders 
 Haematoxylin Dark blue Cell nuclei 
Trichrome Fast green Green Collagen 
 Orange G Orange Red blood cells 
 Haematoxylin Dark blue Cell nuclei 
Adapted from Young et al., 2006 
 
Histological examination of the kidney cortex indicated no obvious morphological or 
structural abnormality in either the glomeruli or distal and proximal convoluted tubules in 
any of the diet groups (Figure 4.7 A, C-F).  In addition there was neither evidence of 
consistent monocyte/lymphocyte infiltration (example shown in Figure 4.7 B) nor any 
indication of glomerulosclerosis. 
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Figure 4.7: Histological staining of adult kidney sections at 2 years of age 
Representative section from the LPE group stained with haematoxlin and eosin, showing normal kidney 
structure (A,magnification x 200); representative section from the control group showing monocyte infiltration 
around the glomeruli (B, magnification x 200); representative histological sections from the LPE group (C, 
magnification x200; D, magnification x400) stained with Periodic Acid Schiffs reagent shows normal kidney 
structure; representative histological section (x200) from the LPE group stained with trichrome (E) and showing 
red blood cell staining (orange) as indicated by white arrows (F).  
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Table 4.4: PCR results for endoplasmic stress markers 
  Sex P value 
 Treatment Male Female Diet Sex Diet.sex 
ATF4 CP 5.85 ± 0.80 4.95 ± 1.13 
NS NS NS LPE 5.00 ± 1.13 5.29 ± 0.72 
LPL 4.51 ± 1.13 6.33 ± 0.80 
ATF6 CP 5.36 ± 0.98 5.86 ± 1.39 
NS NS NS LPE 5.90 ± 1.39 4.73 ± 0.88 
LPL 4.88 ± 1.39 4.83 ± 0.98 
Bax CP 8.37 ± 0.98 9.23 ± 1.38 
NS NS NS LPE 8.39 ± 1.38 8.51 ± 0.87 
LPL 10.40 ± 1.38 8.48 ± 0.98 
CD68 CP 0.09 ± 0.03 0.11 ± 0.04 
NS NS NS LPE 0.11 ± 0.04 0.18 ± 0.03 
LPL 0.22 ± 0.04 0.17 ± 0.03 
DDIT3
 
CP 0.68 ± 0.16 0.46 ± 0.15 
0.02 NS NS LPE 0.81 ± 0.26 1.17 ± 0.24 
LPL 0.62 ± 0.20 1.08 ± 0.25 
HSPA5
 
CP 2.80 ± 0.47 2.28 ± 0.54 
NS NS NS LPE 2.10 ± 0.50 2.84 ± 0.43 
LPL 2.06 ± 0.49 2.76 ± 0.47 
MCP-1
 
CP 1.26 ± 0.30 0.69 ± 0.43 
NS NS NS LPE 1.45 ± 0.43 1.40 ± 0.27 
LPL 1.80 ± 0.43 1.27 ± 0.30 
Advanced relative quantification of mRNA normalised to cyclophilin using Roche Lightcycler® 480 software. Data 
are Means ± S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or a low protein diet during early 
gestation (days 0-65; LPE, n=7) or a low protein diet during late gestation (days 66-term; LPL, n=6). There were 3 
males and 3 females in CP and LPL and 3 males and 4 females in LPE.  Data were analysed by General Linear 
Model for the fixed effects of treatment, sex and their interaction (Genstat v13, VSNi, UK). NS, not significant; 
CP, control protein diet; LPE, low protein early diet; LPL, low protein late diet. Gene symbols according to HUGO 
nomenclature (http://www.genenames.org/); ATF, Activating Transcription Factor; DDIT3, DNA Damage 
Inducible Transcript 3; HSPA5, Heat Shock 70 kDa Protein 5; MCP1, Monocyte Chemotactic Protein 1. 
 
4.3.7 Endoplasmic reticulum stress 
A previous study (Sharkey et al., 2009a) indicated that juvenile obesity led to increased 
intra-renal endoplasmic reticulum (ER) stress.  This study tested many of the same markers 
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of ER stress, but only one (DDIT3) was found to be significantly different, with increased 
mRNA expression in the LPE group compared to the control and LPL groups (Table 4.4).   
4.3.8 Mean glomerular area 
Mean glomerular area was assessed using 2-D images taken from 20 randomly selected 
areas of kidney cortex per animal.  There were no significant differences between diet 
groups (Figure 4.8), however, there was an effect of gender, with females having larger 
ŐůŽŵĞƌƵůĂƌĂƌĞĂƚŚĂŶŵĂůĞƐ ? ? ? ? ? ? ?A? ? ? ?ǀƐ ? ? ? ? ? ?A  ? ? ?ʅŵ2; P= 0.034).  However, 2-D 
analysis has been criticised on a number of fronts (see discussion), and therefore the gold 
standard method of stereological analysis was used instead to calculate mean glomerular 
volume. 
 
Figure 4.8: Mean glomerular area of two year old adult kidneys 
Data are Means ± S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or a low protein diet during 
early gestation (days 0-65; LPE, n=7) or a low protein diet during late gestation (days 66-term; LPL, n=6). There 
were 3 males and 3 females in CP and LPL and 3 males and 4 females in LPE. Data were analysed by General 
Linear Model for the fixed effects of treatment, sex and their interaction with (Genstat v13, VSNi, UK). CP, 
control protein diet; LPE, low protein early diet; LPL, low protein late diet; NS, non-significant.  
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4.3.9 Stereology 
As assessed by stereology, there was a strong trend for reduced nephron number (~16% 
fewer) in the LPE group compared to controls and the LPL group (CP, 1,042,981 ± 83,165; 
LPE, 876,694 ± 55,682; LPL, 1,018,677 ± 58,297; P = 0.054; Figure 4.9 A), although there was 
no effect of sex.  Total glomerular volume was not different between dietary groups (Figure 
4.9 B), but there was a significant effect of sex, with males having higher total glomerular 
volume than females (males, 2.14 ± 0.13; females, 1.65 ± 0.11 cm3), which probably reflects 
the higher kidney volume in male animals.  Conversely the mean glomerular volume was 
not affected by sex but was significantly higher in the LPE group (CP, 1.94 ± 0.15; LPE, 2.29 ± 
0.13; LPL, 1.66 ± 0.14 mm2; P = 0.022; Figure 4.9 C).   
However, although nephron number and mean glomerular volume were altered in the LPE 
group, the overall size and structure of the kidney were not different.  As expected, kidney 
volume was highly correlated with kidney weight (PeaƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶĐŽĞĨĨŝĐŝĞŶƚŽĨƌ2 = 
0.91; P < 0.001).  Kidney volume was not different between dietary groups (CP, 72.6 ± 5.15; 
LPE, 65.4 ± 4.42; LPL, 71.6 ± 4.65 cm3), however there was a weak trend for a difference 
between males and females (males, 75.4 ± 4.43; females, 65.4 ± 3.58 cm3; P = 0.097).  In 
addition there were no effects of diet or sex observed on the volume of the renal cortex 
(CP, 46.3 ± 3.68; LPE, 44.8 ± 3.15; LPL, 48.7 ± 3.32 cm3).  Furthermore there were no 
diet.sex interactions for any of the stereological variables. 
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Figure 4.9: Nephron number, total and mean glomerular volume 
Variables were assessed using unbiased stereology. Data are Means ± S.E.M. for offspring of ewes fed a control 
protein diet (CP, n=6), or a low protein diet during early gestation (days 0-65; LPE, n=7) or a low protein diet 
during late gestation (days 66-term; LPL, n=6). There were 3 males and 3 females in CP and LPL and 3 males and 
4 females in LPE. Data were analysed by General Linear Model for the fixed effects of treatment, sex and their 
interaction with (Genstat v13, VSNi, UK). CP, control protein diet; LPE, low protein early diet; LPL, low protein 
late diet; NS, non-significant, *P < 0.05 
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4.3.10 Estimation of mammalian nephron number 
This study reported a nephron number in sheep that was higher than other reported 
estimates from control animals, as shown in Table 4.5.  Therefore the possibility of an error 
in the stereological method  was considered .  The method was checked by Professor 
Antonio Ribeiro, Professor of Stereology at University of Sao Paulo who confirmed it to be 
correct.  Given the substantial variation in the reported nephron numbers, next it was 
considered whether it was possible to predict the nephron number of any given mammal, 
based upon analysis of nephron number and body weight from other studies.   
Table 4.5: Nephron number in control animals in sheep studies 
Paper Nephron number N 
Bains et al., 1996  289,439 ± 36,263 6 
Douglas-Denton et al., 2002  365,672 ± 36,016 7 
Wintour et al., 2003  402,787 ± 30,458 7 
Mitchell et al., 2004  559,000 ± 19,800 6 
O'Connell et al., 2006  425,406 ± 27,560 5 
Zohdi et al., 2007  371, 219 
a 
7 
Brandon et al., 2008  423, 520 ± 22,194
 b
 9
 
Gray et al., 2008 423,177 ± 17,178 5 
Muhle et al., 2010 681,000 ± 46,000 9 
Zhang et al., 2010 896,814 ± 45,772 11 
Galinsky et al., 2011 600,000 
c 
4 
Data are means ± s.e.m. 
a 
s.em. or s.d. not reported; 
b 
one animal was excluded as an outlier for having a 
nephron number of 701, 450; 
c 
numbers not given in the paper, this is an estimate from a graph.  
 
A paper published in 1930 (Kunkel, 1930) was the first to consider this in detail, and 
reported that animals such as dogs (which vary hugely in size according to breed) varied in 
nephron number and size according to their weight.  This paper also reported details of 
nephron number in a variety of other mammals.  By updating these data for nephron 
estimates from studies using modern stereological methods wherever possible, and adding 
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other species reported more recently, it was possible to observe a strong correlation 
between body weight and nephron number (R2 = 0.98; P < 0.0001).  Using log10 data for 
published values of nephron number from a mouse weighing 20 g to an elephant weighing 
3700 kg (Figure 4.10) generates an equation of y = 0.613x + 3.116, therefore accurately 
predicting an adult sheep (50 - 70 kg) to have between 994,050  W 1,221,839 nephrons per 
kidney. 
 
Figure 4.10: The relationship between mass and nephron number in mammals 
Data are log10 of mass (g) and nephron number per kidney. R
2
 = 0.98; P < 0.0001. 
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4.3.11 Lectin staining 
As the reduction in nephron number was only around 16% it is unlikely that this alone 
would cause a reduction in renal function during young adulthood, so other structural 
changes in the kidney were considered, in particular the vascular system.   
Lectins are non-immune proteins that have specificity for certain carbohydrate residues 
(Rhodes and Milton, 1998), and these are exploited for use in histochemical methods. 
Mammalian vascular endothelial cells act as ligands for lectins, and Griffonia simplicifolia 
lectin and the isolectin GSL B4 bind to the endothelial cells of most species, excluding 
humans (Rhodes and Milton, 1998). 
/ŶŝƚŝĂůůǇ ?ĐŽŶĐĞŶƚƌĂƚŝŽŶƐŽĨůĞĐƚŝŶĂƚ ? ? ? ?ĂŶĚ ? ?ʅŐ ŵů-1 were trialled, along with bovine 
ovary as a positive control as this has been previously shown to stain with this lectin when 
incubated at room temperature for 2 hours.  Although the positive control worked (Figure 
4.11 G), there was no staining on the sheep kidney sections (Figure 4.11 A), therefore the 
lectin was applied at ƚŚĞŽƌŝŐŝŶĂůĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ?ƉůƵƐĂŚŝŐŚĞƌŽŶĞ ? ? ?ʅŐ ?ŵů-1) and 
ŝŶĐƵďĂƚĞĚŽǀĞƌŶŝŐŚƚĂƚ ? ? ?ƚ ?ʅŐ ?ŵů-1 there was no staining (not shown) and at 10 and 20 
ʅŐ ?ŵů-1 there was evidence of non-specific staining (Figure 4.11 B and C respectively) but no 
staiŶŝŶŐŽĨĞŶĚŽƚŚĞůŝĂůĐĞůůƐ ?ƚ ? ?ʅŐ ?ŵů-1 there was clear staining of endothelial cells 
(white arrows, Figure 4.11 D) although the non-specific staining in the proximal tubules was 
stronger (Figure 4.11 E).   
To try to counteract the non-specific staining, various strategies were used, including 
increasing the time of the blocking steps during the protocol.  A citrate buffer antigen 
retrieval method was also used to see whether this improved the specificity of the staining, 
but this made the staining in the proximal tubules even more pronounced, even at a lower 
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concentration of lectin (Figure 4.11 F), and also resulted in staining in the negative control 
that omitted lectin.   
Without antigen retrieval the omission of lectin resulted in a section without positive 
staining (Figure 4.11 H), but the other negative control of a competing sugar, galactose, 
stained just as much as the lectin itself did.  Therefore although the lectin did seem to stain 
endothelial cells, it was impossible to be sure this was specific.  There was also a large 
amount of non-endothelial staining in the proximal tubules.  A similar finding has also been 
found in pigs (Kirkeby and Mikkelsen, 2008), where isolectin GSL B4 was shown to bind to 
both the  basement membrane and brush borders of proximal convoluted tubules. 
Thus it would appear that the lectin is not suitable as an endothelial cell marker for ovine 
kidney.   
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Figure 4.11: Staining with Griffonia (Bandeiraea) simplifolia lectin 1 isolectin B4 
 Representative micrographs show absence of lectin staining with 2h room temp incubation at 20 µg.ml
-1
 (A; magnification x200); non-specific staining with overnight incubation at 4ÛC at 10 
µg.ml
-1
 (B; x400) and 20 µg.ml
-1
 (C; x400); specific staining at 40 µg.ml
-1
 in endothelial cells indicated by white arrows (D; x400) but intense non-specific staining in proximal tubules (E; x200), 
antigen retrieval amplified non-specific staining even at 5 µg.ml
-1
 (F, x400). Positive control was bovine ovary (G, x200), negative control (omission of lectin) with and without antigen retrieval 
(J & H respectively, x200) and stained for competing sugar, galactose (I, x200). 
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4.3.12 CD31 and CD34 
As the lectin staining was not successful due to non-specific staining, other endothelial cell 
markers were needed.  Due to a lack of availability of antibodies successfully reported for 
use in sheep, four antibodies were trialled for two other endothelial cell markers CD31 (also 
known as platelet/endothelial cell adhesion molecule 1, PECAM) and CD34. 
4.3.12.1 CD31 ab32457 and ab83959 and CD34 ab63985 
All three of these antibodies were tried using both the Vectastain Elite ABC system (section 
2.6.1) and the automated Bondmax system with and without antigen retrieval (section 
2.6.2).  
The CD31 ab32457 antibody was tried at five different concentrations ranging from 1:100 
to 1:2000.  However, there was no evidence of specific staining of endothelial cells.  
Representative micrographs of control sections as shown in Figure 4.12 demonstrate that 
at higher concentrations (1:250 and above) there was evidence of non-specific staining 
however this starts to be diluted out by 1:500 and by 1:1000 there is no staining at all.   
The CD31 ab83959 antibody was tried at concentrations ranging from 1:50 to 1:1000, and a 
similar pattern was observed to the other CD31 antibody, with the highest concentration 
(1:50) having non-specific staining, which started to fade by 1:100, and had disappeared by 
1:250 (Figure 4.12). 
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Figure 4.12: Immunohistochemistry for endothelial cell markers 
Representative micrographs at magnification x200 show non-specific staining for CD31 ab32457 at 1:250 and 1:500, which disappears by 1:1000; non-specific staining for CD31 ab83959 at 
1:50, which has largely disappeared by 1:100 and totally disappeared by 1:250; non-specific staining for CD34 ab63895 at 1:50, which has largely disappeared by 1:250 and totally disappeared 
by 1:500. Negative controls were omission of antibody and rabbit IgG control which evidenced the non-specific staining at a higher concentration of 1:50, and a smaller amount at 1:500. 
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The CD34 ab63895 showed exactly the same pattern as the CD31 ab83959 at the same 
concentrations (Figure 4.12), with no evidence of specific staining of endothelial cells.  
The negative controls where the primary antibody was omitted were all negative regardless 
of method or antigen retrieval status.  However the rabbit IgG control stained the tissue 
when it was diluted to match the higher primary  antibody concentrations.   Once the IgG 
control was diluted low enough to remove this non-specific staining, the primary antibodies 
were diluted such that all staining from them also disappeared.  However, the final 
antibody (CD34 ab81289) was successful. 
4.3.12.2 CD34 ab81289 
CD34 ab81289 was tried at concentrations ranging from 1:25 to 1:500 initially.  At the 
higher concentrations there was an abundance of non-specific staining, which was also 
seen in the rabbit IgG control at the same concentrations; however by 1:500 dilution the 
IgG control had very little staining and genuine specific staining could be seen on the 
sample albeit alongside some additional staining in the proximal tubules.  This was 
counteracted by diluting further to 1:1000, where the staining could be seen in endothelial 
cells alone (indicated by white arrows in Figure 4.13 A), and staining was entirely absent in 
both negative controls (omission of primary antibody, Figure 4.13 C; Rabbit IgG Figure 4.13 
D). 
There was a significant decrease in the abundance of CD34 protein in the LPE group 
compared to CP and LPL groups (Figure 4.13 B, P <0.001) which suggests a reduction in the 
microvascular structures in the kidney.   
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Figure 4.13: Immunohistochemistry for CD34 protein 
A representative micrograph of a control kidney with staining for CD34 indicated by the white arrows (A, 
magnification x 400); negative controls were omission of antibody (C, x200) and rabbit IgG (D, x200).  The graph 
(B) shows means ± S.E.M. for offspring of ewes fed a control protein diet (CP, n=6), or a low protein diet during 
early gestation (days 0-65; LPE, n=7) or a low protein diet during late gestation (days 66-term; LPL, n=6). There 
were 3 males and 3 females in CP and LPL and 3 males and 4 females in LPE. Data were analysed by General 
Linear Model for the fixed effects of treatment, sex and their interaction with (Genstat v13, VSNi, UK). CP, 
control protein diet; LPE, low protein early diet; LPL, low protein late diet; NS, non-significant, *** P < 0.001 
 
4.3.13 Vascular Endothelial Growth Factor 
To explore whether the effects of VEGFA seen in the fetus (section 3.2.3) were also 
observed in the adult tissue, qPCR and immunohistochemistry were carried out.  In direct 
contrast to the fetal results where VEGFA was significantly lower in LPE animals, the mRNA 
of VEGFA tended to be increased in the LPE group compared to controls and LPL animals, 
whereas the mRNA for the receptors tended to be increased in both LPE and LPL groups 
compared to controls (Figure 4.14 A-C; VEGFA, P = 0.07; VEGFR1, P = 0.05; VEGFR2, P = 
0.09).  At the protein level, VEGFA was significantly increased in both LPE and LPL groups 
compared to controls (Figure 4.14 D  W F).  
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Figure 4.14: VEGFA mRNA and protein expression in the adult kidney 
Quantification of mRNA expression of VEGFA (A), VEGFR1 (B) and VEGFR2 (C); representative micrographs (magnification x200) of immunostaining for VEGFA for the control group (D) and LPE 
group (E); and its quantification (F). Negative controls were omission of primary antibody (G) and rabbit IgG (H); positive control was mouse kidney (I). Data are Means ± S.E.M. for control 
protein (CP, n=6), low protein early (days 0-65 gestation; LPE, n=7) and low protein late (days 66-term; LPL, n=6). There were 3 males and 3 females in CP and LPL and 3 males and 4 females in 
LPE.   Data were analysed by General Linear Model for the fixed effects of treatment and sex with their interaction (Genstat v13, VSNi, UK). NS, non significant; VEGF, vascular endothelial 
growth factor, * P < 0.05
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4.4 Discussion 
In this study of maternal protein-energy malnutrition, despite a 50% reduction in protein 
availability, the diet had few effects on maternal body weight or body condition score, 
which indicates that the nutrient restriction was relatively mild.  However, there were 
effects on the fetus that were determined by the timing of the nutritional insult, as the 
group fed low protein from day 65  W term (LPL group) had a significantly lower birth weight 
than the controls (CP) or those fed the maternal low protein diet from day 0 -65 gestation 
(LPE).  In addition, the LPL group exhibited a period of early catch-up growth such that by 
weaning there were no differences in body weight between groups.  Both low birth weight 
and early catch-up growth are considered developmental markers for later adult disease 
(Barker et al., 1989; Osmond et al., 1993).  This study illustrates, however, that the quality 
of nutrition early in development is of more importance with respect to the programming 
of later adult dysfunction and potentially disease.  Although the LPL animals had lower birth 
weight and a period of catch-up growth early in life, there was no evidence of a detrimental 
effect on kidney function at two years of age.  In contrast, the LPE group, which had normal 
birth weights and early growth patterns, had reduced kidney function in adulthood.  
There were few effects of diet on fetal organ weight (Chapter 3) or on adult organ weights 
at 2 years of age.  This contrasts with laboratory rodent studies in which a similar degree of 
protein restriction has often resulted in disproportionate growth (Langley-Evans et al., 
1999), low birthweight (Levy and Jackson, 1993; Desai et al., 1996), smaller kidneys 
(Langley-Evans et al., 1999) and misshapen kidneys (Nwagwu et al., 2000).  One possible 
explanation for the difference between rodent studies and this study is that the ewes in this 
study were monocotous (i.e. the uterus was supporting a singleton pregnancy) and thus the 
growth of the utero-placental unit has a lower anabolic demand than on polycotous species 
(where the uterus supports multiple pregnancies) such as rodents (McCance and 
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Widowson, 1986).  Indeed, other nutritional programming studies of sheep have also 
shown no effect on kidney weight (Gray et al., 2008; Braddick et al., 2011), and in another 
monocotous species (marmoset monkeys) kidney weight was also unaffected by maternal 
diet (Bramlage et al., 2009).   These findings suggest that the effects on smaller mammals 
are not necessarily replicated in larger mammals.  Thus, as is often the case, laboratory 
rodents are likely to present a more severe response to a dietary regimen that has much 
less effect on larger animals. 
Additionally a number of small animal studies have suggested that reduced maternal 
protein intake, regardless of when the intervention occurs during gestation, can have quite 
remarkable effects on anatomical development of the fetal kidney with reports of a 20-50% 
deficit in nephron number (Vehaskari et al., 2001; McMullen et al., 2004; Hoppe et al., 
2007).  Here, as in larger animals (Brennan et al., 2005; Braddick et al., 2011), few gross 
effects on kidney size or development are observed, but on closer examination there are 
some subtle renal effects.  In the adult animals exposed to maternal protein restriction 
during early gestation only, a small reduction (~15%) in nephron number was evident, 
together with an increase in mean glomerular volume (determined stereologically).  This 
study is the first to demonstrate a renal phenotype after changes to the macronutrient 
composition  W rather than energy content - of the maternal diet and suggests that the 
protein-energy ratio of the maternal diet is more important in terms of developmental 
programming than a balanced reduction in nutrient intake (Brennan et al., 2005).  In 
humans, there is much descriptive evidence to suggest that an optimal fetal environment is 
a prerequisite for adequate development of the kidney and for good blood pressure control 
later in life;  low birth weight babies have fewer nephrons (Manalich et al., 2000; Hughson 
et al., 2003) and tend to develop higher blood pressure later in life (Brenner et al., 1988; 
Mackenzie and Brenner, 1995b; Keller et al., 2003).  In addition, individuals with a history of 
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hypertension have significantly fewer nephrons than normotensive controls (Keller et al., 
2003).  
Furthermore our estimate of nephron number in control sheep (~1,042,981) is of academic 
value and interest  for although it was determined stereologically, it contrasts with other 
estimates for sheep, e.g. from 289,000 to 420,000(Table 4.5).  Nephron number may vary 
subtly within a species (Zimanyi et al., 2009; McNamara et al., 2010), but this is usually due 
to size and lean mass as the number of glomeruli is highly correlated with both birth weight 
(Manalich et al., 2000) and weight-adjusted metabolic mass between species (Kunkel, 
1930).  Using log10 data for nephron number from a range of species predicts a sheep 
(weighing between 50 and 70kg) to have between 994,050  W 1,221,839 nephrons per 
kidney; the value found in this study (1,042,981) falls within this range.  In a study (Holt and 
Rhode, 1976) that considered the similarity of various renal glomerular dynamics between 
mammals, a log relationship between nephron number and bodyweight was observed that 
applied to mammals ranging from mice to whales.  This relationship would also predict a 
nephron number of ~1.2 million in sheep. 
It may be that there are breed differences between sheep, however no other data are 
reported for the Scottish Blackface breed used in this study, and due to the sparsity of 
similar sheep studies it is not possible to draw meaningful conclusions.  However, for the 
three studies which have used Merino: Border-Leicester crosses (Mitchell et al., 2004; Zohdi 
et al., 2007; Gray et al., 2008) it is interesting to note that whilst they provide substantially 
lower values than the predicted nephron number reported here, they still vary considerably 
(from 371,000 to 559,000).  This may suggest that the effects of prenatal programming on 
nephron number are best considered relative to their own control groups, rather than to 
species specific values. 
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Stereology is defineĚĂƐ P “ĂďŽĚǇŽĨŵĂƚŚĞŵĂƚŝĐĂůŵĞƚŚŽĚƐƌĞůĂƚŝŶŐƚŚƌĞĞ-dimensional 
parameters defining the structure to two-dimensional measurements obtainable on 
ƐĞĐƚŝŽŶƐŽĨƚŚĞƐƚƌƵĐƚƵƌĞ ? (Weibel, 1979) and is currently considered to be the gold 
standard for estimating nephron number.  It has largely superseded the acid maceration 
method previously used, which exploited ƚŚĞĐĂƉĂĐŝƚǇŽĨƚŚĞŽǁŵĂŶ ?ƐĐĂƉƐƵůĞƚŽƌĞƐŝƐƚ
acid digestion, thus leaving the glomeruli intact whilst the rest of the kidney is dissolved.  
The acid maceration method had several limitations including the assumption that the acid 
maceration affects all the glomeruli equally, whereas damaged glomeruli may actually have 
differing levels of acid resistance (Schreuder and Nauta, 2007).  Alternative methods using 
histological sections were developed, however, one limitation of estimating numbers of 3-D 
particles such as glomeruli from 2-D sections is that the likelihood of them appearing on a 
2-D section is not equal to their frequency in 3-D, but rather to their size (Bertram, 2001).  
Indeed in this study there were contrasting results with a 2-D analysis of mean glomerular 
area showing no effect of diet, whereas the stereological analysis of mean glomerular 
volume revealed glomerular hypertrophy in the LPE group. 
The effect of renal dysfunction in the LPE animals is significant, but fairly subtle.  This may 
reflect the age of the animals (young adults, around 2 years out of a 10  W 12 year life 
expectancy), and had it been possible to keep the animals into old age then more marked 
effects may have been observed.  Although GFR is the most useful measure of renal 
function in a clinical setting, the use of gamma scintigraphy in this study meant the 
possibility of measuring additional renal functional parameters on a real-time basis, such as 
the upslope and downslope of the renogram, the time to peak from injection in the carotid 
artery to the peak level of radioactive nuclide in the kidney, and the transit time though the 
kidney.   
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Nevertheless, microalbuminuria is an excellent early predictive marker of future 
progressive renal disease; thus, it would appear that exposure to a defined period of 
malnutrition in utero may put the offspring at greater risk of progressive renal failure.  In 
the adult, the kidney has marked functional redundancy and the subtle changes to renal 
development observed here are unlikely to result in symptoms of clinical disease.   
However, in a study from the Dutch Famine cohort, young adults protein restricted during 
early gestation displayed microalbuminuria, one of the first signs of early-stage renal 
disease (Painter et al., 2005a), when metabolically challenged with obesity as adults.  Those 
individuals exposed to famine conditions as early gestation fetuses were at higher risk of 
developing obesity (Ravelli et al., 1976) and microalbuminuria in middle age (Painter et al., 
2005a).  This finding is also replicated in the present study.  Taken together with the 
impaired renal function and mild glomerular hypertrophy observed, this suggests that the 
young kidneys in these obese sheep have been permanently adversely affected by the 
protein-energy malnutrition in utero.  With age, the mild hyperfiltration of the remaining 
nephrons and increased pressure in the capillaries (Hershkovitz et al., 2007b) will ultimately 
lead to an earlier onset of CKD.  At this early stage, however, the lack of any morphological 
change, apparent monocyte infiltration, or glomerulosclerosis suggests the existence of 
Minimal Change Disease in the young adult LPE group.   
In addition, although previous research in sheep (Sharkey et al., 2009a) demonstrated 
increased gene expression of endoplasmic reticulum stressors in response to juvenile 
obesity, this was not the case in the present study. This may be due to differences between 
the studies in terms of timing of the obesity, as the obesogenic environment was from 
weaning to one year of age in the former study, but from 18 months onwards in this 
current study.   
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The microalbuminuria observed in the LPE animals is suggestive of reduced glomerular 
barrier function, and this is likely to be due in part to single-nephron hyperfiltration, as this 
can be a consequence of obesity (Williams et al., 2007).  However, in this study the 
combination of other factors including reduced nephron number, and microvascular 
rarefraction (evidenced by reduced levels intra-renal endothelial CD34) and increased intra-
renal pressure (indicated by reduced TC-99m DTPA time to peak and transit time) are likely 
to exacerbate this.  Furthermore additional evidence of a compromised glomerular 
filtration barrier is provided by the increased levels of VEGFA in the LPE group, as over-
expression of VEGFA is implicated in renal disease.  In a model of induced diabetic 
nephropathy in rats, VEGFA gene expression increased (Cooper et al., 1999).  Over-
expression of VEGF is also linked to renal cell carcinoma (Jacobsen et al., 2000) and, in the 
cortex only, to ageing (Kang et al., 2001).  VEGF receptors also have important roles in the 
maintenance of normal renal function and in progression of kidney disease.  Diabetic 
nephropathy led to increased VEGFR2 gene expression (Cooper et al., 1999), and inhibitors 
of VEGF receptors ameliorated the albuminuria associated with the disease (Sung et al., 
2006).  Also, where VEGFA was increased in response to hypertension, an inhibitor of 
VEGFR2 led to severe glomerulosclerosis (Advani et al., 2007).  Interestingly, although an 
increase in VEGFA is indicated in some diseases of the kidney, under-expression also has 
deleterious effects.  Under-expression of VEGFA has been linked to thrombotic 
microangiopathy in the kidney (Eremina et al., 2008b), and focal segmental 
glomerulosclerosis (Shulman et al., 1996).  Thus the levels of VEGFA are strictly regulated 
for normal kidney function. 
The disparity between VEGFA gene and protein levels at different ages  W decreased in the 
fetal LPE group, yet increased in the same group in the adults  W probably reflects the 
differing roles of VEGFA throughout the lifespan.  In fetal kidneys its primary role is in the 
regulation of angiogenesis (Carmeliet et al., 1996; Tufro et al., 1999), whereas in the adult 
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kidneys a significant part of its role is in the maintenance and repair of the glomerular 
barrier (Eremina et al., 2007).   
To summarise, this study has identified a renal phenotype in adult LPE (but not LPL) sheep, 
with reduced nephron number and a decline in renal function despite evidence of some 
compensatory glomerular hypertrophy.  Although the general morphological structure of 
the kidneys was not affected by the diets there is evidence for microvascular rarefaction. 
In the final experimental chapter the macro- and micro-vascular structure of the fetal 
kidney is considered in more detail.  In addition, mechanistic links between diet and kidney 
development are explored further by measuring metabolites and amino acids in both the 
maternal and fetal environments. 
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5. Study 2: The effect of a maternal low protein diet on the 
ewe and her fetus 
5.1 Introduction 
In the previous chapters it was demonstrated that a low protein diet during early, but not 
late, gestation led to reduced nephron number and poorer kidney function during early 
adulthood in the offspring.  In addition, at a molecular level, changes in gene and protein 
expression of VEGFA and its receptors were observed.  At this relatively young age 
glomerular filtration rate was preserved and there were no gross morphological differences 
between the kidneys of the adult animals subjected to a low protein diet in utero and the 
control group.  Nevertheless, a reduction in CD34 (a marker of endothelial cells) in their 
kidneys suggested blunted microvascular development and function in these adult animals.   
Examination of  fetal kidneys at day 65 (0.44 gestation in sheep) identified increased 
apoptosis and decreased angiogenic factors in the low protein exposed fetal kidneys 
relative to controls, suggesting a mechanism explaining the adult phenotype of reduced 
nephron number and microvascular rarefaction.  However, the mechanistic pathway from 
maternal low protein through to inadequate fetal kidney development could not be 
ascertained.  Hence, in the present study, the low protein diet paradigm was again 
employed in order to study more closely the relationship between maternal nutrition, fetal 
nutrition and fetal kidney development.  
Several studies of sheep have shown that reduced nutrition during early or mid-gestation 
does not affect fetal growth or body weight at birth (Trahair et al., 1997; McCrabb et al., 
1991).  Furthermore nutritional restriction during sheep pregnancy is associated with 
increased placental weight (Faichney and White, 1987; McCrabb et al., 1991), which may 
have compensatory effects for protecting the fetus from the lack of nutrients. Thus this 
study aimed to measure metabolites in both the maternal and fetal environments to assess 
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the precise effects of the maternal low protein diet.  The same amino acids are essential to 
sheep and humans.  However, one key difference is that whilst humans must get these 
through their diet, for ruminants there is an additional source of amino acids through the 
breakdown of proteins synthesised by microbes in the rumen (McDonald et al., 2011).  Thus 
dietary amino acid intake in a sheep may not entirely correlate with the amino acid levels in 
the maternal plasma, and therefore during this second study it was considered whether the 
amino acid profile in ewes was indeed different between the dietary groups, and whether 
an effect could be seen in the fetal environment. 
In addition this study considered the vascular structure of the developing kidney.  To 
visualise and analyse the macrovascular structure of the kidney a corrosion casting method 
was used to create a resin structure that replicates the vascular architecture of the fetal 
kidney.  Using a micro-computed tomography (micro-CT) scanner a 3-D model can be 
constructed from a series of 2-D slices (Mondy et al., 2009), and this can be analysed using 
software to provide accurate estimations of vessel surface area and volume, including small 
ǀĞƐƐĞůƐŽĨůĞƐƐƚŚĂŶ ? ?ʅŵŝŶĚŝĂŵĞƚĞƌ(Marxen et al., 2004).  Corrosion casting has been 
used to visualise the vascular structure of a variety of organs including the ovaries of cattle 
(Jiang et al., 2003) and rabbits (Macchiarelli, 2000), sheep lungs (Schraufnagel et al., 1995), 
the kidneys of pigs (Xu et al., 1994) or mice (Wagner et al., 2011), and also cancerous 
tumours in mice (Konerding et al., 1999).  However, it is most commonly used in placental 
studies, where a number of species have been studied, including horse (Abd-Elnaeim et al., 
2006), cow (Pfarrer et al., 2001), donkey (Saber et al., 2008), and goat (Leiser et al., 1997).  
In sheep the maternal and fetal microvasculature of the placenta at different time points 
throughout gestation has been studied using resin casts (Hafez et al., 2010), and another 
study examined the anatomy of the renal arteries in the sheep (Aksoy et al., 2004).  
However, no study has so far considered the renal vascular structure in the fetal ovine 
kidney in the context of nutritional programming. 
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To summarise, this chapter builds upon Chapter 3 and considers further the effect of a low 
protein diet on the ewe during the early part of pregnancy and the fetus at day 65 (or 0.44 
gestation).  The chapter characterises the effect of a low protein maternal diet on maternal 
and fetal nutritional status, and examines the vascular development in the fetus. 
5.2 Materials and Methods 
5.2.1 Study Design  
Full details of general methods are given in Chapter 2.  A brief summary of further 
methodological approaches used specifically in Chapter 5 are:  
All procedures were performed in accordance with the UK Animals (Scientific Procedures) 
Act, 1986 and were approved by the relevant local ethical review committees of the 
Macauley Institute and the University of Nottingham. 
Thirty-one pregnant Scottish Blackface ewes carrying twins were randomly allocated to 
groups fed either a control diet (CP; n = 15) providing adequate protein from day 0 to day 
65 gestation (term ~147 days), or a protein-restricted diet from day 0  W 65 gestation (LPE, 
days 0  W  ? ?ŐĞƐƚĂƚŝŽŶ ?ŶA? ? ? ) ?KŶĂŶ ‘ĂƐĨĞĚďĂƐŝƐ ? ?ƚŚĞĚŝĞƚƐǁĞƌ ŝƐŽĐĂůŽƌŝĐǁŝƚŚƚŚĞ
effective level of protein restriction being 8.7 vs.  ? ?ŐĐƌƵĚĞƉƌŽƚĞŝŶ ?D:D ?ŵĞƚĂďŽůŝƐĂďůĞ
energy).  At day 65 gestation, ewes were euthanised.  Amniotic fluid and fetal plasma were 
collected.  One fetus was corrosion cast, and from the other fetus organs were weighed, 
one kidney snap frozen in liquid nitrogen and stored at -80°C and the other fixed in 4% 
paraformaldehyde. 
5.2.2 Corrosion casting 
KŶĞĨĞƚƵƐĨƌŽŵĞĂĐŚĞǁĞǁĂƐĐŽƌƌŽƐŝŽŶĐĂƐƚƵƐŝŶŐĂƚƐŽŶ ?ƐEŽ ? ? ?WůĂƐƚŝĐZĞƉůŝĐĂĂŶĚ
ŽƌƌŽƐŝŽŶ<ŝƚŝŶĂĐĐŽƌĚĂŶĐĞǁŝƚŚƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů ?ƚŽǀŝƐƵĂůŝƐĞĂŶĚƋƵĂŶƚŝĨǇƚŚĞ
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gross vasculature of the fetus.  Full details are given at section 2.13.  The casts were 
weighed, and then scanned using a micro CT scanner, from which volume and surface area 
were calculated. 
5.2.3 Plasma analysis: Randox Imola 
Maternal plasma was sampled prior to pregnancy, and then at days 13, 28, 42 and 65 of 
gestation, and stored at -20°C.  All maternal plasma samples were defrosted, and analysed 
for glucose, NEFA, triglycerides, albumin, total protein, urea, lactate and D-3-
hydroxybutarate using a Randox Rx Imola autoanalyser and quantitative enzymatic 
colorimetric assay kits, as described in section 2.3.2.  Plasma samples from day 65 fetuses 
were defrosted and analysed for glucose and lactate only.   
5.2.4 Plasma analysis: Osmolality 
Osmolality of maternal plasma samples prior to pregnancy and at days 13, 42 and 65 of 
gestation was determined using an automatic cryoscopic osmometer (Osmomat 030; 
Gonotec, Berlin, Germany), see section 2.14.   
5.2.5 Plasma analysis: Amino Acids 
Amino acids were isolated from maternal and fetal plasma and derivatised using the 
 PĨĂĂƐƚ ?ŵŝŶŽĐŝĚ<ŝƚĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů ?ĨƚĞƌĚĞƌŝǀĂƚŝƐĂƚŝŽŶƚŚĞ
samples were analysed on a gas chromatography mass spectrometer.  Full details are given 
at section 2.3.3. 
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5.2.6 Amniotic fluid analysis: Amino acids 
The EZ:Faast kit described above was not able to detect two, and gave poor results for a 
further three amino acids in amniotic fluid.  Thus, a further analysis was conducted using an 
ion exchange chromatography system as described in section 2.3.4.  
5.2.7 Renal immunohistochemistry 
5.2.7.1 VEGFA 
Renal sections were analysed for abundance of VEGFA (SC-152; Santa Cruz Biotechnology, 
Santa Cruz, USA) using a biotinylated ABC kit (Vector Labs, Peterborough, UK).  The full 
method is given in section 2.6.1, and further details of the VEGFA protein sequence and 
antibody selection are given in section 2.6.3.  Negative controls were omission of primary 
antibody and rabbit IgG, and mouse kidney was used as a positive control. 
5.2.7.2 CD34 
Renal sections were analysed for abundance of CD34 (ab81289; Abcam, Cambridge, UK) 
using the Leica BOND-Dy ?ĂƵƚŽŵĂƚĞd system.  The full method is given in section 2.6.2, 
and further details of the CD34 protein sequence and antibody selection are given in 
section 2.6.4.  Negative controls were omission of primary antibody and rabbit IgG, and 
adult ovine kidney was used as a positive control. 
5.2.8 Quantitative PCR 
Total RNA was extracted using RNeasy Mini Kit (Qiagen, Crawley, UK), and cDNA 
synthesised using an Omniscript reverse transcriptase kit (Qiagen, Crawley, UK).  QPCR 
performed using a Roche SYBR Green kit (Roche Diagnostics, Burgess Hill, UK) on a Roche 
Lightcycler® 480.  Melt curves were used to confirm reaction specificity and cyclophilin, 
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beta actin and GAPDH were used as housekeeping genes.  Negative controls were H2O and 
samples with Omniscript omitted.  MRNA quantities were normalised to housekeeping 
genes using Roche Lightcycler® 480 advanced relative quantification software.  Full details 
of the method are described at sections 2.12.1.2, 2.12.2, 2.12.4.2 and 2.12.5. 
5.2.9 Statistical Analysis 
All data were analyzed using a General Linear Model (GLM) or general linear mixed model 
approach where appropriate (Genstat v13, VSNi, UK) after checking for normality (or 
otherwise) of the error distribution.  Data with skewed errors were log transformed before 
analysis.  Predicted means are presented with SEM to represent the measurement error.  
Correlations between variables were tested using PeĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶƚĞƐƚƐ ? P < 0.05 was 
accepted as indicating statistical significance.  Full details are described at section 2.15. 
5.3 Results 
5.3.1 Maternal characteristics 
There was no difference in weight gain during pregnancy up to day 65 gestation between 
dietary groups, although weight increased with time (Figure 5.1A).  In addition there were 
no differences in body condition score between the CP and LPE groups, and although there 
was an improvement with time this was during the pre-pregnancy period, rather than 
during gestation (Figure 5.1B).  There was also statistical evidence of a diet.time interaction 
for both variables.   
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Figure 5.1: Weight and body condition score of ewes prior to, and during early gestation 
Data are Means ± S.E.M. for ewes fed a control protein diet (CP, n = 15), or a low protein diet during early 
gestation (days 0-65; LPE, n = 16).  There were 8 males and 7 females in CP and 8 males and 8 females in LPE. 
Data were analysed by General Linear Model for the fixed effects of diet, time and their interaction with 
(Genstat v13, VSNi, UK). CP, control protein diet; LPE, low protein early diet; NS, non-significant; significance 
indicated by P < 0.05. 
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5.3.2  Post mortem data at day 65 
Post mortem data is presented in Table 5.1.  The ewe weight at post mortem was 
significantly lower in the LPE group compared to controls (CP, 60.5 ± 0.72; LPE, 58.4 ± 0.68 
kg), however the percentage difference was small, i.e. a reduction of ~3.5%.  In addition a 
significant effect of diet on gravid uterus weight was observed, with the LPE group weighing 
~8% less (CP, 3.00 ± 0.08; LPE, 2.77 ± 0.07 kg).  However, the effects on the ewe and uterus 
were not translated to the fetus itself.  Diet and sex had no effect on the fetal weights at 
post mortem of kidney, heart, or liver, nor on total body weight or crown rump length 
(Table 5.1).  Adjusting organ weight for total body weight had no effect on the findings.  
Total gonad weight did not vary according to diet, but testes were significantly larger than 
ovaries (male, 4.80 ± 0.45 x 10-2; female, 2.29 ± 0.49 x 10-2 g).   
When compared to study 1, fetuses at day 65 gestation weighed more in study 2 (study 1, 
101 ± 4.13; study 2, 125 ± 3.71 g; P < 0.001) and had larger hearts (study 1, 0.99 ± 0.05; 
study 2, 1.16 ± 0.03 g; P < 0.001), however, the other organs measured in both studies 
(kidney, liver) were not significantly different.   
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Table 5.1: Effect of maternal low protein diet on fetal weights at 65 days gestation 
 Data are predicted means ± S.E.M. for ewes (CP, n = 15; LPE, n =16) fed a control protein diet (CP fetuses, male, 
n=8; female, n=7) or a low protein diet to day 65 gestation (LPE fetuses, male, n=8; female, n=8). Data were 
analysed by General Linear Model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, 
UK). Statistical significance was accepted at P<0.05, NS, not significant; CP, control protein diet; LPE, low protein 
early diet. 
 
 
 
 
 
 
 
 
 
 
  Sex P value 
 Diet Male Female  Diet Sex Diet*Sex 
Body weight (g) CP 130 ± 6.54 131 ± 6.18 
NS NS NS 
LPE 128 ± 5.87 118 ± 5.77 
Total Kidney weight (g) CP 1.79 ± 0.12 1.68 ± 0.13 
NS NS NS 
LPE 1.74 ± 0.12 1.73 ± 0.12 
Liver weight (g) CP 8.68 ± 0.55 9.03 ± 0.58 
NS NS NS 
LPE 8.40 ± 0.55 8.26 ± 0.54 
Heart weight (g) CP 1.21 ± 0.07 1.14 ± 0.08 
NS NS NS 
LPE 1.11 ± 0.07 1.17 ± 0.07 
Crown rump length (mm) CP 166 ± 4.08 173 ± 4.36 
NS NS NS 
LPE 175 ± 4.36 167 ± 4.36 
Total gonads weight     
(g x 10
-2
) 
CP 4.80 ± 0.45 2.29 ± 0.49 
NS <0.001 NS 
LPE 5.02 ± 0.52 2.01 ± 0.45 
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5.3.3 Corrosion casts 
Figure 5.2 shows examples of micro CT pictures of the kidneys of a male control fetus 
(147M) and a male low protein fetus (127M).  Weight was highly correlated with both 
volume (R2 = 0.93; P < 0.001) and surface area (R2 = 0.88; P < 0.01).  The micro CT results of 
volume and surface area were also strongly correlated (R2 = 0.97; P < 0.001).  There was a 
large variation in the cast weights, volumes, and surface areas, precluding any significant 
difference between diet groups, or between sexes (Figure 5.3).  As there was no clear 
indicator of an effect of diet on the macrovasculature, the microvasculature was considered 
instead, using CD34 as a marker of endothelial cells. 
 
Figure 5.2: Micro CT pictures of fetal kidneys at day 65 gestation 
Sample 147M is a male control fetus and sample 127M is a low protein male fetus, and volumes are shown in 
mm
3 ?ŽƌƌŽƐŝŽŶĐĂƐƚŝŶŐǁĂƐĐĂƌƌŝĞĚŽƵƚƵƐŝŶŐĂƚƐŽŶ ?ƐEŽ ? ? ?WůĂƐƚŝĐZĞƉůŝĐĂĂŶĚŽƌƌŽƐŝŽŶ<ŝƚ ?WŽůǇƐĐŝĞŶĐĞƐ/ŶĐ ?
Eppelheim, Germany). The volume of the resin casts was quantified using a Nanotom® high resolution 
computed tomography (CT) scanner (GE Sensing and Inspection Technologies, Wunstorf, Germany). 
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Figure 5.3: Weight, volume and surface area of cast fetal kidneys at day 65 gestation 
Corrosion casting usiŶŐĂƚƐŽŶ ?ƐEŽ ? ? ?WůĂƐƚŝĐZĞƉůŝĐĂ& Corrosion Kit. Surface area and volume of resin casts 
were quantified using a Nanotom® high resolution computed tomography scanner. Data are predicted means ± 
S.E.M. for ewes fed a control protein diet (CP fetuses, male, n = 8; female, n = 7) or a low protein diet to day 65 
gestation (LPE fetuses, male, n = 8; female, n = 8). Data were analysed by General Linear Model for the fixed 
effects of diet, sex or their interaction using Genstat v13 (VSNi, UK). Statistical significance was accepted at 
P<0.05, NS, not significant. 
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5.3.4 Immunohistochemistry: CD34 
The percentage of the tissue section that stained for CD34 was reduced in LPE compared to 
CP fetuses in both the whole of the kidney and in the nephrogenic zone around the edge of 
the developing cortex (Figure 5.4).  In the whole of the kidney, LPE fetuses had 25% less 
staining than controls (CP, 3.60 ± 0.28 %; LPE 2.83 ± 0.26 %; P = 0.054), and the same 
proportional reduction was also found in the nephrogenic region (CP, 4.41 ± 0.35 %; LPE 
3.29 ± 0.33 %; P = 0.029).  
Compared to the adult kidney, the fetal kidney microvascular network was proportionally 
more of the total area of the kidney (adult, 1 - 2 %; fetal, 2 - 5 %).  In addition, although still 
significant, the effect of the maternal diet on the LPE group was less striking in the fetuses 
compared to the adults (adult, ~50 % reduction in the LPE group; fetal ~25% reduction).   
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Figure 5.4: CD34 staining in day 65 fetal kidneys 
Representative micrographs of the nephrogenic zone (A) and developing medulla (B); CD34 staining is brown, black arrows indicate endothelial cells, white arrows show staining of glomerular 
capillaries. D, positive control, adult ovine kidney; negative controls were omission of primary antibody (E) and rabbit IgG (F) All pictures are x200 magnification. Data in graphs are predicted 
means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; male, n=8; females n=7) or a low protein diet to day 65 gestation (LPE; male, n=8; female, n=8). Data were analysed by 
General Linear Model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, UK). Statistical significance P<0.05, NS, not significant.
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5.3.5 Angiogenic factors 
To check for reproducibility of the angiogenic factor results seen in the fetuses in Chapter 3, 
qPCR and immunohistochemistry were carried out.  In Study 1 for a range of angiogenic 
promoters, LPE males (but not females) had reduced mRNA expression compared to 
controls.  In the current study, two of these factors (angiopoietin and Tie 2 receptor) were 
measured, and although there was a strong trend for the LPE fetuses to have lower mRNA 
expression, this was true for both sexes, and not just males (Figure 5.5).  In Study 1 VEGFA 
was significantly reduced in the LPE group compared to controls, which was replicated in 
this present study with the exact same pattern of gene expression as was found in the 
earlier study, with LPE fetuses having less mRNA than controls (CP, 1.37 ± 0.06 x 10-1; LPE, 
1.14 ± 0.06 x 10-1 units).  VEGFR1 mRNA showed the same pattern of results in both studies.  
However, in the current study the results were more uniform across both sexes, whereas in 
the first study it was more pronounced in males than females (see Figure 3.4) in VEGFA, 
angiopoietin and Tie 2.   
At the protein level, VEGFA results in Study 1 were replicated in this current study (Figure 
5.6), with a significant reduction of VEGFA staining in the nephrogenic zone in the LPE 
fetuses.  As before, the staining was primarily evident in the ureteric buds and the 
developing collecting ducts.   
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Figure 5.5: MRNA of angiogenic factors in day 65 fetuses 
Data are predicted means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; male, n = 8; females n = 7) or a low protein diet to day 65 gestation (LPE; male, n = 8; female, n = 8). Data 
were analysed by General Linear Model for the fixed effects of diet, sex or their interaction using Genstat v13 (VSNi, UK). Statistical significance P<0.05, NS, not significant; VEGF, vascular 
endothelial growth factor. 
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Figure 5.6: : Vascular Endothelial Growth Factor immunohistochemical staining 
Representative micrographs of the nephrogenic zone (A) and developing medulla (B); VEGFA staining is brown; 
white arrows indicate ureteric buds; black arrows indicate collecting ducts. Negative controls were omission of 
primary antibody (C) and rabbit IgG isotype control (D). Positive control (E) was mouse kidney. All micrographs 
taken at x200 magnification. Data in graphs are predicted means ± S.E.M. for fetuses of ewes fed a control 
protein diet (CP; male, n = 8; females n = 7) or a low protein diet to day 65 gestation (LPE; male, n = 8; female, n 
= 8). Data were analysed by General Linear Model for the fixed effects of diet, sex  or their interaction using 
Genstat v13 (VSNi, UK). Statistical significance P<0.05, NS, not significant. 
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5.3.6 Metabolites and protein 
To consider the maternal and fetal nutritional environments, various metabolites and 
protein levels were measured in the plasma of the ewes at 10 days prior to pregnancy and 
at days 28, 42 and 65 of gestation, and in the fetuses at post mortem. 
In the ewes prior to pregnancy no plasma metabolite was different between groups, with 
the exception of non-esterified fatty acids (NEFA) which was lower in the LPE group 
compared to controls.  Over the course of gestation the metabolites (NEFA, triglycerides, 
glucose and lactate) became significantly higher in the LPE ewes compared to controls 
(Figure 5.7), and there was also a significant effect of time.  In addition, total protein and 
albumin were also significantly higher in the LPE group compared to the CP group (Figure 
5.8), which was unexpected given the lower protein content of the diet.  D-3-
hydroxybutyrate was not significantly different between groups or over time.  Urea was 
significantly lower in the LPE ewes compared to controls (Figure 5.8), with a reduction of 
around 20% (average of all time points, CP, 5.52 ± 0.26; LPE, 4.51 ± 0.25 mmol.l-1). 
To investigate if the findings translated into the fetal environment, lactate, glucose and 
urea were measured in fetal plasma (Figure 5.9).  Glucose was not significantly different 
between groups.  Lactate and urea results reflected the maternal environment, with lactate 
being significantly higher in LPE fetuses compared to controls (CP, 4.22 ± 0.14; LPE 4.79 ± 
0.14 mmol.l-1), and urea being significantly reduced (CP, 6919 ± 351; LPE, 3511 ± 340 
mmol.l-1).  There were no effects of sex.  
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Figure 5.7: Metabolites in maternal plasma 
Metabolites were measured prior to pregnancy, and at days 28, 42 and 65 of gestation using a Randox Imola 
autoanalyser. Data in graphs are predicted means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; 
male, n=8; females n=7) or a low protein diet to day 65 gestation (LPE; male, n=8; female, n=8). Data were 
analysed by General Linear Model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, 
UK). Statistical significance P<0.05, AI, artificial insemination at day 0; NP, non-pregnant at ten days prior to AI; 
NS, non significant. 
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Figure 5.8: Total protein, albumin and urea in maternal plasma 
Variables were measured prior to pregnancy, and at days 28, 42 and 65 of gestation using a Randox Imola 
autoanalyser. Data in graphs are predicted means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; 
male, n=8; females n=7) or a low protein diet to day 65 gestation (LPE; male, n=8; female, n=8). Data were 
analysed by General Linear Model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, 
UK). Statistical significance P<0.05, AI, artificial insemination at day 0; NP, non-pregnant ewes at ten days prior 
to AI; NS, non significant. 
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Figure 5.9: :  Urea in amniotic fluid and lactate and glucose in fetal plasma at day 65 gestation 
Variables were measured using a Randox Imola autoanalyser. Data in graphs are predicted means ± S.E.M. for 
fetuses of ewes fed a control protein diet (CP; male, n=8; females n=7) or a low protein diet to day 65 gestation 
(LPE; male, n=8; female, n=8). Data were analysed by General Linear Model for the fixed effects of diet, sex  or 
their interaction using Genstat v13 (VSNi, UK). Statistical significance P<0.05, NS, non significant. 
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5.3.7 Osmolality 
Maternal plasma and fetal amniotic osmolality results are shown in Figure 5.10.  Maternal 
plasma osmolality was not different between the LPE and CP groups in non-pregnant ewes, 
however, during gestation the LPE group had significantly higher osmolality compared to 
the control ewes (for all time points, CP, 303 ± 3.29; LPE, 314 ± 3.28 mOsm), and there was 
also an effect of time.  However, the opposite effect was observed in the fetal amniotic 
fluid, with LPE fetuses having significantly lower osmolality than CP fetuses (CP, 288 ± 4.10; 
LPE 275 ± 3.80 mOsm, P = 0.030).  There was no effect of sex on fetal amniotic osmolality, 
nor was there a diet.sex interaction. 
5.3.8 Amino acid analysis 
5.3.8.1 Maternal plasma 
In maternal plasma, most standard amino acids were not significantly different between 
dietary groups but changed as gestation progressed (Table 5.2).  Four amino acids were 
different in the LPE group compared to controls: asparagine concentration was reduced in 
the LPE ewes compared to CP ewes (average for all time points: CP, 25.8 ± 1.79; LPE, 21.5 ± 
2.26 µM), as was the concentration of leucine (average for all time points: CP, 122 ± 5.90; 
LPE, 103 ± 6.10 µM).  Conversely, lysine concentration was higher in the LPE group 
compared to controls (average for all time points: CP, 162 ± 31.1; LPE, 196 ± 40.3 µM), and 
also tryptophan concentration (average for all time points: CP, 41.7 ± 7.55; LPE, 58.9 ± 9.54 
µM).  Linear discriminant analysis showed no particular overall effects of an interaction 
between diet groups and timing of gestation. 
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Figure 5.10: Osmolality of maternal plasma and fetal amniotic fluid 
Variables were measured prior to pregnancy, and at days 13, 42 and 65 of gestation using a Gonotec 
Osmometer. Data in graphs are predicted means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; 
male, n=8; females n=7) or a low protein diet to day 65 gestation (LPE; male, n=8; female, n=8). Data were 
analysed by General Linear Model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, 
UK). Statistical significance P<0.05, NS, non significant. 
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Table 5.2: Standard amino acid concentrations in maternal plasma (µM) 
 
 Non pregnant Day 28 Day 42 Day 65 P-value 
Amino acid CP LPE CP LPE CP LPE CP LPE Diet Time Diet.time 
Alanine 389 ± 22.3 368 ± 21.6 345 ± 76.5 516 ± 85.4 331 ± 35.1 364 ± 32.8 300 ± 30.2 302 ± 30.0 NS 0.041 NS 
Asparagine 35.9 ± 4.17  33.9 ± 4.93 32.0 ± 5.04 20.6 ± 7.10 21.2 ± 1.85 15.0 ± 1.90 14.3 ± 2.78 16.5 ± 2.48 0.031 <0.001 NS 
Aspartic acid 6.65 ± 1.72 4.88 ± 1.91 4.63 ± 1.69 7.33 ± 2.03 7.20 ± 2.31  5.25 ± 2.50 10.0 ± 3.52 8.18 ± 3.39 NS NS NS 
Glutamic acid 103 ± 12.1 85.4 ± 15.2 162 ± 27.7 124 ± 40.8 45.6 ± 4.36 50.0 ± 4.46 49.9 ±10.8 48.1 ± 8.15 NS <0.001 NS 
Glycine 622 ± 49.5 582 ± 49.3 919 ± 121 1077 ± 149 563 ± 58.4 811 ± 54.7 823 ± 95.1 974 ± 91.3 NS <0.001 NS 
Isoleucine 116 ± 9.81 119 ± 9.50 102 ± 12.4 74.4 ± 16.0 85.3 ± 6.51 71.0 ± 6.06 66.0 ± 5.57 72.3 ± 5.57 NS <0.001 NS 
Leucine 143 ± 10.4 147 ± 10.0 133 ± 15.2 96.6 ± 16.9 113 ± 7.60 83.4 ± 7.10 100 ± 9.70 83.9 ± 9.40 <0.01 <0.001 NS 
Lysine 171 ± 32.9 257 ± 41.1 253 ± 85.1 223 ± 132 127 ± 24.8 155 ± 21.1 95.6 ± 22.8 149 ± 21.1 <0.01 <0.01 0.047 
Phenylalanine 80.1 ± 7.33 74.8 ± 7.29 67.6 ± 9.64 54.1 ± 11.8 49.1 ± 4.02 51.0 ± 3.77 60.2 ± 7.63 47.8 ± 7.35 NS <0.001 NS 
Proline 84.6 ± 6.45 84.7 ± 6.45 85.1 ± 9.86 68.3 ± 13.5 66.1 ± 4.29 48.8 ± 4.31 49.3 ± 5.47 55.7 ± 5.06 NS <0.001 NS 
Threonine 68.8 ± 13.4 81.9 ± 16.6 64.0 ± 15.4 74.4 ± 23.9 40.1 ± 7.84 42.6 ± 8.66 27.6 ± 11.7 45.6 ± 9.31 NS 0.047 NS 
Tryptophan 61.3 ± 10.8 78.1 ± 14.1 55.0 ± 20.4 81.7 ± 30.0 20.4 ± 6.54 44.0 ± 7.18 30.1 ± 11.8 31.8 ± 9.25 0.032 <0.01 NS 
Tyrosine 70.6 ± 9.92 61.0 ± 10.9 48.8 ± 9.17 30.1 ± 11.1 36.3 ± 4.43 33.4 ± 4.42 29.5 ± 4.72 28.6 ± 4.24 NS <0.01 NS 
Valine 497 ± 43.8 563 ± 42.4 434 ± 61.8 356 ± 74.3 358 ± 28.5 263 ± 26.8 315 ± 27.4 259 ± 27.4 NS <0.001 NS 
Total 2956 ± 213 2527 ± 159 2736 ± 464 2988 ± 485 1949 ± 61 1969 ± 101 1738 ± 253 2115 ± 77 NS <0.001 NS 
Data are predicted means ± S.E.M. for ewes fed a control protein diet (CP; n=15) or a low protein diet to day 65 gestation (LPE; n=16). Data were analysed by General Linear Model for the 
fixed effects of diet, time or their interaction using Genstat v13 (VSNi, UK). Statistical significance P<0.05, NS, non significant.  
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5.3.8.2 Fetal plasma 
In fetal plasma the only standard amino acid that was significantly different between 
groups was glycine, which had concentrations ~25% higher in the LPE group compared to 
the CP group (Table 5.3).  In addition, glycine had a diet.sex interaction, with the increase in 
the LPE group compared to controls being much more marked in female fetuses.  
Furthermore, asparagine (female, 49.5 ± 2.71; male, 59.6 ± 2.80 µM) and also proline 
(female, 108 ± 5.18; male, 128 ± 6.35 µM) were lower in female compared to male fetuses.  
 
Table 5.3: Standard amino acid concentrations in fetal plasma (µM) 
  P-value 
Amino acid CP LPE Diet Sex Diet.sex 
Alanine 285 ± 14.5 266 ± 14.5 NS NS NS 
Asparagine 54.6 ± 2.87 54.1 ± 2.73 NS 0.012 NS 
Aspartic acid 9.66 ± 0.66 9.16 ± 0.60 NS NS NS 
Glutamic acid 218 ± 16.8 224 ± 15.9 NS NS NS 
Glycine 397 ± 22.8 479 ± 26.2 0.016 NS 0.018 
Isoleucine 78.9 ± 4.44 76.1 ±4.11 NS NS NS 
Leucine 140 ± 6.06 127 ± 5.93 NS NS NS 
Lysine 702 ± 65.1 540 ± 61.8 NS NS NS 
Phenylalanine 175 ± 8.97 174 ± 8.75 NS NS NS 
Proline 119 ± 5.99 116 ± 5.57 NS 0.019 NS 
Serine 700 ± 49.1 691 ± 48.1 NS NS NS 
Threonine 448 ± 35.3 463 ± 32.9 NS NS NS 
Tryptophan 87.2 ± 12.7 88.6 ± 12.7 NS NS NS 
Tyrosine 277 ± 27.7 231 ± 22.9 NS NS NS 
Valine 212 ± 12.3 199 ± 11.3 NS NS NS 
Total 3821 ± 179 3580 ± 170 NS NS NS 
Data are predicted means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; male, n=8; females n=7) or 
a low protein diet to day 65 gestation (LPE; male, n=8; female, n=8). Data were analysed by General Linear 
Model for the fixed effects of diet, sex or their interaction using Genstat v13 (VSNi, UK). Statistical significance 
P<0.05, NS, non significant. 
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Discriminant analysis (Figure 5.11) however did reveal differences between the 
experimental groups and sexes. 
There were few correlations between fetal and maternal plasma, and those that existed 
were generally weak.  The strongest correlation between maternal and fetal plasma was for 
ŐůǇĐŝŶĞ ?WĞĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶ ?Z2 = 0.31, P = 0.028). 
 
Figure 5.11: Discriminant analysis of standard amino acids in fetal plasma 
X marks the mean and the circles represent 95% confidence intervals after linear discriminant analysis (Genstat 
v13, VSNi, UK) of normalised data (i.e. Z-scores) for fetal plasma amino acid concentrations. 
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5.3.8.3 Amniotic fluid 
In amniotic fluid, there were no significant differences between dietary groups, nor any 
effects of sex or a diet.sex interaction (Table 5.4).  Linear discriminant analysis did not 
reveal any further effects of diet or sex. 
There was a moderate correlation between fetal plasma and amniotic fluid (for all standard 
ĂŵŝŶŽĂĐŝĚƐ ?WĞĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶ ?Z2 = 0.42, P < 0.001), however there were no significant 
correlations between the variables in maternal plasma and amniotic fluid.   
5.3.8.4 Ornithine 
As well as measuring the standard amino acids, the plasma and amniotic fluid 
concentration of ornithine was measured.  Although ornithine was not different between 
LPE and control ewes (Figure 5.12), it was significantly lower in both amniotic fluid (CP, 109 
± 11.0; LPE, 74.3 ± 7.21 µM) and in fetal plasma (CP, 432 ± 31.1; LPE, 264 ± 30.0 µM). 
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Table 5.4: Standard amino acids in amniotic fluid (µM) 
  P-value 
Amino acid CP LPE Diet Sex Diet.sex 
Alanine 178 ± 31.1 192 ± 30.1 NS NS NS 
Arginine 39.4 ± 7.88 37.6 ± 7.31 NS NS NS 
Asparagine 30.8 ± 4.50 33.6 ± 4.35 NS NS NS 
Cysteine 6.65 ± 0.72 6.75 ± 0.70 NS NS NS 
Glutamic acid 46.8 ± 43.4 43.4 ± 8.39 NS NS NS 
Glutamine 124 ± 18.6 152 ± 21.9 NS NS NS 
Glycine 117 ± 19.2 160 ± 18.6 NS NS NS 
Histidine 9.98 ± 1.76 12.1 ± 2.22 NS NS NS 
Isoleucine 11.7 ± 2.18 13.1 ±2.41 NS NS NS 
Leucine 24.1 ± 5.05 25.1 ± 5.16 NS NS NS 
Lysine 98.9 ± 11.6 98.5 ± 11.3 NS NS NS 
Methionine 9.87 ± 1.98 11.7 ±2.18 NS NS NS 
Phenylalanine 10.8 ± 1.96 12.3 ± 2.05 NS NS NS 
Proline 66.8 ± 6.18 57.7 ± 5.20 NS NS NS 
Serine 80.3 ± 11.2 98.8 ± 10.8 NS NS NS 
Threonine 61.7 ± 21.1 84.2 ± 12.1 NS NS NS 
Tryptophan 1.28 ± 0.37 1.61 ± 0.34 NS NS NS 
Tyrosine 14.0 ± 2.58 16.0 ± 2.75 NS NS NS 
Valine 30.6 ± 5.63 36.3 ± 6.67 NS NS NS 
Total 1325 ± 122 1329 ± 102 NS NS 0.037 
Data are predicted means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; male, n = 8; females n = 7) 
or a low protein diet to day 65 gestation (LPE; male, n = 8; female, n = 8). Data were analysed by General Linear 
Model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, UK). Statistical significance 
P<0.05, NS, non significant. 
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Figure 5.12: : Ornithine concentrations in maternal and fetal plasma and amniotic fluid 
Data are predicted means ± S.E.M. for fetuses of ewes fed a control protein diet (CP; male, n = 8; females n = 7) 
or a low protein diet to day 65 gestation (LPE; male, n = 8; female, n = 8). Data were analysed by General Linear 
Model for the fixed effects of diet, sex  or their interaction using Genstat v13 (VSNi, UK). Statistical significance 
P<0.05, NS, non significant. 
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5.4 Discussion 
The previous chapters have revealed an adult phenotype with reduced nephron number 
and kidney function that may be as a consequence of changes in angiogenesis and 
apoptosis in the fetal kidney during its early development. 
This second study repeated the experimental conditions of Study 1, but involved a change 
of location and environment which may introduce random error into the experiment.  
Hence, it was critical to ensure consistency between the two studies so that any 
conclusions about the effect of a low protein diet on fetal development are valid, 
comparable and repeatable.  Maternal body condition score and weight gain up to day 65 
of pregnancy were not different between the dietary groups in Study 1, and this was 
replicated in Study 2, showing that at this stage of pregnancy the effect of diet on the ewe 
is not pronounced, which is likely due to the isocaloric nature of the diet, despite a 
reduction in protein content.   
However, the second study did show a weight gain over time that was not reflected in the 
earlier study up to day 65 gestation.  However, most of the gain in the variables was in the 
two weeks prior to pregnancy, which was the acclimatisation period; therefore these 
changes were due to improvements in living environment and diet during this time, rather 
than as a consequence of the study. 
Fetal body and organ weights were also not significantly different between the dietary 
groups in either study, although in the first study there was an effect of sex, with body, liver 
and heart weight all being slightly higher in the male fetuses.  This finding was not 
replicated in the current study, nor in two studies of fetal sheep at day 53  W 58 gestation 
(MacLaughlin et al., 2005; MacLaughlin et al., 2010), both of which had around double the 
number of fetuses compared to Study 1.  Therefore it seems likely that the observation 
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regarding sex differences shown in this previous study (section 3.3.2) maybe have been a 
type I error. 
However, the fetal body weight was higher in the second study compared with the first 
study.  The larger fetal size may be due to small differences in the dietary intake, as in both 
studies the food intake varied from 600  W 1200 g.d-1 depending upon the stage of gestation, 
but this was not exactly the same between the studies. However, the percentage protein 
intake remained exactly the same between both studies, so there were no overall 
differences in the proportions of the diet consumed. 
The macrovascular structure of the fetal kidneys was determined using corrosion casting.  
ĂƚƐŽŶ ?ƐŵĞƚŚǇůŵĞƚŚĂĐƌǇůĂƚĞĐŽƌƌŽƐŝŽŶĐĂƐƚŝŶŐŵĞƚŚŽĚŚĂƐďĞĞŶĚĞŵŽŶƐƚƌĂƚĞĚƚŽďĞĂ
superior method for accurate high resolution imaging of microvascular structures when 
compared to other resins (Mondy et al., 2009). Micro-CT allows imaging of the larger blood 
vessels in the kidney, however in this study it was not possible to see the individual 
glomeruli or peritubular capillaries, as to observe these tiny structures either 
nanotomography or laser scanning confocal microscopy is needed (Wagner et al., 2006; 
Wagner et al., 2011).  The corrosion casts showed no significant differences in 
macrovascular structures in the kidney between dietary groups, however it was clear that 
some kidneys were far less developed than others, and these tended to be in the males of 
the LPE group. However, the large variation in results meant that this did not reach 
statistical significance, and indeed both the highest and lowest surface areas and volumes 
were observed in the same group (LPE males).  This taken in conjunction with the fact that 
there were not obvious morphological differences in the kidneys in adulthood (Chapter 4) 
suggests that the renal macrovascular development may potentially only be delayed, rather 
than halted by the dietary regime.  Unfortunately it was not possible to check this 
possibility in the current study as all ewes were killed at the same time in gestation.   
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However, at a microvascular level, the reductions observed in the angiogenic factors 
(VEGFA, VEGFR1, Ang1 and Tie 2) in both Study 1 and Study 2 in the LPE group would 
suggest that there are likely to be differences in blood vessel  (particularly endothelial cell) 
development.  Immunohistochemical staining for endothelial cells using a CD34 antibody as 
a marker, showed a clear reduction in the amount of staining in the LPE group in the 
peritubular and glomerular capillaries, thus showing an effect of the LPE diet on the 
microvascular development in the fetus at this stage of gestation.   As observed in a 
previous study (Ferraz et al., 2008), CD34+ staining was found only in the peritubular 
capillaries and mature nephrons, and not in the primitive nephrons.  However, the 
difference between the LPE and CP groups was more marked in adult animals (Chapter 4) 
than at day 65 in the fetus.  The lower level of reduction in the fetus suggests that either 
vascular network development continues to be detrimentally affected later in gestation, or 
that obesity or another factor in the adult environment damages the smaller blood vessels 
in adulthood. 
To investigate further the effect of the nutritional environment on the mother and fetus, 
metabolites and protein were measured in maternal and fetal plasma.  Plasma metabolite 
concentrations in ruminants may vary according to the diet, age, breed and reproductive 
status (Alonso et al., 1997; Lindsay et al., 2005; Forbes et al., 1998).  Most metabolites 
measured in this study fell within the published reference ranges for sheep (Aitken, 2007), 
or reported values during pregnancy (Redmer et al., 2012; Moallem et al., 2012; Dubreuil et 
al., 2005).  The exceptions were triglycerides which were slightly below reference values, 
and total protein and albumin which were below the reference range in the control group, 
although just within the lower end of the range for LPE animals. 
Maternal glucose in the control ewes (varying between 2.33 and 2.87 mmol.l-1, depending 
on the stage of gestation) was similar to reference values in non-pregnant sheep (Aitken, 
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2007) and values reported in pregnant sheep (Redmer et al., 2012; Tanaka et al., 2008; 
Sharma et al., 2012).  In fetal plasma, the glucose concentration was far lower than 
maternal levels, as also observed by other studies (Redmer et al., 2012; Bazer et al., 2012) 
and in the latter study where glucose concentrations were measured at 14 time points 
during gestation, the concentrations varied from 0.11  W 0.70 mmol.l-1, and were not 
significantly different over the period of gestation.  
Fewer studies have ƌĞƉŽƌƚĞĚǀĂůƵĞƐĨŽƌŽƚŚĞƌŵĞƚĂďŽůŝƚĞƐŝŶƉƌĞŐŶĂŶƚĞǁĞƐ ?ƉůĂƐŵĂ ?dŚŝƐ
study found triglyceride levels slightly lower than either reference values (Aitken, 2007) or 
for ewes at day 140 gestation (Tanaka et al., 2008).  The latter study showed no effect of a 
global restriction diet on glucose, triglycerides, or total protein, although lactate was 
significantly lower in the group fed around 50% than an ad libitum group.  Lactate 
concentrations in this current study (3.3  W 6.09 mmol.l-1) were above reference values (1.0  W 
3.0; Aitken, 2007), but not significantly different between groups until day 65 where they 
were higher in LPE ewes compared with CP ewes.  In a previous study comparing ad libitum 
feeding to a diet 50% less in calorie intake, lactate concentrations were reduced in the 
lower calorie intake group (2.0 ± 0.4 vs. 3.2 ± 0.4 mmol.l-1; Tanaka et al., 2008).   
Conflicting results between studies make the identification of what are normal 
concentrations during pregnancy somewhat difficult.  For example, one study reported no 
difference in glucose concentrations between pregnant and non-pregnant ewes (Alonso et 
al., 1997) whereas another reported that glucose concentrations were significantly lower in 
pregnant ewes (Lindsay et al., 2005).  However, in nutritional studies where ewe weight 
during pregnancy may be affected by reductions in nutrient intake, the blood metabolites 
such as glucose, triglycerides, lactate, and total proteins remain largely unaffected 
(McMullen et al., 2005; Tanaka et al., 2008; Sosa et al., 2009).  In a study of adolescent 
sheep which had previously been over-nourished during early pregnancy (Redmer et al., 
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2012) subsequent under-nutrition during late gestation had no significant effect on 
metabolites, with the exception of NEFAs, which were raised in the low dietary intake 
group, a finding that was replicated in a study considering a global nutrient restriction in 
mid-gestation (McMullen et al., 2005), and in this current study. 
Surprisingly, the total protein content in maternal plasma was higher in the ewes fed less 
protein in their diets.  In addition, the levels of total protein and albumin in the ewes in this 
study were far lower than those reported in other studies (Dubreuil et al., 2005; Tanaka et 
al., 2008; Khatun et al., 2011), although the latter two reported values far in excess of the 
reference range for sheep (Aitken, 2007) and should therefore be viewed with some 
caution.  One study of young Merino sheep (Lepherd et al., 2009) calculated a lower 
reference range for total protein (51  W 64 vs 60  W 79 g.l-1; Aitken, 2007), suggesting that 
there may be species or age variation; however most of the values in this study still fell 
below this range.  Blood analyses are highly dependent upon the conditions during 
specimen collection (Braun et al., 2010), although these samples were collected in optimal 
circumstances and there is no reason to doubt their validity.   
Physiological adaptations occur during pregnancy to allow the cardiovascular system of the 
mother to adapt to increased metabolic needs to ensure delivery of oxygenated blood to 
the fetus and peripheral tissues (Silversides and Colman, 2007).  A rise in cardiac output 
occurs, alongside a decrease in mean arterial pressure and a rise in plasma volume 
expansion (Longo, 1983; Chapman et al., 1998).  The latter occurs primarily in response to 
oestrogen which in turn stimulates the renin-angiotensin system (Longo, 1983).  In humans, 
plasma volume increases from around 6 weeks (0.15) of gestation (Chapman et al., 1998; 
Bernstein et al., 2001) up to 34 weeks (0.85 gestation), where it plateaus out (Pirani and 
Campbell, 1973).  These changes are also observed in other mammals, including rats 
(Atherton et al., 1982) sheep (Magness et al., 1993), and baboons (Phippard et al., 1986).  
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Although red blood cell mass also increases during gestation (Taylor and Lind, 1979), this is 
in a lesser proportion to the plasma volume expansion; hence haemodilution occurs 
(Silversides and Colman, 2007).  Plasma volume expansion in human pregnancies has been 
shown to correlate with birth weight (Pirani and Campbell, 1973), and this expansion is 
reduced in women with pre-eclampsia or fetal growth restriction (Salas et al., 1993; Salas et 
al., 2006), suggesting that plasma volume expansion is needed to provide an optimum 
uterine environment for the fetus. In this study total plasma volume was not measured, 
however, the concentration of plasma metabolites in LPE together with increased 
osmolality suggests a lack of appropriate plasma volume expansion in the LPE group.  In 
rats, a low protein diet has been demonstrated to result in significantly reduced plasma 
volume expansion compared to control animals (Rosso and Streeter, 1979).  
In the fetal environment, the changes observed in the ewe were not translated in all cases; 
fetal plasma glucose concentration was similar between diet groups.  The increase in 
lactate observed in the LPE ewes (36% higher) was blunted in the fetuses (a 13% increase), 
suggesting that the placenta has a primary role in modifying the nutritional provision to the 
developing fetus and further reiterating that maternal nutrition does not necessarily equate 
to fetal nutrition. 
Glucose, lactate and amino acids are the primary sources of energy for fetal oxidative 
metabolism and growth (Harding, 2001; Bell and Ehrhardt, 2002).  Fetal amino acids are 
generally in higher concentration than those in maternal plasma, although the ratios 
between the two vary both according to the amino acid and the timing of gestation (Kwon 
et al., 2003; Jobgen et al., 2008).  Fetal plasma amino acid concentrations in other 
published studies of sheep (Kwon et al., 2003; Kwon et al., 2004) show some variability 
between the concentrations reported and those found in this study.  Nevertheless, the 
same patterns are observed, with the most abundant amino acids being glycine, serine and 
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threonine, and the least abundant being aspartic acid.  However, in this study lysine 
concentrations were far higher in the control group than in the previous two studies (this 
study, 702 µM; Kwon et al., 2003, 200 µM; Kwon et al., 2004, 272 µM).  In the maternal 
plasma, the pattern of amino acids is replicated in this study and others (Kwon et al., 2003; 
Kwon et al., 2004; Ashworth et al., 2011) with the highest concentrations for alanine, 
glycine and valine and lowest for aspartic acid, although the amounts reported also varied 
between studies.  The only study with published values for amino acid concentrations in 
ovine amniotic fluid (Kwon et al., 2003) showed similar patterns to those in the current 
study with alanine having the highest concentration and tryptophan having the lowest.   
Studies investigating the effects of maternal under-nutrition on maternal and fetal amino 
acid concentrations have shown differing results.  In a sheep model of a maternal 50% 
global nutrient restriction from day 28  W 135 gestation most amino acids were reduced in 
both ewes and fetuses in the restricted group (Kwon et al., 2004).  However in sheep fed 
the same diet from day 28  W 78 only nine of the amino acids were lower in the ewes and 
none were significantly different between the control and nutrient restricted fetuses 
(Jobgen et al., 2008).  This may reflect differences between breeds of sheep, as one of the 
studies used Colombian/Suffolk crosses (Kwon et al., 2004) and the other used Baggs ewes 
(Jobgen et al., 2008); or it may be that the longer duration of nutrient restriction in the 
Kwon study had more effect.  However, a further study looking at the effect of a maternal 
diet with a 25% reduction in energy requirements in two different breeds of sheep found 
that the ewe breed had a greater effect on amino acid concentrations than the restricted 
diet (Ashworth et al., 2011).  
Taken together, the metabolite and amino acid data suggest that there is no consistent 
pattern of change in nutritional substrate that may explain the differences in microvascular 
development of the fetal kidney.  However, the concentration of ornithine was lower in 
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both fetal plasma and amniotic fluid and may well reflect the significant reduction in 
maternal and fetal plasma urea, since ornithine is derived from urea metabolism and urea 
can freely cross the feto-placental unit.  Nitrogen intake is highly correlated with plasma 
urea concentration in sheep (Nolan and Leng, 1970), and a low protein diet in sheep has 
been shown to lead to lower plasma urea in ewes (Rabinowitz et al., 1973).  In all mammals 
nitrogenous waste is excreted in order to prevent accumulation and toxicity (Solomon et 
al., 2004).  During metabolism of amino acids the amino group is deaminated then 
converted to ammonia, and the liver converts the ammonia to urea, which is less toxic and 
easily excreted in the urine (Solomon et al., 2004).  Urea is synthesised by the liver in larger 
amounts than is excreted in the urine, as some of the urea enters the digestive tract and is 
reabsorbed or utilised by microbes as a source of nitrogen to enable the synthesis of 
protein (Sarraseca et al., 1998).  This occurs in all mammals including monogastric species 
such as humans (Jackson, 1995), pigs (Torrallardona et al., 1994) and rats (Torrallardona et 
al., 1996); however in ruminants, the large number of microbes in the forestomachs 
enhances this effect (Sarraseca et al., 1998). 
Other nutritional studies in humans (Meakins and Jackson, 1996) and sheep (Whitelaw et 
al., 1990) have shown that a reduction in protein intake leads to urea-nitrogen production 
exceeding nitrogen intake and this is effected through mobilisation of protein stores and a 
negative nitrogen retention.  In a study of sheep fed either a control diet or low protein 
diet, although nitrogen intake was nearly 60% lower in the low protein group, the effect on 
microbial protein synthesis was negligible (Tebot et al., 2002), suggesting that urea is 
recycled to meet the needs of the animal rather than being excreted.  During pregnancy 
there is an increased need for protein to meet the needs of the placenta and fetus, 
hoǁĞǀĞƌ ?ƚŚŝƐĐĂŶďĞŵĞƚĨƌŽŵƚŚĞŵŽƚŚĞƌ ?ƐŽǁŶŶƵƚƌŝĞŶƚƌĞƐĞƌǀĞƐŝŶůĞĂŶĂŶĚĨĂƚƚŝƐƐƵĞŝŶ
addition to that provided by the diet (Duggleby and Jackson, 2002), therefore it is to be 
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expected that a reduction in dietary protein may lead to greater utilisation of these 
reserves as a compensatory mechanism. 
To conclude, this second study has confirmed the findings from study 1, i.e. a maternal low 
protein diet leads to a reduction in angiogenic factors, such as VEGFA.  This has an impact 
on blood vessel development, but at the micro- rather than macro-vascular level, as 
evidenced by CD34+ staining of endothelial cells in the peritubular and glomerular 
capillaries.  In addition, despite few changes in amino acid concentrations, a pathway from 
lower urea to reduced ornithine concentrations in the LPE group compared with controls 
has been identified.   
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6. Final Discussion 
This thesis has described the effect of mild PEM on the ewe and her fetus, and how the 
fetus is particularly sensitive to PEM during early but not late gestation.  In addition it has 
described how PEM blunts microvascular, but not macrovascular development of the fetal 
kidney and how the effects of PEM carry through to a structurally and functionally 
compromised adult kidney when challenged by obesity.  
The potential implications of the work are relevant for those individuals born to mothers 
with varying degrees of PEM which may retain residual, asymptomatic effects of the 
maternal nutritional imbalance within their kidneys.  These effects may manifest later in life 
as an early onset of CKD, especially when coupled with the ever-increasing likelihood of 
having to adjust metabolically to an obesogenic adult environment.  
In this study of PEM in sheep, despite a 50% decrease in the availability of protein (8.7 vs. 
 ? ? ? ?Ő ?ŬŐ-1 ?MJ) fed to pregnant ewes, there were few effects of the diet on maternal weight, 
her body condition score or on fetal body or organ weights at 0.44 gestation or at term, 
suggesting the overall dietary regimen to be modest.  As described in chapter 4 this differs 
from rodent studies  where a similar degree of protein restriction has resulted in 
disproportionate fetal growth (Langley-Evans et al., 1996), low birth weight (Zeman, 1967, 
Desai et al., 1996, Levy and Jackson, 1993) and a 20-50% deficit in nephron endowment in 
the kidney (Hoppe et al., 2006, McMullen et al., 2004, Vehaskari et al., 2001).  In this study 
only a small (~15%) reduction in nephron number was observed in LPE animals, although 
this was coupled with a larger (~45%) compensatory increase in mean glomerular volume.  
The likely explanation is first due to allometry: larger mammals like sheep and humans have 
a lower surface area:volume ratio and a greater metabolic reserve capacity compared to 
smaller mammals and are therefore more able to adjust metabolically to nutritional deficit.  
Secondly, as sheep usually carry singletons or twins the anabolic demands required to 
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support the utero-placental unit are much lower relative to rodents with large litters 
(McCance and Widdowson, 1986).  Hence, nutritional paradigms in laboratory animals are 
likely to present a more severe phenotype, due to the relatively greater impact of 
malnutrition.  
 Although few consistent effects on metabolites or amino acid concentrations were 
observed in this study, one key metabolic cycle appeared to be affected: the urea cycle.  
Previous studies have shown a link between protein intake and urea production in sheep 
(Payne and Morris, 1969, Rabinowitz et al., 1973) and that is also reflected in this current 
study.  In the pregnant ewes in this study, urea was decreased in both the maternal and 
fetal compartments in the LPE group compared with controls, probably due to the ingested 
protein being utilised to meet the needs of the developing fetus as well as those of the 
ewe.  In addition, another important intermediate the urea cycle, ornithine, was also 
reduced in the LPE fetuses compared with controls, in both amniotic fluid and fetal plasma.  
As ornithine is a precursor of polyamines, which are involved in the key processes of 
proliferation and differentiation during fetal development (Heby, 1981, Thomas and 
Thomas, 2001, Childs et al., 2003), future work will investigate this more deeply. 
Despite relatively few differences between the groups in terms of nutritional variables, the 
mild maternal PEM did have an effect on the fetal environment, with a significant impact 
upon the fetal kidney, an organ that is undergoing hyperplastic growth during that time.  
This is emphasised by the observation that for Group LPL which experienced a longer 
period of maternal protein restriction (day 65  W term) spanning almost the entire period of 
hypertrophic growth of the fetus, there was no consistent renal phenotype.  This study is 
the first to demonstrate a renal phenotype in large animals after changes to the 
macronutrient composition of the maternal diet and it suggests that the protein-energy 
ratio of the maternal diet (i.e. diet quality) is more important in terms of developmental 
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programming than a balanced reduction in nutrient intake.  The lack of effect of a global 
nutrient restriction on kidney development is also reported in other species (Brennan et al., 
2005, Braddick et al., 2011).  This clearly has in the context of the marked changes in 
nutritional quality and macronutrient balance that have occurred over the last 50 years, in 
the UK (Prynne et al., 1999) but also elsewhere. 
In a rodent study (Welham et al., 2002), a potential mechanistic pathway to explain loss of 
nephrons with maternal protein restriction was suggested: increased apoptosis of 
mesenchymal cells (either nephron progenitor or interstitial supportive cells).  However, 
the determining factor remained elusive.  Here, these findings are for the first time 
replicated in a large animal model and demonstrate a potential mechanism in which fetal 
kidneys exposed to a maternal low protein diet had increased apoptosis and decreased 
angiogenesis in the nephrogenic zone.  Whilst previous work has shown how one or other 
of these pathways may be influenced by maternal nutrition (Welham et al., 2002, Cox et al., 
2006) this study shows a consistent effect on both.  Taken together, the data suggest that 
maternal PEM specifically limits fetal intra-renal vascularity, resulting in blunted 
nephrogenesis and restricted nephron endowment of the permanent kidney.  These effects 
are asymptomatic until revealed later in life when the adult sheep is exposed to an 
obesogenic environment and renal dysfunction becomes apparent.  
The extent of the renal dysfunction in LPE, demonstrated through microalbuminuria and 
blunted intra-renal transit of a radionuclide, is subtle but, considering the age of the 
animals (young adults), is significant.  Microalbuminuria is a good early predictor of later 
renal disease (Viberti et al., 1982, Mogensen et al., 1995) and the likelihood is that this 
programmed phenotype would deteriorate with age as GFR declines with age, even in a 
normal population (Coresh et al., 2003).  However, without aged sheep this is only an 
assumption, although a programming study of humans exposed to famine in the early 
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stages of pregnancy also revealed microalbuminuria in middle age (Painter et al., 2005).  In 
this current study, microalbuminuria in LPE animals was an indicator of reduced renal 
barrier function.  This is partly due to single-nephron hyperfiltration which occurs with 
obesity (Williams et al., 2007) but may also have been exacerbated in this study by reduced 
nephron number, increased intra-renal pressure, and microvascular rarefaction.  
Microvascular rarefaction in LPE animals compared with controls occurred during 
adulthood, and to a lesser extent during fetal development, suggesting that although 
microvascular development is blunted by the LPE diet during development, it is 
exacerbated by other factors in the adult such as obesity (Frisbee, 2005, Pasarica et al., 
2009).  With no clear difference in gross renal morphology, inflammatory infiltration or 
indices of intra-renal stress, the functional deficits in LPE (both males and females) suggest 
Minimal Change Disease, perhaps due to podocyte effacement (Haraldsson et al., 2008, 
Veron et al., 2010).  However, lack of appropriately fixed tissue for transmission electron 
microscopy precludes this possibility being explored.  Nevertheless, the molecular and 
immunohistochemical data for the adult animals (increased VEGFA) suggest greater support 
for a compromised renal barrier:  VEGFA is highly expressed in podocytes, plays an 
important role in establishing and maintaining the glomerular barrier (Eremina et al., 2008) 
and when overexpressed, is associated with glomerular disease in mice (Veron et al., 2010) 
and impaired angiogenesis in rats (Kang et al., 2001).  
Finally, in the first fetal study, many aspects of the adverse renal phenotype described 
appeared to be sex-specific, that is the effect was greater in males than females (e.g. the 
reduction in angiogenic factors in the male LPE fetal kidney).  A sex effect in the 
experimental endpoints of studies examining relationships between maternal diet and 
offspring phenotype (males being adversely affected more often than females) is not 
uncommon (Grigore et al., 2008).  These effects are unlikely to be due to differences in the 
plasma concentration of sex-hormones (very low in the fetus, and the male adult offspring 
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were castrates) but could be related to growth since male fetuses and offspring grow at a 
faster rate than females (seen at day 65 gestation and in fractional growth rate postnatally).  
Faster growing animals may be more susceptible to deficits and/or changes in the pattern 
of substrate supply, in particular of amino acids.  Alternatively, the effect may be a product 
of nutritionally-induced sex-specific epigenetic programming  W a paradigm recently 
described in bovine blastocysts (Bermejo-Alvarez et al., 2010) but also in adult sheep 
(Sinclair et al., 2007).   
However, in this current study at two years of age, the sex-specific programming of the 
kidney was less evident.  The study was powered to reveal sex-specific differences in renal 
function (e.g. transit-time) as the primary outcome.  Thus, if any clear sex-specific 
differences in renal function and molecular end-points were to exist they would have been 
revealed with the study design.  The second fetal study indicated there were no sex-specific 
effects, and this taken in  conjunction with the adult data would seem to suggest that the 
sex-specific effects revealed in the first fetal study were the result of a type I error.  
Nevertheless, an adult renal phenotype has been described that indicates a specific effect 
of maternal low protein acting during early development of the fetal kidney.  A suggestion 
for a potential mechanism at this time is that it is mediated through the key nexus for 
control of angiogenesis, VEGF.  
Future work will aim to determine the nature of the relationship between maternal PEM, 
the fetal nutritional environment and organ growth by studying other organs, such as the 
liver, to see whether the effects seen in the kidney are common to other developing 
organs.  In addition, as ornithine was identified as the key amino acid reduced by the low 
protein diet, this warrants further investigation.  Aside from its role in the urea cycle, 
ornithine is also a precursor for the synthesis of the polyamines putrescine, spermine and 
spermidine (Wu and Morris, 1998).  Polyamines have a variety of roles, including the 
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regulation of cell proliferation (Porter and Bergeron, 1983) and differentiation (Heby, 
1981), and therefore if levels of polyamines were reduced in LPE animals compared to 
controls this may be another mechanism which affects fetal development.  Thus levels of 
polyamines in amniotic fluid and fetal liver will be measured.  
To conclude, PEM is highly prevalent in developing countries (WHO, 2011), and also  to 
some degree in women in westernised countries who suffer from pregnancy-induced 
nausea (75-90% of women) and who may as a result experience some degree of 
macro/micronutrient deficiency (Fejzo et al., 2009).  This current study has shown that PEM 
at this time may specifically affect the developing fetal kidney by limiting renal 
vascularisation and nephrogenesis. This may have functional consequences later in life, 
exacerbating the age-related decline in renal function.   
In the scientific literature there are no reports of a new nephron forming in its entirety in a 
mammalian adult kidney.  As the adult kidney has such limited opportunity for repair 
compared with other organs, it is vital to understand those processes which adversely 
affect kidney development.  With the prevalence of renal morbidity increasing by ~5% per 
annum, largely through the increased prevalence of obesity and type II diabetes (Lysaght, 
2002), a clinical focus on a good, balanced and high quality maternal diet during pregnancy 
as a potentially modifiable risk factor may help to mitigate a proportion of the expected 
cases of CKD in the future. 
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